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Cardiovascular disease and dysfunction (CVD) are leading causes of Intensive Care 
Unit (ICU) admission, costs, and mortality worldwide. Aging populations demand 
increasingly personalised and optimised cardiovascular care in the ICU to meet demand 
for more care at lower costs. However, inadequate or incorrect diagnosis of cardiac 
disturbances resulting in increased length of stay, cost and mortality is an ongoing 
issue.  
Cardiac management in the ICU is informed by measurements taken from a variety of 
instruments, such as catheters placed near the heart. However, despite the rich 
information available from such instruments, their use is not necessarily associated 
with improved clinical outcomes. This discrepancy may be due to the clinical 
simplification of instrument outputs into lumped metrics that can be easily and rapidly 
parsed, but fail to preserve much of the initially gathered, patient-specific information. 
Thus, patient-specific information is lost and care is titrated based on population driven 
metrics, reducing the potential quality of care. Hence, improvement in the extraction 
of patient-specific cardiac information from these instruments has the potential to yield 
significant patient-centred, social, and economic value from clinically available data 
that has potentially been under-utilised to date. 
This thesis develops a patient-specific modelling framework for the non-additionally 
invasive clinical estimation of a number of key, interlinked, and patient-specific 
cardiovascular metrics, including the end-systolic pressure-volume relation (ESPVR), 
pressure-volume (P-V) loop, unstressed or ‘dead space’ ventricular volume (Vd), time-
varying elastance (TVE), and end-systolic elastance (Ees). These metrics are already 
accepted parts of clinically standard frameworks of understanding the underlying 
physiological behaviour of the circulatory system. However, they are not currently 
available in the ICU, forcing clinicians to make links between simple, observed 
xv 
 
parameters and these metrics using their own mental models of understanding, 
experience, and intuition.  Hence the provision of these particular patient-specific 
metrics from clinically available measurements in the ICU has the potential to provide 
significant benefits in clinical decision making, and personalisation of care, at little 
additional cost by leveraging models and computation. 
This thesis further explores directly extracting information about the condition of the 
systemic circulation from various commonly measured pressure waveforms. In 
particular, relationships between the aortic, femoral and central venous pressures are 
explored through the medium of both transfer functions and a simple waveform 
energetics framework. The goal of this additional research is to provide further simple, 
intuitive and clinically sensitive metrics of systemic circulation condition from 
commonly available clinical data. 
Each area of study is validated across two experimental animal trial data sets. These 
data sets encompass several popular clinical interventions in cardiac and circulatory 
management, such as fluid resuscitation, the administration of inotropic drugs, and 
recruitment manoeuvres. They also include an animal model of septic shock, which is 
a leading cause of acute circulatory and/or cardiac failure. In each case, a wide variety 
of information was invasively measured, allowing direct validation of model generated 
outputs against direct, invasively measured equivalents. Additionally, the interventions 
and conditions selected were designed to provide a diverse and challenging range of 
cardiovascular states, ensuring an overall robust and rigorous validation of each metric, 
model and method developed. 
Overall, this thesis provides a coherent, interlinked framework for the non-additionally 
invasive model-based estimation of patient-specific and time-specific cardiovascular 
metrics central to titrating clinical care. The provision of these metrics in the ICU has 
the potential to optimise patient monitoring, aid real-time clinical decision making at 
xvi 
 
the patient bedside, and provide personalised care, closing the gap between the 
conceptual models of understanding a clinician relies on, and the surface level 
measured and summarised metrics clinically available. In essence, using available data, 
models and computation to create a much clearer physiological and patient-specific 











This first chapter provides a broad overview of the current state of the medical industry, 
the significance of cardiovascular disease, both within this industry and in general, and 
the state of current research surrounding diagnosis and treatment of cardiovascular 
disease. This overview is used to place the research goals, laid out in the second half 
of the chapter, in context. 
1.1 General Background 
1.1.1 Cardiovascular Disease and the Intensive Care Unit 
Cardiovascular disease and dysfunction (CVD) are leading causes of illness, mortality 
and healthcare associated costs worldwide. CVD was responsible for 31% of global 
deaths in 2013, and the estimated worldwide cost associated with CVD in 2010 was 
$863 billion USD, accounting for approximately 1.39% of gross world product in the 
same year [1]. Further, cardiac events are estimated to account for over 50% of 
postoperative deaths [2, 3]. CVD can occur in many areas of the cardiovascular system 
(CVS) due to a wide variety of causes including age, congenital defects and illness. 
Because of its prevalence, CVD is a leading cause of intensive care unit (ICU) 
admission [2, 4-8], including both patients who require cardiac and circulatory 
monitoring for disease or dysfunction [9-11]  and intraoperative complications [3, 11, 
12]. The estimated medical cost associated with CVD in the US is approximately $273 




This rapid escalation in costs, driven by rising obesity, sedentary lifestyles, and, 
predominantly, aging populations, means management and treatment of CVD patients 
in the ICU will continue to be a major clinical and economic burden for the foreseeable 
future. 
1.1.2 Patient Monitoring in Intensive Care 
Patients admitted to the ICU with CVD generally require intensive monitoring and 
support [14-16]. A number of instruments are typically attached to an ICU patient to 
assess their cardiac and haemodynamic condition in real time. These measurements 
include electrocardiograms (ECGs), which measure the electrical signals generated by 
heart muscle activation, in addition to various catheters that measure blood pressure 
and/or flow [17]. Current clinical decision making takes into account metrics derived 
from these instruments such as cardiac output, mean or peak arterial or venous 
pressures, heart rate and blood oxygenation to assess patient condition and titrate dose 
[16, 18]. The goals of using haemodynamic monitoring to inform decision making are 
[15]: 
 Haemodynamic monitoring can be used to identify disease or cause of 
dysfunction, even if the link between the monitored variable and dysfunction 
are unclear. 
 Haemodynamic parameters can be used to define cardiovascular state, thus 
restoration of these parameters to their normal values should improve tissue 
perfusion and patient outcomes. 
 Haemodynamic parameters can be used to drive goal-directed therapy in a 
clear, consistent manner. 
However, despite the rich information available from many of the instruments 
employed, such as arterial catheters, their use is not necessarily associated with 
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improved clinical outcomes [19, 20]. This perhaps unexpected result occurs because 
the information gained from these measurements is not always recorded or used 
effectively [21]. For example, while continuous measurement of the entire arterial 
pressure waveform is common, treatment is typically titrated based on discrete, 
intermittently used measures derived from this waveform, such as peak or average 
systolic and diastolic pressure. Thus, potentially clinically useful information in the 
shape of the arterial pressure waveform is lost [22]. Similarly, the monitoring of stroke 
volume and cardiac output have been shown to have little effect on clinical outcomes 
[15, 23], despite the clear importance of these metrics as indicators of cardiovascular 
health and function. 
There are a number of potential causes for this outcome. One major cause is the limits 
of human ability to process multiple sources of information simultaneously. The human 
mind can simultaneously track only three to four variables effectively [24], and the 
volume of information presented to clinicians in an ICU environment is often far 
greater than this number, which is easily surpassed by data dense waveforms. This 
difficulty drives the simplification of information, such as catheter waveforms, into 
mean and peak pressures that clinicians can parse rapidly, and be fit easily to population 
based care guidelines.  
The need for simplification of information from instrumentation will not change. 
Specifically, the human mind is simultaneously a superior decision making machine to 
a computer, but unable to parse as much information. The potential use of 
cardiovascular modelling to extract more meaningful, clinically relevant, yet still 
simple, metrics from the wealth of information available in an ICU is thus of great 
interest. The ability to transform, with models, waveform data into metrics providing a 
clear physiological picture, and to present these metrics to the clinician for decision 
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making, provides a means of mitigating this issue and best utilising the advantages of 
both. 
However, for current clinical practice, the standard approach frequently relies on “one 
size fits all” protocols [25] for general populations, which titrate care based on single, 
localised metrics and generalised targets that often fail to provide a full picture of 
cardiovascular health [26-29]. These protocols, while sometimes beneficial across an 
entire population, can be excessively simple and actually harm individual patients [30]. 
The alternative is relying purely on rules-of-thumb, clinical surrogates of the desired 
treatment target, and ultimately clinical experience to select and dose therapies [31], 
which leads to variable care between ICUs and quality of care highly dependent on a 
clinician’s experience and expertise  [32].  
Thus, inadequate or incorrect diagnosis of cardiac disturbances resulting in increased 
length of stay, cost and mortality is an ongoing issue [33, 34]. Simultaneously, there is 
sufficient individualised information available, but unused in the ICU, to titrate patient 
care within a standardised framework on a more patient specific basis [35-39]. As 
expressed in a recent overview of ICU Haemodynamic Monitoring, “the quest for the 
holy grail of non-invasive cardiac output assessment methods continues” [40]. 
1.1.3 Model Based Patient Care 
The applicability and efficacy of a model based approach to assisting clinical decision 
making and patient care have already been demonstrated in the field of glycaemic 
control [35-39], among others [25, 41-43]. Ideal model based methods for 
haemodynamic monitoring should avoid requiring additional invasive instrumentation 
of the patient and increasing the workload of clinicians, while simultaneously providing 
real-time, clinically relevant and easily interpretable metrics at the patient bedside. In 
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such a case, improved, patient specific understanding of a patient’s disease state and 
response to care could be provided at little extra cost or effort.  
Thus, there is significant potential, and a definite need, for new model-based 
approaches to help ICU clinicians optimise and customise treatments for each 
individual patient, based on their specific state and response to treatment and without 
requiring any additional, invasive measurements [25, 44, 45]. This non-additionally-
invasive model-based approach would combine information from various, commonly 
measured ICU metrics and synthesize this data into meaningful information pertaining 
to the normally obscured internal dynamics of the heart and circulation. Such a model-
based approach would help create a clear physiological and patient-specific picture that 
would improve clinical decision making. The end outcome would provide improved, 
personalised care and thus help ease the significant economic and human cost 
associated with ICU care of patients with CVD [8]. 
1.2 Goals of this Thesis 
The aim of this thesis is to develop a simple, patient-specific modelling framework for 
the CVS to improve information extraction and synthesis in critical care. Rather than 
modelling the entire circulatory system, which, while having a lot of promise, can 
create issues with over-parameterization, parameter trade-off and identifiability, this 
research takes a different approach. Specifically, the research in this thesis seeks to 
combine a number of open loop estimation methods, which avoid simultaneous 
parameter identification, and a clinically standard framework of understanding the 
underlying behaviour of the circulatory system.  
Thus, this thesis looks at direct estimation of the interlinked concepts of the end-
systolic pressure-volume relation (ESPVR), pressure-volume (P-V) loop, unstressed or 
‘dead space’ ventricular volume (Vd), time-varying elastance (TVE) and end-systolic 
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elastance (Ees). This set of physiological metrics are part of the physiological 
framework used to define the fundamental functioning of the heart, and frequently 
employed by clinicians as a way to understand and predict the underlying behaviour of 
the CVS [46]. However, due to direct measurement requiring invasive instrumentation 
not employed in the ICU, these metrics are not clinically available. Thus, clinicians 
must make the link between observed parameters, such as heart rate, and mean and 
peak arterial pressures, and these metrics reflecting underlying CVS behaviour using 
their own mental models of understanding, experience, and intuition.  
As such, using simple, localised modelling to estimate these underlying metrics tied 
directly to heart function, rather than relying on direct clinical interpretation of 
observed metrics, has potential to provide significant benefits in clinical decision 
making. The approach presented in this thesis uses computer modelling to draw a wider 
base of relevant information from the large variety of metrics and full waveforms 
measured in the ICU, and uses this information to provide simple, clinically familiar, 
but far more physiologically relevant parameters, directly to clinicians. It thus seeks to 
maximise the utility of the information already available to clinicians to improve 
insight and decision making. 
The focus of the thesis on the left heart was motivated by several reasons. First, the left 
heart is considerably larger than the right heart, and tends to dominate the coupled 
relationship between the two [46]. Thus, while it is possible to model the left heart as 
independent from the right heart, modelling the right heart must take left heart 
behaviour into account. Second, the left ventricle outputs blood into the systemic 
circulation, which interacts with every major organ in the body, while the right heart 
outputs blood into the pulmonary circulation, which interacts solely with the lungs [46]. 
Finally, instrumentation is more commonly clinically available in the larger and more 
easily accessible arteries and veins of the systemic circulation as opposed to the smaller 
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and more difficult to access arteries and veins of the pulmonary circulation [47-49]. 
Thus, the left heart is a relatively independent and extremely important component of 
the circulatory system, with a relative wealth of associated clinically available data. 
Further work in this thesis explores the direct extraction of information from several 
commonly measured arterial and venous waveforms, and the relationships between 
them. Specifically, the relationships between aortic pressure, femoral pressure and 
central venous pressure, all of which reside in the systemic circulation, are explored. 
These relationships are used to provide several new metrics, derived from a simple 
wave energetics approximation, which provide indications of the behaviour and 
condition of the systemic circulation, rather than the heart. These metrics have the 
potential to aid in diagnosis of conditions such as distributive shock, which primarily 
effect the peripheral circulation. 
The work in this thesis is validated over two experimental animal trial data sets 
encompassing a variety of common clinical interventions such as recruitment 
manoeuvres, fluid resuscitation, and the administration of inotropic drugs, as well as a 
model of septic shock. These data sets provide a wide variety of invasively measured 
information, allowing direct validation of derived metrics against invasively measured 
metrics where relevant. Further, these data sets include interventions and disease states 
specifically designed to challenge model assumptions and provide a diverse range of 
circulatory states, conditions and levels of health encountered in the ICU, ensuring a 
rigorous validation of the model work. 
1.3 Overview 
This thesis is broadly structured as follows: 
Chapters 1 – 2 provide background and context for the content of this thesis. 
Specifically, Chapter 1 provides an overview of the relevant aspects of current clinical 
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practice and the problem of CVD, and places the thesis goals in context relative to 
these. Chapter 2 provides a summary of relevant cardiovascular physiology, and details 
the experimental protocols used to gather the data employed throughout this thesis 
Chapters 3 – 6 develop a modelling framework for the estimation of the TVE curve and 
several related metrics. Specifically, Chapter 3 develops a simple model with a fixed 
shape for estimating TVE. Chapter 4 develops a means of non-additionally invasively 
estimating Vd. Chapter 5 develops a means of non-additionally invasively estimating 
end-systolic and end-diastolic volumes beat-by-beat. Finally, Chapter 6 combines the 
work of Chapter 4 and 5 to estimate the beat by beat left ventricular pressure and 
volume profiles, and use these to estimate TVE without assuming an underlying shape. 
Chapters 7 – 8 look at alternate uses and applications for the modelling framework 
developed in Chapters 3 – 6. Specifically, Chapter 7 looks at using the modelling 
framework from Chapter 6 to estimate the P-V loop, rather than TVE. The P-V loop is 
more clinically applicable, but more challenging to estimate accurately than the TVE 
curve. Chapter 8 looks at the estimation of the ventricular volume at zero pressure (V0) 
using an experimentally standard method, explores the linearity of the ESPVR under 
such conditions, and compares the results with those for Vd in Chapter 4. 
Chapters 9 – 10 explore an alternative approach to providing clinical metrics for 
diagnostic aid. Here, arterial and venous waveforms are directly compared using a 
simple waveform energetics approach. Chapter 9 explores the use of transfer functions, 
which demonstrate physiologically expected relationships but provide spectra as 
outputs that are too difficult to rapidly and easily interpret. Chapter 10 explores using 
a simpler framework where each waveform is treated as a pulse subject to a phase shift, 
amplitude offset and scaling factor. Here, simple metrics which are shown to be 
consistently sensitive to changes due to septic shock are developed, but require further 
validation against current, clinically standard metrics. 
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Finally, Chapters 11 and 12 provide a summary of the contents of this thesis and their 
overall implications, as well as discussing several possible avenues to extend and 










Physiology and Experimental Data 
An important foundation for any research into modelling the cardiovascular system 
(CVS) is the vast amount of existing knowledge about the functioning of this complex 
and vital physiological system. The first half of this chapter provides an overview of 
the CVS along with various methods and metrics used to describe it. The second half 
of this chapter provides details on the experimental data sets and protocols that were 
used as the basis for the research in this thesis. 
2.1 Physiology 
The CVS serves the purpose of circulating blood throughout the tissues of the body. 
Blood is used to carry oxygen and other nutrients to, and to extract waste products 
from, these tissues. The CVS can, broadly, be broken into 3 components, as shown in 
Fig. 2.1. These first of these components is the pulmonary circulation, encompassing 
the lungs and blood vessels leading to and from the lungs where carbon dioxide in the 
blood is exchanged with oxygen. The second is the systemic circulation encompassing 
the vessels leading to and from the organs where oxygen is exchanged for carbon 
dioxide and other waste products. The third and final component is the heart, a pump 





Fig. 2.1: Schematic of the three components of the CVS, and interconnecting arteries 
and veins [50]. 
2.2.1 The Heart 
The heart serves as the pump that drives the entire circulatory system, and consists of 
four chambers constituting two parallel pumps. The right side of the heart, 
encompassing the right atrium and right ventricle, pumps deoxygenated blood 
returning from the systemic circulation into the pulmonary circulation for oxygenation. 
Similarly, the left side of the heart, encompassing the left atrium and ventricle, pumps 
oxygenated blood from the pulmonary circulation into the systemic circulation to 
supply the organs.  
Each atrium serves as both an elastic reservoir which prevents the interruption of 
venous flow into the heart during, and a means of aiding in, ventricular contraction. 
The ventricles serve as the ‘pump’ itself, sealable chambers that alternately fill with 
and then forcibly eject blood. The inflow and outflow into each ventricle are controlled 
by a valve that allows flow in only one direction. Inflow into the right ventricle from 
the vena cava in the systemic circulation is controlled by the tricuspid valve (1 in Fig. 
2.2), and outflow into the pulmonary artery controlled by the pulmonary valve (2 in 
Fig. 2.2). Similarly, inflow into the left ventricle from the pulmonary vein is controlled 







controlled by the aortic valve (4 in Fig. 2.2). The two ventricles share a common muscle 
wall called the septum, meaning the ventricles directly interact with one another. 
 
Fig. 2.2: The chambers and valves of the heart [50]. 
2.2.1.1 Electrical Activation of the Heart 
The sequential relaxation and contraction of the chambers of the heart is driven by an 
electrical signal, detectable by an electrocardiogram (ECG) [51, 52]. This signal 
manifests as a distinct, rhythmic pattern of peaks and troughs in an ECG signal, 
corresponding to the electrical activation of different heart chambers, as shown in Fig. 
2.3. The P wave represents the contraction of the atria, which increases preload on the 
ventricles and occurs prior to ejection of blood from the heart. The large peak, referred 
to as the QRS complex, corresponds to the contraction of the left and right ventricles, 
and thus ejection of the blood from the heart into circulation, during which the heart 
serves its primary output function. Relaxation of the atria occurs during the QRS 
complex, and is thus masked by the larger electrical signal associated with the ventricle 









Fig. 2.3: An ideal ECG signal for a single heartbeat [50]. 
2.2.1.2 The Cardiac Cycle 
The beat-by-beat cycle of the heart can be broken down into two regions and four 
segments. Systole encompasses the contraction of the ventricle and ejection of blood 
into the circulation, and diastole encompasses the relaxation and subsequent filling of 
the ventricle. The four segments of the cardiac cycle can be described with regards to 
the pressure and volume in a given ventricle, and form a close loop called the pressure-
volume (P-V) loop as shown in Fig. 2.4. The four sides of the closed loop correspond 
to: filling (near-isobaric volume increase), contraction (near-isovolumetric pressure 
increase), ejection (near-isobaric volume decrease) and relaxation (near-isovolumetric 
pressure decrease). The P-V loop is a fundamental means of expressing information 
about cardiac dynamics and function [46].  
The difference between the maximum (end-diastolic, Ved) and minimum (end-systolic, 
Ves) ventricular volume for a given heartbeat is the stroke volume (SV): 
𝑆𝑉 = 𝑉𝑒𝑑 − 𝑉𝑒𝑠 (2.1) 
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This value corresponds to the volume of blood ejected by the ventricle in a given 
heartbeat. When multiplied by the heart rate (HR) this becomes the cardiac output 
(CO): 
𝐶𝑂 = 𝑆𝑉 ×  𝐻𝑅 (2.2) 
where CO is a measure of the rate at which blood is being supplied to the circulation 
by the heart.  
 
Fig. 2.4: The cardiac cycle, stroke work and stroke volume as described by a P-V 
loop. 
The area enclosed by the P-V loop is the stroke work (SW), an important metric. It is 
sensitive to cardiac dysfunction and corresponds to work done by the ventricle ejecting 




2.2.1.3 Cardiac Elastance 
Ventricular elastance represents the ability of the heart to contract independent of 
loading conditions, and is thus representative of the intrinsic contractility of the heart 
tissue independent of the condition of the surrounding circulatory system. This 
elastance is frequently expressed as a pair of boundary relationships for the P-V loop, 
the end-systolic pressure-volume relation (ESPVR) and end-diastolic pressure-volume 
relation (EDPVR) [55, 56], which are shown in Fig. 2.5. The top left (end-systolic) and 
bottom right (end-diastolic) corners of the P-V loop are bound by the ESPVR and 
EDPVR lines, roughly defining a full set of possible P-V loops for the current 
contractile state, with shifts along the lines caused by changes in loading conditions, 
typically referred to as preload and afterload, which are discussed in Section 2.2.1.4.  
 
Fig. 2.5: The ESPVR and EDPVR, and their relation to P-V loops and V0. 
The gold standard measure of cardiac elastance is the slope of the linear ESPVR, called 
the end-systolic elastance (Ees) [55, 57, 58] and mathematically derived: 
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𝑃𝑒𝑠 = 𝐸𝑒𝑠 × (𝑉𝑒𝑠 − 𝑉0) (2.3) 
where Pes is the end-systolic pressure and V0 is the linear intercept of the ESPVR with 
the x-axis, the ventricular volume at zero pressure. This V0 value is closely related to 
Vd, the unstressed or ‘dead space’ volume of the ventricle [59]. The ESPVR and Ees 
define the maximum pressure that can be produced by the ventricle wall for a given 
amount of volume, and is thus the pressure that can be exerted by the ventricle to eject 
blood, and a measure of how ‘hard’ the heart is able to ‘beat’. Elastance can be 
clinically altered through the use of inotropic drugs [57, 60, 61], which either increase 
Ees to improve SV and CO or, in the opposite case, reduce Ees to reduce cardiac 
workload. 
2.2.1.4 Preload and Afterload 
As mentioned, changes in CVS behaviour for a given contractile state are driven by 
changes in loading conditions. These boundary conditions are commonly expressed in 
terms of preload and afterload. Succinctly, they are measures of cardiac pump priming, 
and the exiting resistance the heart must overcome, respectively.  
Preload represents the loading conditions upstream from the heart, and is strictly 
defined as the maximum extension in a single cardiac cell prior to contraction. It thus 
assesses the circulation’s ability to fill the heart chambers. However, due to the clinical 
unavailability of the cellular definition of the measure, it is more commonly defined by 
the surrogate measure Ved [62]. Increased preload increases ventricular filling and thus 
SV, and vice versa via the Frank-Starling Law (Section 2.2.3.1). Preload is subject to 
various influences, including venous return, venous pressure, and respiration. Preload 
can be clinically regulated by fluid infusion, a common and core ICU therapy in 
circulatory management [30, 63-66], which increases total blood volume and thus 
venous return and pressure [67]. 
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Afterload is the load downstream from the ventricle, against which the ventricle must 
act to eject blood. Technically, it is defined as the maximum stress developed in the 
ventricle wall during ejection. However, this measure is not available directly under 
clinical conditions, so downstream arterial pressure such as Pao is a common surrogate 
[68]. Afterload can be clinically influenced by vasoactive drugs that either broaden 
vascular diameter, decreasing flow resistance and thus afterload, or narrow vascular 
diameter, increasing flow resistance and thus afterload. Again, these drugs are a 
common and core therapeutic approach [11, 66, 69-72].  
Both afterload and preload change according to a variety of cardiovascular, regulatory, 
clinical and disease state influences. They are thus a function of patient response to 
disease, insult, or dysfunction, as well as a clinically managed variable. Overall, 
preload and afterload provide an indicator on the overall state of the CVS, but not 
necessarily a clear metric for specific diagnosis. 
2.2.2 The Circulation 
As previously mentioned, the circulation consists of two parallel loops separated by the 
heart, the systemic and pulmonary circulation. Each loop consists of an arterial system 
which carries blood away from the heart, a dense network of narrow capillaries where 
gas exchange occurs and a venous system that returns blood to the heart. 
2.2.2.1 Pulmonary Circulation 
The pulmonary circulation is, broadly, responsible for carrying deoxygenated blood to 
the lungs where gas exchange occurs, expelling carbon dioxide from the blood and 
introducing oxygen into the bloodstream. This oxygenated blood is then returned from 
the lungs to the heart. The artery carrying deoxygenated blood from the heart into the 
pulmonary circulation is the pulmonary artery, while the vein carrying oxygenated 
blood from the lungs to the heart is the pulmonary vein. While the pulmonary circuit is 
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important, a combination of relatively narrow vessel diameters and integration with 
fewer organ systems than the systemic circulation means instrumentation of the 
systemic circulation is favoured over the pulmonary circulation in clinical practice [47-
49], thus the pulmonary circulation is less of a focus in this thesis. 
2.2.2.2 Systemic Circulation 
The systemic circulation is responsible for carrying oxygenated blood to the various 
organs and tissues of the body, and carrying waste products away from these organs 
and tissues. These waste products are expelled through several means including blood 
filtration in the kidneys, and removal of carbon dioxide from the bloodstream in the 
lungs. The artery responsible for supplying oxygenated blood from the heart to the 
systemic circulation is the aorta, and the vein responsible for returning deoxygenated 
blood from the systemic circulation to the heart is the vena cava. Relative to the 
pulmonary circulation, blood vessels are larger, all organs are integrated, and more 
blood volume resides in the systemic circulation. Clinically, instrumentation is more 
common in the systemic circulation, due to a combination of large vessels making 
instruments easier to insert and the systemic circulation’s direct interaction with a large 
variety of organs making it more likely to contain broad diagnostic information [47-
49]. 
The aorta, as previously mentioned, is the large artery situated directly downstream 
from the left ventricle, separated by the aortic valve. Due to the large diameter of the 
aorta and its direct proximity to the heart, measuring aortic pressure is relatively 
popular in clinical practice [47, 48]. A typical aortic pressure (Pao) waveform, measured 
from a pig, is shown in Fig. 2.6. The Pao waveform is pulsatile, with a steep increase in 
pressure between minimum aortic pressure (MN) and maximum aortic pressure (MX) 
as ventricular ejection occurs while the aortic valve is open and a less steep decrease 
in pressure between MX and MN as the aorta, which is highly elastic, relaxes and 
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continues to force blood downstream during ventricular filling while the aortic valve is 
closed. In this way, the aorta serves to lessen the pulsatile nature of blood flow, 
ensuring a more steady, continuous supply of blood to the systemic circulation. A 
topographical feature of note in the aortic pressure waveform is the Dicrotic notch 
(DN), which is a distinct dip in the aortic pressure waveform that occurs when the aortic 
valve closes as pressure in the left ventricle falls below pressure in the aorta during 
ventricular relaxation. 
 
Fig. 2.6: A typical Pao waveform, where MN represents the minimum aortic pressure, 
MX the maximum aortic pressure and DN the Dicrotic Notch.  
The femoral artery sits downstream from the aorta, and is considerably narrower and 
less elastic [46]. Femoral pressure (Pfe) can be measured as an indicator of ‘peripheral 
pressure’, pressure near the organs, further away from the heart [73]. A typical Pfe 
waveform, measured from a pig, is shown in Fig. 2.7, with a Pao waveform overlaid in 
black. As can be seen, a combination of the elastic action of the arteries and narrowing 
of vessels both smooths the waveform, eliminating the Dicrotic notch, and concentrates 
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it, resulting in typically slightly larger peaks and troughs. Also of note is the time lag 
between MX and MX* and MN and MN*, indicative of the pulse wave velocity in the 
arterial system. Pfe is not as commonly clinically measured as Pao, as the artery is 
smaller and more difficult to locate, and does not necessarily provide additional 
information not available from Pao. 
 
Fig. 2.7: A typical Pfe waveform, with a Pao waveform overlaid in black, where MN 
represents the minimum aortic pressure, MN* the minimum femoral pressure, MX 
the maximum aortic pressure and MX* the maximum femoral pressure. 
The vena cava is situated in the venous system, on the far side of the capillary beds 
from the aorta and femoral artery. A combination of the high flow resistance in these 
capillaries due to their narrow diameter, and the highly elastic walls of the subsequent 
veins results in a significant decrease in flow velocity and pressure in the venous system 
relative to the arterial system. As can be seen in Fig. 2.8, the pressure in the vena cava 
(Pvc) is an order of magnitude lower than that in the arterial system. It is sufficiently 
low, in fact, that a significant portion of the central venous pressure waveform is 
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influenced by downstream behaviour of the right ventricle, rather than upstream 
behaviour of the left ventricle.  
In Fig. 2.8, the ‘A’ peak represents right atrial contraction, where the lack of a valve 
upstream from the right atria combined with the low pressure in the vena cava creates 
slight backflow. The ‘C’ peak is associated with the ventricle contracting and the 
tricuspid valve bulging outwards due to the increase in pressure. Thus, only the area in 
the latter half of the waveform, from the ‘X’ trough to the ‘V’ peak and back to the ‘Y’ 
trough, represents the flow of blood arriving from the left ventricle via the systemic 
circulation. 
 
Fig. 2.8: A typical Pvc waveform, where the ‘A’ and ‘C’ peaks are the result of the 
downstream action of the right heart, while the ‘V’ peak is the result of the upstream 
flow of blood from the left heart. 
These factors combine to make information extraction from Pvc somewhat difficult. On 
the one hand, it serves as an output to the systemic circulation. On the other hand, its 
low magnitude, influence by upstream, as well as downstream behaviour, and the fact 
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that the body seeks to maintain Pvc at all costs, because it is necessary for venous return, 
make its sensitivity to changes in condition a point of ongoing clinical and research 
discussion [30, 74, 75]. 
2.2.3 Cardiovascular Regulation and Interaction 
2.2.3.1 Homeostasis 
Homeostasis refers to the body’s active regulation of various properties to a near 
constant value. The CVS contains a variety of homeostasis mechanisms to ensure 
continual distribution of blood and oxygen to where it is most needed [76]. These 
homeostasis mechanisms act to continually maintain an equilibrium state, perturbed by 
changes in condition or therapy. 
Neural regulation is homeostasis controlled by the autonomous nervous system [46]. 
This regulation acts through two main pathways, the sympathetic nervous system, 
which drives a ‘fight or flight’ response, increasing HR and Ees, and diverting blood 
flow to muscles and lungs, and the parasympathetic nervous system, which drives a 
‘rest and digest’ response, decreasing HR and Ees, and diverting blood to the gastro-
intestinal tract. An example of neural regulation is the baroreflex, a negative feedback 
loop in which elevated blood pressure drives a fall in HR, and thus a fall in blood 
pressure, and vice versa. This process is controlled by baroreceptors, a system of 
pressure sensors throughout the CVS that interact with the sympathetic and 
parasympathetic nervous systems [46]. 
Auto regulatory mechanisms refer to local mechanisms that maintain homeostasis 
without neural oversight. Examples of this form of regulation include circulatory auto 
regulation, where the small arteries in an organ automatically dilate in response to 
decreased perfusion pressure and thus decreased blood flow. The amount of dilation is 
organ specific, with increased dilation in vital organs such as the brain, ensuring that 
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even in the absence of neural regulation blood is diverted to organs where it is most 
needed. Another example of auto regulatory mechanisms is the Frank-Starling law, 
where increased stretching of the ventricle walls due to increased filling causes the 
ventricles to contract more forcefully, ejecting more blood [46, 77-79]. Thus, the 
ventricles act as a ‘demand pump’, ejecting whatever blood is received and ensuring 
output and input into the heart is intrinsically synchronised. 
Finally, humoral regulation refers to the regulation of circulatory behaviour through 
the release and absorption of hormones and ions throughout the body. These hormones 
are typically secreted by specialised glands, and can have either localised or circulatory 
system wide effects, including vasoconstriction and vasodilation. Thus, these 
hormones can be used to regulate both local and global flow resistance, and the 
relationship between pressure and flow throughout the body. 
2.2.3.2 Cardiopulmonary Interaction 
The cardiovascular and pulmonary systems interact in several significant ways. First, 
the pulmonary system is the sole organ system that the pulmonary circulation passes, 
thus changes in pulmonary conditions have a large influence on one of the two loops 
of the CVS. The inflation of the lungs causes the small capillaries in the lungs to stretch, 
increasing pulmonary vascular resistance and thus resistance in the pulmonary 
circulation. The subsequent deflation of the lung during exhalation causes the larger 
arteries and veins in the pulmonary circulation to compress, increasing the resistance 
in these arteries and veins. 
Second, intrathoracic pressure, the common pressure in the thoracic cavity, is highly 
subject to the behaviour of the pulmonary system and acts as an external pressure on 
the heart, as well as proximal arteries and veins. Increased thoracic pressure increases 
pressure in the right atrium and decreases the relative peak ejection pressure of the left 
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ventricle [80-82]. This increase in the downstream, right atrial pressure and decrease 
in the upstream, peak ejection pressure of the left ventricle combine to reduce the 
pressure gradient for venous return, leading to decreased intrathoracic volume. This 
effect is often exacerbated in the ICU by positive pressure ventilation, where a sedated 
subject’s inhalation is driven by an externally applied increase in end-expiratory 
pressure rather than a local, diaphragm driven, decrease in pressure. The outcome of 
this therapeutic choice is an increase in thoracic pressure above what would normally 
be seen in a healthy individual. 
2.2 Experimental Data 
This section details the experimental protocols for the two data sets that were used 
throughout this thesis [59, 83]. All experimental procedures and protocols 
were reviewed and approved by the Institutional Animal Care and Use Ethics 
Committee of the University of Liège, Belgium (Reference Number 14-1726). Their 
guidelines conform completely with the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health (NIH Publication No. 85-
23, revised 1996), as well as EU DIRECTIVE 2010/63/EU on the protection of animals 
used for scientific purposes. 
2.2.1 Protocol D, Dobutamine 
Seven male, pure Piétrain pigs were sedated and anesthetised by an initial 
intramuscular dose of Zoletil 100 (0.1 mL/kg) and Ketamine 1000 (0.1 mL/kg).  
Sedation and anaesthesia was maintained by a continuous infusion of Nimbex (1 
mL/kg/h at 2 mg/mL), Sufenta (0.1 mL/kg/h at 0.005 mg/mL) and Thiobarbital (0.1 
mL/kg/h) via a central venous catheter positioned within the superior vena cava. The 
pigs were mechanically ventilated (GE Engstrom CareStation) through a tracheotomy, 
with a baseline positive end-expiratory pressure (PEEP) of 5 cmH2O and tidal volume 
of 270 mL. The heart was accessed via a median sternotomy, and a micromanometer-
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tipped admittance pressure-volume catheter (Transonic, NY, USA) with a sampling 
rate of 250 Hz inserted into the left ventricle via an apical stab [84, 85]. Proximal aortic 
and femoral pressures were continually sampled using pressure catheters (Transonic, 
NY, USA) with sampling rates of 250 Hz. Euthanasia was performed via a bolus of 
Pentobarbital (30 mg/kg) and Sufentanil (5 µg/kg) causing respiratory arrest. The 
instrumentation set up is shown in Fig. 2.9. 
 
Fig. 2.9: Example experimental equipment set up. 
The dobutamine protocol encompassed: 
 An infusion of dobutamine over a period of 30 minutes. Dobutamine directly 
increases contractility in order to improve cardiac output, and is and is a core 
circulation management therapy [11, 66, 69-72]. 
 Several positive end-expiratory pressure (PEEP) driven recruitment 
manoeuvres (RMs), from 5 cmH2O to 25 cmH2O in steps of 5 cmH2O, both 
pre- and post- dobutamine infusion. RMs drive a change in preload conditions 
and are typically associated with a decrease in mean blood pressure and cardiac 
output [86]. 
 Two vena cava occlusion manoeuvres, performed with a fluid filled balloon, 
at each PEEP level during a RM. Vena cava occlusion manoeuvres cause a 
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sharp decrease in cardiac preload, and can be used to provide a short term 
estimate of the ESPVR [87]. 
 2-6 rapid 225mL saline solution boluses. Infusions were given before and after 
dobutamine infusions. Saline infusions change circulatory volume and 
simulate fluid resuscitation, important components of typical hemodynamic 
management [30, 63-66]. 
The experimentally available waveforms include: 
 Continuous left-ventricular pressure (Plv) from a pressure-volume catheter in 
the left ventricle 
 Continuous left-ventricular volume (Vlv) from a pressure-volume catheter in 
the left ventricle 
 Continuous aortic pressure (Pao) from a pressure catheter in the aorta 
 Continuous femoral pressure (Pfe) from a pressure catheter in the femoral artery 
Issues with the admittance pressure-volume catheter being incorrectly situated in the 
ventricle led to one pig being excluded. A second pig, which was included, suffered 
sensor drift in the Vlv waveform which will be discussed in Chapters 5 and 7. As the 
shape of the Vlv waveform, and the shape and magnitude of all pressure waveforms 
were correct, it was decided to retain this data. Note that not all pigs completed the 
entire protocol, and as such the length of the monitoring period varies across the cohort. 
However, each included dataset consists of at least 5,000 heartbeats of data.  
2.2.2 Protocol S, Sepsis 
Eight male, pure Piétrain pigs weighing between 18.5 and 29 kg were sedated, 
anaesthetised and mechanically ventilated identically to the pigs described in Section 
2.2.1. The heart was accessed via a median sternotomy, and an admittance pressure-
volume catheter (Transonic, NY, USA) with a sampling rate of 250 Hz inserted into 
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the left ventricle via an apical stab [84, 85]. Proximal aortic, femoral and central venous 
pressures were continually sampled using pressure catheters (Transonic, NY, USA) 
with sampling rates of 250 Hz. Euthanasia was performed via a bolus of Pentobarbital 
(30 mg/kg) and Sufentanil (5 µg/kg) causing respiratory arrest.  
The sepsis protocol included: 
 An endotoxin infusion (lipopolysaccharide from E. Coli, 0.5 mg/kg) over 30 
mins, an induced model of septic shock, which causes inflammatory responses 
and capillary leakage, decreasing afterload, leading to hypovolemia, global 
tissue hypoxia,  and cardiac failure [88]. As such, this model of septic shock 
would be expected to cause dramatic changes in the behaviour of the systemic 
circulation. 
 Several PEEP driven recruitment manoeuvres (both pre- and post- endotoxin 
infusion), which drive a change in preload conditions and are typically 
associated with a decrease in mean blood pressure and cardiac output [86]. 
 One to four infusions of 500 mL saline solution over 30 minute periods (both 
pre- and post- endotoxin infusion), simulating fluid resuscitation therapy, a key 
component of hemodynamic resuscitation in patients with severe sepsis, which 
results in a change in circulatory volume [30, 63-66]. 
The experimentally available waveforms include: 
 Continuous Plv from a pressure-volume catheter in the left ventricle 
 Continuous Vlv from a pressure-volume catheter in the left ventricle 
 Continuous Pao from a pressure catheter in the aorta 
 Continuous Pfe from a pressure catheter in the femoral artery 
 Continuous Pvc from a pressure catheter in the superior vena cava 
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Three pigs from Protocol S were excluded due to equipment issues. In one case, the 
admittance catheter was incorrectly situated in the ventricle, in another equipment 
became disconnected and needed to be replaced during the experiment and in the final 
case there was a data acquisition issue. The data from the final case, where there was a 
data acquisition issue, was still usable, but consisted of an extremely large number of 
disjointed data segments with short gaps between them. As such, this data was 
extremely labour intensive to process and make use of, and was only used in Chapter 
4, where the relatively simple, robust modelling required and the unusual and 
ambiguous nature of Vd made the effort involved with including this additional data 
worthwhile. 
 Once sepsis was sufficiently progressed and the various ventricular, arterial and 
venous waveforms became drastically different and largely incoherent, information 
was discarded. Due to the extremely advanced stage of circulatory failure at which this 
level of disturbance to the measurements occurred, this information is likely of no use 
for diagnostic ICU monitoring. Note that not all pigs completed the entire protocol due 
to varying reactions to the endotoxin infusion. As such, the length of the monitoring 
period varies. However, each dataset consists of at least 5,000 heartbeats. 
A summary schematic of the two protocols is shown in Fig. 2.10. 
 
Fig. 2.10: A schematic of experimental protocols D (top) and S (bottom). ‘Dobu’ 
denotes a dobutamine infusion, ‘Endo’ denotes an endotoxin infusion and ‘RM’ 




This chapter provided a comprehensive overview of the aspects of cardiovascular 
physiology and clinical models of understanding that will be relevant throughout this 
thesis. These include the concepts of the P-V loop, elastance and pressure wave 
profiles. Further, this chapter provided a detailed explanation of the two experimental 
protocols used to generate the data sets on which this thesis is validated, as well as any 







Time Varying Elastance 
An existing model for the time varying elastance (TVE) developed by Stevenson et al. 
[89, 90] was used as the basis for this chapter. The approach had previously shown 
promise, but been validated only across a small data set of 80 heartbeats. With a 
considerably larger amount of data now available, the intent of this chapter was to 
perform a large-scale validation of the approach’s performance and sensitivity, and to 
modify the approach based on the results. 
3.1 Background 
TVE is an important means of expressing internal cardiac dynamics and function [55]. 
The TVE curve represents the active elastance changes in the ventricles that drive heart 
contraction, thus providing valuable intra-beat information about cardiac behaviour and 
energetics [55, 91, 92]. The TVE curve has a wide range of potential applications. It is 
often employed as an input in large cardiovascular models that seek to model the entire 
circulatory system [93-97], and also frequently used in the determining of important 
cardiac metrics, such as the End-Systolic Pressure-Volume Relation (ESPVR) [91]. 





where Plv is the left-ventricular pressure, Vlv is the left-ventricular volume, and Vd the 




equivalent to V0, the intercept of the ESPVR with the volume axis [57]. In this chapter, 
Vd is set to 0, as in [89, 90], due to the highly invasive and specialised experimental 
procedures typically needed to establish this subject specific value [55, 57, 98]. The 
maximum magnitude of the TVE curve is usually normalised to a value of 1.0 for 
modelling, serving as an intra-beat indicator of relative, dynamic ventricular elastance, 
and coupled with a separate estimate of End-Systolic Elastance (Ees) [98]. 
There has been more limited investigation into the utility of the TVE curve in isolation. 
The area under the TVE curve is analogous to work done by the ventricle. It is thus a 
potentially significant indicator of patient condition. However, the typical 
normalisation of the TVE curve means only relative changes in work for a given 
inotropic state can be compared.  
The TVE curve relies on a combination of ventricular pressure and volume waveforms 
similar to pressure-volume (P-V) loops. It thus contains information concerning cardiac 
work [53, 54] and contractility [55, 56], both of which change in response to cardiac 
dysfunction.  As such, it has been suggested that the shape of the ventricular elastance 
curve itself may have diagnostic use [44, 89, 90, 99].  
Unfortunately, the TVE curve can only be directly measured by placing catheters into 
the heart chambers, which is, understandably, not common practice. As such, the 
traditional approach to non-invasively generate a TVE curve is to fix it as a population 
based waveform [91, 95, 96]. Most existing work surrounding TVE curves is focused 
on using the TVE curve to estimate a clinical parameter, such as ejection fraction [100], 
and, most commonly, end-systolic elastance [91, 101, 102]. However, these studies are 
validated on correlations with the derived parameter, rather than on the shape and 
change in shape of the TVE curve itself. Thus, these approaches are not validated for 
use as part of a larger model of cardiac dynamics, or for direct use as a diagnostic aid.  
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Previous work specifically focused on experimentally generating a TVE curve and 
validating it based on its correlation with the analytically derived function showed 
promise, and noted changes in the TVE curves during pulmonary embolism and septic 
shock [89]. This previous work, which forms the basis for this chapter, was limited by 
the availability of data for validation [89, 90], a limitation this chapter seeks to alleviate. 
Work has also been undertaken in modelling time varying  ventricular elastance, split 
into active and passive components, in humans [99]. Active elastance was shown to 
compare well with other metrics of contractility, and the properties of these elastance 
curves were shown to change for different disease states. However, this method 
required highly invasive ventricular catheterisation and thus is not broadly 
implementable in a clinical environment. Hence, there is a significant gap created by 
the current clinical inability to directly measure or estimate the TVE curve every beat. 
This chapter presents a validation and concordant modification of a previously 
described approach for estimating the TVE curve [89, 90], taking advantage of a large 
amount of experimental data across multiple porcine subjects, a volume of data 
unavailable in the original study. The approach uses population values to determine the 
majority of the TVE curve, but selects the activation and deactivation timing of the 
TVE curve using strong correlations (R > 0.97) with readily measurable and clinically 
available aortic pressure waveform features. The use of population values in this 
chapter is distinct from the approach presented in [89, 90], which avoids their use. This 
modification of the methodology was driven by a combination of low correlation 
coefficients and low model sensitivity for certain parameters, as established in this 
chapter using the relative wealth of relevant data now available. The modified approach 
presented in this chapter captures the general form of the TVE curve on a beat-to-beat 





3.2.1 Experimental Data 
This chapter makes use of the Protocol D data from all 6 pigs. The waveforms 
employed include continuously sampled aortic pressure (Pao) as a method input, and 
continuously sampled Plv and Vlv to provide the invasively measured TVE curve for 
direct comparison and validation. 
3.2.2 Time Varying Elastance Model 
The general form of the TVE curve was modelled using a phenomenological three-part 
piecewise equation featuring a Gaussian rise followed by a shoulder and subsequent 
Gaussian decay as shown in Fig. 3.1. This phenomenological piecewise waveform, as 
originally described in [89, 90], is uniquely defined using 7 parameters derived from 
desired TVE curve: the time (t1), height (x1) and value (?̇?1) of the maximum positive 
gradient, the height (x2) at the beginning of the shoulder section and the time (t3), height 
(x3) and value (?̇?3) of the maximum negative gradient. 
Using these 7 parameters, the following terms are defined: 

































2log (𝑥3)𝑥3 − ?̇?3𝑡3
?̇?3
 (3.3c) 






 𝑓∝(𝑡) 0 < 𝑡 < 𝑐∝
(1 − 𝑥2)(𝑡 − 𝑐∝)
𝑐𝛽 − 𝑐𝛼
𝑐∝ < 𝑡 < 𝑐𝛽
𝑓𝛽(𝑡) 𝑐𝛽 < 𝑡 < 𝑝𝑒𝑟𝑖𝑜𝑑
 (3.4) 
where: 





Fig. 3.1: An example TVE curve generated using Eq. 3.4. 
36 
 
For consistency and ease of comparison between heartbeats, and as in [98], the period 
t of each heartbeat was normalised to 1, and any comparisons with measured data 
involved a concordant normalisation of the measured heartbeats’ period to 1. 
3.2.3 TVE Curve Correlations 
Fig. 3.2 shows an illustrative plot of several experimentally measured TVE curves for 
every 100th heartbeat over a 50-minute period, a total of 45 TVE curves. This plot 
serves to demonstrate the resemblance between the measured TVE curve and Fig. 3.1 
generated by Eq. 3.4. Additionally, as illustrated in Fig. 3.2, t3 appears to vary more 
significantly than the other parameters and, as will be shown later, has a large influence 
on area under the curve error. Parameter x2, the ‘shoulder height’, also exhibits notable 
variation in measured waveforms. 
 
Fig. 3.2: Experimentally measured TVE curves over a 50-minute period. 
Distinct from the methodology presented in [89, 90], the decision was made to explore 
fixing several parameters based on population values, taking advantage of the relative 
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wealth of data available in this study and seeking to address relatively poor correlation 
coefficients and ambiguous physiological relationships in the correlations originally 
used to derive some parameters, which sometimes performed poorly on the broader 
data set employed here. To determine which parameters should be fixed and which 
should be derived from correlations to other measurements to provide the greatest 
approach accuracy for least complexity, a parameter sensitivity analysis was 
conducted. This was performed by using nonlinear least squares (Levenberg-Marquardt 
as implemented by MATLAB’s lsqnonlin function, R2014a, 64-bit, The Mathworks, 
Natwick, MA, USA) to find the ideal value for each parameter, and then varying these 
ideal values by 10% while holding all other parameters constant. Error was calculated 
by taking the absolute value of the difference between the estimated and measured TVE 
curves at each point, and normalising based on the area under the measured TVE curve, 
providing a lumped, normalised indication of the difference in shape between the 
measured and estimated curves. An example of the error area (shaded) between an 
estimated and measured TVE curve is shown in Fig. 3.3. In this example the error is 
8%. 
Using the results from the sensitivity analysis, the parameters t1 and t3 were identified 
as having significant influence on error, thus selected for beat-by-beat correlation. 
These parameters were assessed over a development cohort of 2 pigs (38,106 
heartbeats), and strong correlations with aortic pressure waveform features were 
evaluated for both. To provide a point of comparison, fixed median values for t1 and t3 
were generated across the same development cohort of 2 pigs. These median values 
were calculated for normalised heartbeat lengths and then scaled on a beat-to-beat basis 




Fig. 3.3: Example of error (shaded area) between measured and estimated TVE 
curves. 
3.2.4 Evaluation of Results 
Error was calculated, as in Section 3.2.3, by taking the absolute value of the difference 
between the estimated and actual TVE curves at each point, and normalising based on 
the area under the curve of the estimated driver. The errors were evaluated over a test 
cohort of 4 pigs (54,410 heartbeats), entirely independent from the 2 pigs used in the 
development cohort, although subject to the same protocol. The errors associated with 
TVE curves generated using the dynamic, correlated values for t1 and t3, and those 
associated with the fixed median values for t1 and t3 were calculated for each heartbeat 
and compared to determine whether the dynamic timing resulted in a significant 






3.3.1 Sensitivity Analysis 
The results of the sensitivity analysis of TVE curve error to changing parameters are 
shown in Fig. 3.4, where the box represents the 25th and 75th percentile values, and the 
'whiskers' the 5th and 95th percentile values.  It is clear that the activation and 
deactivation timings of the TVE curve (t1 and t3) are large contributors to area under 
the curve error. Thus, accurate identification of these timings is important to deriving 
an accurate TVE curve. It is also worth noting that a modest 8% median error remains 
even when all parameters are fitted using nonlinear least squares due to model data 
mismatch. 
 
Fig. 3.4: Error sensitivity to different parameter changes for a 10% change from 
optimal values. ‘None’ denotes no parameter variation and thus minimal model error. 
The 5th percentile error for non-ideal cases occasionally being lower than for the ideal 
case is due to the broader error distribution in non-ideal cases resulting in fewer 




3.3.2 TVE Curve Correlations 
Using 38,106 heartbeats across the 2 pig development cohort, t1 was confirmed to have 
a strong, 1:1 correlation with the timing of the minimum aortic pressure (R = 0.972) 
and t3 a strong, 1:1 correlation with the timing of the Dicrotic notch (R = 0.997) as seen 
in Fig. 3.5. These strong, physiologically expected 1:1 correlations were used in the 
approach: 
𝑡1 = 𝑡𝑚𝑖𝑛(𝑃𝑎𝑜) (6a) 
𝑡3 = 𝑡𝐷𝑁 (6b) 
As the minimum aortic pressure occurs directly before the aortic valve opens and blood 
is ejected from the left ventricle, the correlation between this point and t1, which 
represents contraction of the left ventricle, is unsurprising. Similarly, the correlation of 
t3 to the Dicrotic notch is unsurprising given the Dicrotic notch corresponds to aortic 
valve closure and thus the relaxation of the left ventricle, which is where the TVE curve 
decays [103]. Regardless, these correlations provide the ability for significant 
components of TVE curve variation to be easily and accurately captured, thus 
individualising the generic TVE curve and minimising errors. 
The 5 other parameters (x1-x3, ?̇?1, ?̇?3) were assessed across the same 38,106 heartbeats. 
Moderate variability was exhibited by all parameters. These parameters were fixed to 
the median values exhibited, which are shown in Table 3.1. Note that the fixed values 
for t1 and t3 were only employed in the fixed timing approach, which was used to create 






Fig. 3.5: Correlations between aortic pressure features and TVE peak gradient timing 




Table 3.1: Fixed TVE curve parameters, presented as median (25th – 75th percentile). 
Note that parameters are unit-less due to normalisation of both time and elastance. 
Parameter Parameter Value 
x1 0.34 (0.27 – 0.43) 
𝑥1̇ 17.8 (10.6 – 24.2) 
x2 0.58 (0.45 – 0.69) 
x3 0.73 (0.64 – 0.81) 
𝑥3̇ -14.1 (-18.7 – -10.6) 
t1 0.22 (0.21 – 0.23) 
t3 0.68 (0.65 – 0.73) 
 
3.3.3 Evaluation of Approach 
The errors associated with dynamic timing, as opposed to fixed timing, in generating 
the TVE curve are shown in Table 3.2. The median overall error exhibited by the 
dynamic timing approach was 18%, less than half of the median 41% error exhibited 
by the fixed timing approach, and errors for the dynamic approach were, overall, 
significantly lower (p < 0.05, two-tailed Student’s t-test). The median errors for both 
methods varied notably between pigs, from 15.8% to 21.7% for the dynamic and 34.8% 
to 43.5% for the fixed timings. Also of note is that the relative median errors do not 
correspond between the two methods. For example Pig D6 has the lowest median error 
for the dynamic timing (15.8%), yet not for the fixed timing (34.8%). Conversely, Pig 
D2 has the second highest median error for the dynamic timing (20.9%) and the lowest 
median error for the fixed timing (23.3%). 
Table 3.2: Errors associated with the dynamic and fixed timing approaches, 
presented as median (25th – 75th percentile). 
Pig (Test Cohort) Dynamic Timing Error 
Error, % 
Fixed Timing Error 
D2 20.9% (19.3 – 24.3) 23.3% (21.1 – 25.8) 
D4 18.2% (14.3 – 21.3) 40.4% (34.7 – 48.2) 
D5 21.7% (15.3 – 28.1) 43.5% (34.6 – 49.0) 
D6 15.8% (13.4 – 18.6) 34.8% (21.4 – 51.4) 






The dynamic approach produced relatively low errors of median 18% (IQR: 14.4% – 
23.5%). This error was less than half of the error associated with the fixed TVE curve 
of 41% (IQR: 28.9% – 49.3%), and statistically significantly lower overall. This 
significant reduction in error highlights the disadvantage of generic TVE curves, and 
the advantage of individualising this input if it can be obtained, as here, from readily 
available data and established physiological relationships.  
The fact that the approach was derived and validated over entirely independent cohorts 
of pigs lends further support to the applicability of this approach. Further, it is important 
to note that the experimental protocol employed incorporated a dobutamine infusion, 
which directly, rapidly and artificially alters cardiac elastance [104]. As such, while 
population values are established and validated over the same experimental protocol, 
this protocol includes a clinical intervention designed to directly and dramatically alter 
the fundamental cardiac elastance from which TVE is derived, and which different 
individuals are known to respond differently to [105]. 
Median errors varied notably pig-to-pig ranging from 15.8% to 21.7% for the dynamic 
approach and 34.8% to 43.5% for the fixed approach. This outcome implies that some 
inherent, pig specific property of the TVE curve is likely not being captured. A 
combination of sensitivity (Fig. 3.4) and variability (Table 3.1) suggests a significant 
amount of the remaining error is associated with the shoulder height x2, which is in turn 
significantly influenced by the parameter Vd, set to 0 in this work. Thus, it is possible 
that identification of a subject specific Vd for each pig would reduce this difference, 




Mention should be made here of the nature of the original definition of the TVE curve 
in [55]. Here it is suggested that the TVE curve, when combined with Vd, possesses a 
uniform shape and changes solely based on end-systolic elastance (Ees), the maximum 
magnitude of the non-normalised TVE curve. This assumption clearly contrasts with 
the notion that the form of the TVE curve can offer diagnostic information in [44, 89, 
90, 99], and would support the approach presented here of using a fixed form for the 
TVE curve, though devoid of information from Vd. However, as the original TVE study 
[55] was performed over a limited number of heartbeats, subject to extremely 
controlled conditions, including the heart being essentially isolated from cardiac 
reflexes, controls, and systemic input, it seems likely that the TVE curve for an isolated 
heart may be uniform, but the complex network of cardiovascular control and reflex 
systems responding to various external stimuli provides the shape changes observed 
here and elsewhere. 
As such, this approach’s application leans more towards providing a quick, simple 
means of significantly improving the accuracy of the TVE curve as an input to a larger 
model of the entire circulatory system [93, 94]. Use of such a beat-to-beat TVE curve 
as an input can reduce both identification timing and overall simulation error in such 
models. While the TVE curve is also capable of providing information such as trends 
in cardiac work, as Ees typically remains constant for a constant inotropic state [57], the 
simplification of physiological behaviour here and use of a fixed form for the TVE 
curve means the approach is more likely to be useful as a simple, easy means of 
improving a TVE input into a model than as an independent diagnostic tool.  
It is worth noting that the approach was able to maintain accuracy despite the pigs 
undergoing a range of manoeuvres that significantly impact cardiac state. These 
included vena cava occlusions with a fluid filled balloon, which cause a sharp decrease 
in cardiac preload [87], fluid infusions which can cause variation in stressed blood 
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volume [64] and dobutamine infusions which lead to an increase in heart contractility 
[104]. This outcome suggests the approach will be robust to the dynamic cardiac states 
often found in critically ill patients [44]. The use of clinically and readily available 
aortic pressure measurements means that this approach can be implemented in real-
time for this cohort. Overall, this approach is able to provide additional, beat-to-beat, 
patient specific information in real-time without requiring additional, invasive 
instrumentation.  
3.5 Summary 
An existing approach for identifying the TVE curve on a beat-to-beat basis was 
validated and modified, using a combination of strong correlations (R > 0.97) to aortic 
pressure waveform features and population constants assessed across 38,106 heartbeats 
over a development cohort of 2 porcine specimens. Validation of the approach was 
accomplished using 54,410 heartbeats across an independent test cohort of 4 porcine 
specimens. The results of this validation showed a reduction in normalised area under 
the curve error from 41.0%, when using only population constant values, to a median 
of 18.0%. This approach has the potential to provide a simple means of significantly 
improving the accuracy of TVE inputs into a larger model. However, due to the 
simplification of cardiovascular behaviour, lack of Vd as an input and the use of a single, 
rigid shape for the driver function, diagnostics or other cardiovascular information 
directly derived from the TVE curve likely necessitate a more comprehensive model. 











Ventricular Dead Space Volume 
Ventricular dead space volume (Vd) is a somewhat ambiguous physiological term 
intimately associated with the time varying elastance (TVE) concept. Vd is 
representative of the subject specific volume within the ventricle not actively 
participating in ventricular function, but can only be established using highly invasive 
and demanding experimental procedures. As such, it is frequently assumed equal to 
zero in studies. A less demanding means of estimating this parameter would provide a 
means to improve the performance of a number of such models, and more accurately 
non-invasively estimate the TVE curve. 
4.1 Background 
Vd and the related ventricular volume at zero pressure (V0) are important subject-
specific parameters for normalising inter- and intra- subject variation in cardiovascular 
models, including the widely used end-systolic pressure-volume relation (ESPVR) and 
TVE models [55, 57, 58, 89, 90, 98]. Vd was originally conceptualised as an 
‘experimentally determined correction factor’ for the TVE model [55] with a pair of 
similar physiological definitions being established. Vd has been said to ‘represent a 
functionally dead volume at which the ventricle cannot generate any supra-
atmospheric pressure’ [55, 57], a definition generally denoted V0 (referred to as V0 
henceforth). Vd has also been defined as the volume at which ‘the ventricle cannot 
develop any systolic pressure’, which occurs at ‘a volume coordinate only mildly less 




the intersection of the ESPVR and End-Diastolic Pressure-Volume Relation (EDPVR) 
curves, where the maximum (end-diastolic) and minimum (end-systolic) volumes for 
a given heartbeat are identical, and thus no volume or pressure change is developed 
across that heartbeat. The definitions of V0 and Vd are illustrated in Fig. 4.1. 
 
Fig. 4.1: The ESPVR, EDPVR, V0 and Vd. Definitions as in [57]. 
In cardiac models based on the TVE concept, which are widely used in haemodynamic 
studies [55, 57, 58, 89, 90, 98], Vd and V0 are used to account for variations in heart 
size, shape and efficiency between individuals and as an individual’s condition 
changes. Specifically, Vd and V0 represent a subject and condition dependent portion of 
measured ventricular volume that is not actively participating in ventricular function. 
As such, being able to estimate and account for Vd and V0 on a subject and condition 
specific basis improves the physiological accuracy and the ability to accurate compare 
results from these models, where such models offer significant potential clinical 
benefits [89, 90, 107, 108]. Hence, this chapter presents new approaches to estimating 
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these values to better enable the use of TVE and associated models clinically and thus 
enhance their clinical impact.  
In addition, the physical definitions of Vd and V0, and their sensitivity to contractile 
state, suggests a potential direct use for these terms as a diagnostic aid [58, 109]. For 
example, one would expect an increase in Vd to suggest a heart behaving less 
‘efficiently’ as a pump, and, for obvious reasons, a connection between these terms and 
the left ventricular ejection fraction (LVEF) [110]. Hence, this term alone may provide 
further diagnostics in addition to its use and need in other models from Chapter 3. 
However, Vd cannot be directly measured without difficult experimental protocols due 
to the necessity of reducing the ventricle to atmospheric or sub-atmospheric pressure. 
Initial experiments validating the TVE model involved cross-circulated canine hearts 
[55, 98], a procedure which elegantly separates cardiac behaviour from systemic 
influences and allows reduction of the living heart to atmospheric pressure, but is 
clearly not applicable to an intensive care unit (ICU) patient. A less invasive alternative 
is the approximation of V0, which has a similar value to Vd, via the ESPVR [109, 111]. 
However, this procedure typically relies on occlusion of the vena cava, a specialised 
intervention that places a significant added burden on both medical staff and patients, 
and is thus largely constrained to experimental studies. Further, the short time interval 
necessitated by such a procedure means that transient, rather than steady state, 
behaviour is captured, unless cardiac reflexes are suppressed, obfuscating the true 
ESPVR curve [112, 113], explored in Chapter 8. As such, there is no easy, practical 
means to assess Vd or V0 in the ICU, where it might add clinical value. 
This chapter presents a novel method for deriving Vd as physiologically defined in 
[106]: the volume at which ‘the ventricle cannot develop any systolic pressure’. It relies 
upon the extrapolation of a Frank-Starling curve (SV-Ved) and its end-systolic 
equivalent (SV-Ves) to the point where stroke volume (SV) is 0, and ‘the ventricle cannot 
50 
 
develop any systolic pressure’. The method utilises common ICU procedures, such as 
mechanical ventilation recruitment manoeuvres, to develop this curve, and does not 
require specialised clinical intervention. The method is demonstrated across both a 
healthy, baseline case, as well as a compromised state after an endotoxin infusion to 
demonstrate the method’s applicability to both healthy and compromised 
cardiovascular systems. 
The method as presented here employs an invasive left ventricular catheter to measure 
end-diastolic (Ved) and end-systolic (Ves) volume. Such volume measurements are 
increasingly available non-invasively via methods such as echocardiography [114], 
though it is important to note that the number of Ved and Ves measurements required are 
demanding by the standards of modern echocardiography. While further validation and 
a modified protocol would be required, this method has the long-term potential to allow 
non-additionally invasive, patient-specific evaluation of Vd in a clinical environment, 
and thus an assessment of its clinical value beyond use in physiological models. 
4.2 Methods 
4.2.1 Experimental Data 
This chapter makes use of the Protocol S data from 6 pigs, including the pig largely 
excluded due to data acquisition issues. The data from this pig was still usable, but 
extremely labour intensive to employ due to frequent gaps in the recorded data. 
However, due to the relatively simple, robust modelling required and the unusual and 
ambiguous nature of Vd, inclusion of this data in this chapter was deemed worthwhile. 
The waveform employed is continuously sampled left-ventricular volume (Vlv), 
providing invasively measured SV, Ves and Ved. Data from the Protocol D pigs were not 
used in this chapter, as the fluid boli and dobutamine infusions present in Protocol D 
tended to induce sharp shifts in Ves and Ved. In contrast, the more gradual fluid infusion 
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and RM driven shifts present in the Protocol S data were better suited to the 
methodology presented in this chapter. 
4.2.2 Estimation of Vd 
This method uses the definition of  Vd as the volume at which ‘the ventricle cannot 
develop any systolic pressure’ [57, 106]. Ves, Ved and SV for each heartbeat were 
established from catheter data. This data was used to generate a Frank-Starling curve 
(SV-Ved) and its end-systolic equivalent (SV-Ves) for each subject. Separate linear 
regression of the SV-Ves and SV-Ved curves was performed using a total least squares 
algorithm [115]. Independent extrapolation of each curve to the y-axis should result in 
both converging to a single point at which SV = 0. At this point, no systolic pressure is 
developed over the course of a heartbeat, as Ved = Ves, and Vd is the value of the 
ventricular volume y-intercept. Separate linear regression of the SV-Ves and SV-Ved 
curves was chosen, as opposed to simultaneous regression with forced convergence of 
the two curves on the y-axis, as separate regression provides two separate Vd estimates, 
the agreement between which can be used to evaluate the physiological validity of the 
assumptions that drive the method. 
4.2.3 Evaluation of Method 
Ventricular Dead Space Volume (Vd) is extremely difficult to physically measure, and 
some ambiguity as to the exact definition of this value exists [57]. These difficulties 
make validation via a measured ‘ground truth’ Vd value impractical. As such, validation 
of the method used to derive Vd must rely on validating individual model assumptions 
and the physiological reasonability of the results. This validation process encompasses: 
 Evaluation of the agreement between the separate Vd values derived from the 
SV-Ves and SV-Ved curves for each pig. Theoretically, the two curves should 
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intersect at an identical Vd value if the linear approximation of the Frank-
Starling curve holds. 
 Assessment of the validity and strength of linear regression via Pearson’s 
correlation coefficients, presented as R values, to ensure a linear, physiological 
relationship, rather than chance, creates the observed lines. 
 Evaluation of the reasonability of the derived Vd values, both in terms of 
physiology and in comparison to invasively measured values presented in 
literature. 
The analysis of data for each pig was separated into pre- and post- endotoxin infusion, 
as the development of sepsis should modify contractility and result in an increase in Vd. 
This hypothesis was evaluated using a one-tailed paired Wilcoxon Signed-Rank Test 
[116]. This non-parametric statistical test does not rely on data being normally 
distributed. A single value for Vd pre- and post- endotoxin infusion was provided from 
each of 6 pigs (n = 6). Overall, the method was employed across a total of 59,513 
heartbeats worth of data, and 6 different animals in multiple circulatory states.  
Once severe sepsis developed, the Frank-Starling curve generally collapsed to the 
extent nonlinear behaviour was present in the observable data range. Data gathered 
during this period of severe sepsis, the onset of which was defined as a drop in LVEF 
of greater than 33% for greater than 60 seconds [117], is excluded, as linear behaviour 
is a poor approximation to make at this point. This observable non-linear behaviour is 
illustrated by the Frank-Starling curves [46, 118], approximated by hand, and the 




Fig. 4.2: Example Frank-Starling curves with data from Pig S2 overlaid. 6841 
heartbeats, illustrative trend lines drawn by hand. 
4.3 Results 
Table 4.1 shows the absolute and relative values of Vd derived from the end-systolic 
Vd(Ves) and end-diastolic Vd(Ved) curves, as well as the variation between these values. 
Vd values for each subject are specified separately for the pre- and post-endotoxin 
infusion periods. Due to the relatively small number of subjects, it is possible the data 
set is not normally distributed and thus overall values are presented as median (25th 
percentile–75th percentile). 
Fig. 4.3 shows the SV-Ves and SV-Ved curves used to derive Vd, and the corresponding 
regression lines and correlation coefficients for each pig, pre- and post- endotoxin 
infusion. The stroke and absolute volumes for each pig occupy a reasonably diverse 
range both inter- and intra- subject. The correlation coefficients, R = 0.78 and R = 0.80 
average for pre- and post- endotoxin infusion respectively, are consistently high, again 
supporting the validity of a linear model over these periods and interventions.  
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Nc 26.8 27.5 0.7 2.7% 
60.6 
44.3% 45.5% 
Sc 33.6 34.0 0.4 1.2% 55.5% 56.2% 
S2 
N 22.8 22.8 0.1 0.4% 
49.3 
46.2% 46.4% 
S 40.7 40.2 0.5 1.2% 82.6% 81.5% 
S3 
N 29.8 32.1 2.3 7.8% 
61.6 
48.3% 52.0% 
S 43.2 43.8 0.6 1.4% 70.1% 71.0% 
S4 
N 26.2 26.8 0.6 2.3% 
52.6 
49.8% 50.9% 
S 41.8 42.0 0.2 0.4% 79.4% 79.7% 
S5 
N 27.1 26.0 1.1 4.1% 
51.1 
53.1% 50.9% 
S 32.3 32.2 0.1 0.4% 63.2% 62.9% 
S6 
N 31.9 31.2 0.7 2.2% 
71.2 
44.7% 43.8% 









































a Vd(Ves) and Vd(Ved) denote Vd values derived from the SV-Ves and SV-Ved curves respectively. 
b Ves(0) denotes the baseline end-systolic volume, averaged over the first 10 heartbeats of the experiment. 
c N denotes data from the pre-infusion (normal) region while S denotes data from the post-infusion 
(developing sepsis) region. 
d ‘All’ values are presented as median (25th percentile–75th percentile). 
The lower correlation coefficients for SV-Ves as compared to SV-Ved, despite very 
similar distribution of data points around the respective linear trend lines, are primarily 
due to the often near horizontal gradients present in the SV-Ves trend lines.  Specifically, 
Pearson’s correlation coefficients ‘punish’ lower trend gradients as, in the extreme, a 
perfectly linear, perfectly horizontal trend does not mean one variable is correlated with 
another, and the associated correlation coefficient is 0, as opposed to 1 [119]. As such, 
these lower correlation coefficients do not represent a poorer linear fit, but a poorer 
guarantee of variable correlation, a concern alleviated here by the physiologically 




Fig. 4.3: Pre- (left) and post- (right) endotoxin infusion SV-Ved, SV-Ves curves and 
regression lines for each pig. Number of heartbeats and Pearson’s correlation 






One of the core assumptions made in determining Vd is that SV is a linear function of 
both Ves and Ved. This assumption is somewhat physiologically intuitive, as both Ves and 
Ved are intrinsically related and largely reliant on the same underlying factors, and such 
behaviour has been observed elsewhere [120]. However, one would expect some 
degree of independent variation, especially as sepsis and thus circulatory distress 
progresses. Fig. 4.3 shows consistently strong linear relationships for SV-Ves (R = 0.69 
average) and SV- Ved (R = 0.89 average) for all 6 Protocol S pigs undergoing a full 
progression from healthy to cardiac failure due to sepsis. This result implies that, while 
some independent variation in Ves and Ved certainly occurs, the variables largely 
maintain a linear relationship even when the cardiac system is under considerable 
stress. 
Another core assumption is that the relationship between SV, Ves and Ved is not just 
linear in the observed range, but can be linearly extrapolated to SV = 0. Table 4.1 and 
Fig. 4.3 both show that independent linear extrapolation of the SV-Ves and SV-Ved lines 
for each pig yields extremely consistent values for Vd with 7.8% variation at most, and 
an overall median absolute difference in paired Vd estimates of 2.1%. This low degree 
of variation across 6 separate subjects exhibiting a range of cardiac behaviour across a 
diverse and demanding clinical protocol provides strong support for this assumption. 
Further, the Frank-Starling Curve (SV-Ved) is known to behave linearly in this region 
[46, 121], and linear behaviour of the SV-Ves curve may thus also be reasonably intuited.  
Further supporting evidence of the validity of linear extrapolation is provided in the 
fact that the method yields extremely consistent, positive, values for Vd relative to Ves. 
These Vd values are 44.3-53.1% of the baseline Ves pre-infusion, and rise to 49.3-82.6% 
of the baseline Ves post-infusion. This consistency supports the idea that Vd varies 
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between subjects in a manner somewhat proportional to ventricular volume for a given 
set of cardiac conditions. The fact that this percentage range of baseline Ves is 
reasonably small for healthy behaviour provides the possibility to estimate baseline Vd 
from baseline Ves, although this range of values may be different for humans compared 
to pigs. 
The derived values for Vd also agree with measured values provided in the literature. 
Although these literature studies typically use the Vd = V0 definition for ventricular dead 
space, the two values have been shown to be similar [57, 106]. For example [109] 
presents several V0 values for cross circulated dogs, and protocols involving preload, 
afterload and inotropic variation. The baseline preload experiment gives a range of 13-
52% and the baseline afterload experiment a range of 46-83% of Ves for V0, overlapping 
with the 44.3-53.1% of Ves range for Vd observed in this chapter. Observations in [58], 
a study conducted on humans, yield V0 values for a normal contractile state in a 24-
84% of Ves range for V0, ignoring non-physiological negative results, across 5 subjects, 
again encompassing the 44.3-53.1% of Ves range for Vd observed in this chapter. 
Further, [58] also observed an increase in V0 values from a baseline average value of 
32 cc/m2 to an average value of 46 cc/m2 for individuals with intermediate and 100 
cc/m2 for individuals with poor contractile function, which agrees with the statistically 
significant increase in Vd observed in this chapter as sepsis developed. Other values 
presented in literature are similarly sized, positive values, as might be expected [111, 
122]. Overall, this further data provides a strong body of evidence for the physiological 
validity of the results and thus the proposed methodology. 
4.4.2 Response to Sepsis 
In the period between endotoxin infusion and cardiac failure, Vd values rose in all cases 
from a range of 44.3-53.1% to 49.3-82.6%. This statistically significant increase in 
dead space volume corresponds to the decreased LVEF observed in sepsis patients, and 
58 
 
the myocardial depression associated with failure to survive sepsis [123]. This 
behaviour agrees well with the physiological definition of Vd, and supports its potential 
clinical use as a diagnostic aid. Importantly, in this region, the agreement between the 
two Vd values remained strong, and correlation coefficients remained high, suggesting 
the Frank-Starling curve remained in its linear region despite significant change in 
cardiac function  
Directly prior to death, the Frank-Starling curve generally underwent a dramatic shift 
to the left and nonlinear behaviour was observable and strong (example in Fig. 4.2). 
This corresponds to the expected behaviour of the Frank-Starling curve as complete 
cardiac failure occurs [118]. This data, characterised by a decrease in LVEF of greater 
than 33% for longer than 60 seconds, was excluded from the ‘post-endotoxin infusion’ 
data as linear behaviour is a poor approximation to make at this point.  
4.4.3 Limitations 
There are some limitations to this study worth discussing. First, the study employs a 
left ventricular catheter to measure Ved and Ves, the insertion of which is an invasive 
procedure that is not common practice in the ICU. Such volume measurements are 
increasingly available non-invasively via methods such as echocardiography [114], but 
the number of measurements required for this method is demanding by current 
echocardiography standards. Further, volume measurement, in addition to specialised 
invasive protocols, is also required for approximation of V0 via the ESPVR [112, 113], 
which is the standard method available for finding a value similar to Vd. In contrast, the 
method presented here requires only common ICU interventions, primarily recruitment 
manoeuvres, to obtain a large enough range of data to fit a line. These interventions 
occur in normal care and are thus less burdensome to obtain. They also occur over a 




Additionally, all data presented here is the result of the same protocol involving sepsis, 
a complex and varied condition [88], and several standardised interventions. While this 
data set encompasses several pigs and the full progression from healthy, baseline 
behaviour to cardiac failure, there are a huge range of possible cardiac conditions that 
could be tested. Thus, further validation over several of these conditions would be 
beneficial. Regardless, the underlying physiology and data supporting the development 
of this method has been discussed in detail, and would be expected to transfer to the 
majority of such conditions. 
4.5 Summary 
Overall, Vd is an important, subject specific, physiological value that is difficult to 
measure or accurately approximate, even when invasive instrumentation is available 
[57]. Thus, the method presented and validated in this chapter offers significant 
potential in its ability to provide a relatively easy, non-additionally invasive means of 
estimating Vd when ventricular volume measurements are available, without requiring 
a specific and highly involved protocol. Though any clinical application requires 
further studies and a modified protocol, this method offers the potential to aid in 
assessment of patient condition through its ability to normalise intra- and inter- patient 
variability in analysing and managing cardiovascular and circulatory dysfunction. 
Importantly for subsequent work, this method also provides a means of estimating Vd 











End-Systolic and End-Diastolic Volume 
In general, intensive care unit (ICU) instrumentation provides a better picture of cardiac 
pressure than of volume, while a number of significant cardiac metrics, such as end-
diastolic volume (Ved) as a surrogate for preload, time varying elastance (TVE) and 
pressure-volume (P-V) loops, rely on volume as an input. To more accurately estimate 
these metrics, additional volume information is required. The unstressed or ‘dead 
space’ ventricular volume (Vd) as discussed in Chapter 4 provides part of this picture, 
as do recent advances allowing the estimation of stroke volume (SV) from aortic 
pressure (Pao) [108, 124]. Beat-by-beat upper and lower limits on ventricular volume 
would thus provide the last piece in the puzzle required to fully estimate the ventricular 
volume profile. 
5.1 Background 
Two important cardiovascular biological markers in the intensive care unit (ICU) are 
preload and afterload. Afterload serves as an indicator of the pressure downstream from 
the left ventricle, and is sensitive to alterations in valve function and arterial tone [46]. 
Afterload is approximated in the ICU via the typically measured, resulting Pao [68]. 
Preload, representing the loading conditions upstream from the heart, is sensitive to 
venous blood pressure and return, which are in turn sensitive to circulatory volume and 




Preload is typically represented by Ved [62], but this value  is not typically measured in 
the ICU as the required instrumentation is too invasive. As a result, clinical 
approximation is difficult. In fact, volume and flow measurements, in general, are 
rarely taken in the ICU [108], resulting in a relative abundance of pressure 
measurements, but an incomplete picture of cardiac behaviour without volume or flow. 
Recent work has provided a means of approximating the beat-to-beat cardiac SV under 
typical ICU instrumentation [108]. SV provides a beat-to-beat indicator of the how 
much heart volume is changing, but must be combined with a beat-to-beat absolute 
maximum or minimum value to provide a more complete picture of cardiac volume 
behaviour, and thus allow approximation of cardiac preload. There is thus a need to 
relate either end-systolic volume (Ves) or Ved to existing pressure measurements. An 
existing and frequently used example of such a relationship is the end-systolic pressure-
volume relation (ESPVR) [58, 91, 125]. However, this relation relies upon several 
subject specific parameters that are measurable in an experimental environment, but 
too invasive to measure clinically. 
This chapter investigates the viability of using a modified ESPVR to provide a beat-by 
beat approximation of Ves, allowing, in concert with SV, approximation of Ved (preload) 
and a more complete picture of cardiac volume behaviour. This modified ESPVR relies 
on continuous heart rate and aortic pressure data, and initial parameters being fixed 
during a brief ~10 heartbeat echocardiography calibration during which non-invasive 
volume measurements are available [126]. Such short echocardiography readings are 
becoming increasingly available clinically [127], enabling the research presented in 
this chapter. This method thus has the potential to aid in the provision of a more 
complete picture of cardiac behaviour under normal ICU instrumentation without 





5.2.1 Experimental Data 
This chapter makes use of the 5 Protocol S pigs as a development cohort and the 6 
Protocol D pigs as a validation cohort. The waveforms employed include continuously 
sampled Pao as a method input, and continuously sampled left-ventricular volume (Vlv) 
to provide invasively measured Ves and Ved. Due to the lack of available equipment, 
baseline catheter readings were used as surrogates for baseline echocardiography 
readings, but it’s important to note both methods show comparable performance and 
correlation to gold standard MRI data [128-130]. 
5.2.2 The ESPVR 
The ESPVR is typically expressed [57]: 
𝑃𝑒𝑠 = 𝐸𝑒𝑠 × (𝑉𝑒𝑠 − 𝑉0) (5.1) 
where Pes is the end-systolic pressure, Ees the end-systolic elastance and V0 the 
ventricular volume at zero pressure. This relationship represents the ventricular volume 
corresponding to a given ventricular pressure when the heart is fully contracted (end-
systole).   
The exact nature of Ees is somewhat controversial. It has been argued that it is constant 
for a given contractility [55], although there is evidence suggesting it varies as a result 
of loading conditions [131, 132]. As the intent is to track Ves through changes in 
contractility, a fixed value for Ees is clearly not appropriate for ICU monitoring, or for 
an experimental data set encompassing sepsis and dobutamine, where contractility is 
directly and dramatically varied due to changes in both condition and drug therapy.  
5.2.3 Proposed Method 
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While a number of the components of ESPVR are not measured under typical ICU 
instrumentation, it is possible to replace these values with physiologically similar and 
more easily obtained measurements. ESPVR is thus re-factored: 
𝑃𝐷𝑁 = 𝐸𝑒𝑠 × (𝑉𝑒𝑠 − 𝑉𝑑) (5.2) 
where: 
 Pes is replaced by PDN, the Dicrotic notch pressure in the aorta, as the aorta sits 
directly downstream from the left ventricle. Thus, aortic and left-ventricular 
pressure are very similar, with a slight difference due to aortic valve resistance, 
during systole. As real-time aortic pressure is typically available in the ICU, 
PDN provides a readily available surrogate for Pes. 
 V0 is replaced by Vd, as the two are often used interchangeably, and have similar 
physiological roles and values [57, 89, 90]. Vd can be more easily estimated 
than V0, via a relationship with baseline Ves as presented in Chapter 4 [59]: 
𝑉𝑑 = 0.48 × 𝑉𝑒𝑠(𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒) (5.3) 
where the factor 0.48 is generated using the average baseline Vd value from Chapter 4 
(which ranges from 0.44 – 0.53). Finally, the fact that Ees changes as patient 
contractility and, potentially, loading conditions vary, needs to be accounted for. The 
decision was made to approximate Ees using a power relationship with heart rate (HR) 
for several reasons. First, changes in HR and Ees are staple cardiovascular system 
responses to changing conditions [46]. As continuous monitoring of HR in the ICU is 
commonplace, it provides a partial, if incomplete, picture of cardiovascular system 
response, which is typically mathematically sympathetic with changes in Ees. For 
example, the neural regulatory baroreflex acts by either increasing or decreasing both 
Ees and HR, rather than acting independently on the two [46]. Second, a power 
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relationship was selected as it suits a mathematically sympathetic relationship and is 
sufficiently simple, provided the exponent is fixed a-priori, that it can be uniquely 
determined during a short, ~10 heartbeat echocardiography calibration.  
Thus, this relationship captures, in a simplified manner, physiological elements and 
suits the need for method simplicity and ease of use. The fully modified ESPVR 





+ 𝑉𝑑 (5.4) 
where EC is a subject-specific coefficient with units mmHg.s3/mL, representing the 
subject specific coupling between HR and Ees, and n is an exponent to be determined 
and then fixed a-priori. Thus, in the model implementation, PDN and HR are inputs that 
are measured every heartbeat, the exponent n is fixed a-priori, and Vd and EC are fixed 
for the duration of monitoring during the calibration phase, where Ves is being 
measured. The results section presents an assessment of the increase in errors 
associated with the transition from a subject specific to an a-priori value of n. 
5.2.4 Method Development 
Linear least squares, performed using MATLAB (R2014a, 64-bit, The Mathworks, 
Natwick, MA, USA) and the ‘lsqlin’ function, was used to determine a subject specific 
exponent n that minimised method errors for each of the 5 Protocol S pigs. Note that 
EC can be analytically determined for a given n during the echocardiography 
calibration, and is thus a dependent parameter. The overall process for determining the 
approximate beat-to-beat Ves curve using the a-priori exponent, n, is defined: 
1. Determine Vd (Eq. 5.3) and EC (Eq. 5.4) from a 10 heartbeat ‘calibration’ 
period, where Ves is measured, simulating an echocardiography reading. 
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2. Determine Ves for each subsequent heartbeat based on the fixed values (Vd and 
EC) and heartbeat specific measured values (HR and PDN). 
Overall, direct evaluation of the effectiveness of the method was accomplished across 
all 5 Protocol S and 6 Protocol D pigs in several ways: 
 Using Pearson’s correlation coefficients (R), which allow evaluation of the 
method’s capability to capture trends in Ves over the course of the two protocols 
investigated, and thus provide benefits in monitoring patient condition. 
 Using the absolute percentage error for each pig, which allows an evaluation 
of the ability of the method to accurately approximate the exact value of Ves, 
and thus the suitability of this method for use as a component of a larger model. 
 Via direct visual evaluation of the trendlines, which is only possible due to the 
relatively small number of subjects (N = 11), but does provide a means of 
evaluating the temporal and procedure based variations in method 
effectiveness.  
A comparison across these metrics was made between Ves curves estimated using 
subject specific exponent, n, and Ves curves estimated using an a-priori fixed exponent, 
n, which provides an indication of how much method accuracy is lost in the reliance 
on an a-priori exponent.  
5.2.5 The Method in Context 
While the previous section details a validation of the process from which the method 
is derived, this section focuses on comparing this method to alternative assumptions 
sometimes used in literature [57, 89, 90]. This analysis thus places the method in 
context. This section specifically looks at the impact on error of the two major 
assumptions made in this method: 
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1. That Vd can be expressed as a function of baseline Ves, as in Eq. 5.3 
2. That Ees can be expressed as a function of HR, as in Eq. 5.4 
Direct evaluation of the tracking of Ves using different forms of ESPVR allows 
validation of both of these assumptions. In particular, 3 different methods of tracking 
Ves were compared: 
1. Fixed Ees and neglected V0: The standard ESPVR (Eq. 5.1) with V0 = 0 (a 
commonly used assumption [57, 89, 90]) 
2. Fixed Ees and fixed V0: The standard ESPVR (Eq. 5.1) with V0 = Vd (allowing 
assessment of the validity of Eq. 5.3) 
3. Dynamic Ees and fixed V0: The ESPVR as used in the proposed method (Eq. 5.4) 
with V0 = Vd, and Ees as a function of HR (allowing assessment of the validity of 
Eq. 5.4) 
5.3 Results 
5.3.1 Method Development 
Table 5.1 provides an overview of the subject specific exponents, n, provided by linear 
least squares, along with the associated correlation coefficients and error values for 
tracking Ves across the development cohort of Protocol S pigs. Correlation coefficients 
are generally high with an overall average of R = 0.87, and errors generally low with 
an average of medians of 3.2%, suggesting the model is effectively able to capture the 
dynamic nature of Ees. It was decided, for simplicity, to set the a-priori value of n = 3 
based on these results. 
Table 5.2 provides a similar overview of the subject specific exponents for the 
validation cohort of Protocol D pigs. While these were not used in model development, 
the provision of these errors and exponents allows a more comprehensive evaluation 
68 
 
of model performance. As can be clearly seen, and as mentioned in Chapter 2, Pig D1 
is an outlier, though interestingly retains a relatively good correlation coefficient. 
While results from Pig D1 are included throughout this chapter, they are excluded from 
mean calculations. Overall correlation coefficients are high, with a mean value of 0.85. 
Further, overall error values are relatively low, but notably higher than for Protocol S 
(p < 0.05, two-tailed Student’s t-test) due to the disruptive nature of dobutamine on the 
coupling between Ees and HR [11, 66, 69-72]. 
Table 5.1: Tracking Ves with subject specific n for Protocol S: correlation coefficients 
and errors, presented as median (25th – 75th percentile). 
Pig Exponent (n) Correlation (R) Magnitude of Error*, % 
S1 3.06 0.93 1.7% (0.9 – 3.0) 
S2 3.98 0.94 2.9% (1.5 – 4.8) 
S3 2.06 0.87 4.6% (2.2 – 7.2) 
S4 2.63 0.80 4.7% (2.1 – 8.2) 
S5 4.13 0.81 2.3% (0.9 – 7.7) 
Mean 3.17 0.87 3.2% (1.5 – 6.2) 
*Magnitude here refers to the fact that the absolute value of the percentage error is taken prior to 
summary statistics being calculated, thus these errors are not representative of a bias and negative and 
positive errors do not cancel out. 
 
Table 5.2: Tracking Ves with subject specific n for Protocol D: correlation 
coefficients and errors, presented as median (25th – 75th percentile). 
Pig Exponent (n) Correlation (R) Magnitude of Error, % 
D1 -5.46 0.82 11.2% (5.4 – 24.4) 
D2 1.86 0.89 11.2% (2.7 – 24.6) 
D3 1.93 0.88 11.5% (5.8 – 22.0) 
D4 2.74 0.87 13.7% (8.5 – 22.6) 
D5 3.55 0.91 15.7% (5.6 – 82.6) 
D6 0.98 0.60 6.6% (2.8 – 13.2) 
Mean 2.21 0.83 11.7% (5.1 – 33.0) 
 
Table 5.3 provides an overview of the correlation coefficients and error values 
associated with tracking Ves using an a-priori exponent n = 3, as would be done 
clinically. Overall, there is only a slight increase in error, from 7.5% to 10.6% (mean 
of median values), and a slight decrease in correlation coefficients, from R = 0.85 to R 
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= 0.84 (mean). There is only once case (Pig D6) in which there is a large increase in 
error between Tables 5.1/5.2 and Table 5.3. The notable difference in error values 
between the sepsis and dobutamine protocol pigs is also present in Table 5.3 values (p 
< 0.01, two-tailed Student’s t-test). The higher correlation coefficients for pigs D5, D6 
and S1 in Table 5.3 as compared to Tables 5.1 and 5.2 are due to the regression process’ 
focus on minimising percentage error rather than maximising correlation coefficient. 
Specifically, it is possible for a non 1-1 relationship to provide higher correlation 
coefficients, but this will never be optimal in linear least squares or, indeed, for this 
model. 
Table 5.3: Tracking Ves with a-priori n = 3: correlation coefficients and errors, , 
presented as median (25th – 75th percentile). 
Pig Correlation (R) Magnitude of Error, % 
D1 0.29 75.1% (17.5 – 109.5) 
D2 0.83 14.1% (3.1 – 26.0) 
D3 0.84 15.2% (9.6 – 23.3) 
D4 0.86 13.3% (9.0 – 23.3) 
D5 0.92 18.4% (7.5 – 85.3) 
D6 0.66 23.3% (12.2 – 28.2) 
S1 0.94 1.8% (1.0 – 3.2) 
S2 0.91 6.4% (4.6 – 9.8) 
S3 0.84 4.5% (2.7 – 7.4) 
S4 0.79 4.7% (2.1 – 8.1) 
S5 0.80 4.2% (2.2 – 7.8) 
Mean 0.84 10.6% (5.4 – 22.2) 
 
Figs. 5.1 and 5.2 visualise the approximation of Ves for each subject across both 
protocols. It is clear that there are a diverse range of subject specific responses to the 
various elements of each protocol, which are generally effectively tracked, with the 
exception of the outlier Pig D1, by the method with only a minor decrease in 
performance when shifting from a subject specific to an a-priori exponent value. The 
sharp, vertical, and long-term changes in Ves exclusive to Fig. 5.1 demonstrates the 
effect of dobutamine in rapidly altering cardiac behaviour and Ees. In contrast, Ves in 
Fig. 5.2 tends to change more gradually as sepsis develops over the course of the 
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experiment. These latter results indicate the method accurately captures expected, 
induced changes in Ves, and does so in a subject specific fashion, capturing subject 
specific response to condition and care. 
 









5.3.2 The Method in Context 
Table 5.4 shows the percentage error associated with the 3 methods specified to track 
Ves in Section 5.2.5 across the 5 Protocol S pigs. Moving from neglected V0 (Method 
1) to fixed V0 (Method 2), via Eq. 5.3, shows a modest reduction in overall error (p < 
0.05, paired two-tailed Student’s t-test), especially 75th percentile error which falls from 
46.4% to 34.5%. Introduction of dynamic Ees (Method 3) as opposed to fixed Ees 
(Method 2), via Eq. 5.4, shows a notable reduction in overall error (p < 0.01, paired 
two-tailed Student’s t-test), and a significant reduction in median errors from 18.5% to 
10.6%. It is worth noting that statistically significant differences despite large, 
overlapping error distributions is due to the paired nature of the data. On certain 
heartbeats all methods perform poorly, on others all perform well, but some methods 
perform better than others consistently across both extremes. Overall, these results 
support the validity and usefulness of Eqs. 5.3 and 5.4, along with their associated 
assumptions, in the tracking of Ves. 
Table 5.4: Magnitude of error associated with different methods of tracking Ves, 
presented as median (25th – 75th percentile). Method 3 corresponds to the method used 
in Section 5.3.1 with an a-priori n = 3. 
Pig 
1. Fixed Ees, 
neglected V0 
2. Fixed Ees, fixed 
V0 
3. Dynamic Ees, 
fixed V0 
D1 13.8% (2.1 – 23.4) 41.4% (6.9 – 66.7) 75.1% (17.5 – 109) 
D2 5.2% (1.6 – 29.8) 13.5% (2.4 – 15.0) 14.1% (3.1 – 26.0) 
D3 30.1% (11.1 – 61.2) 24.1% (5.0 – 55.0) 15.2% (9.6 – 23.3) 
D4 14.9% (7.2 – 37.2) 23.6% (11.9 – 29.5) 13.3% (9.0 – 23.3) 
D5 34.0% (21.1 – 81.6) 36.0% (22.3 – 73.5) 18.4% (7.5 – 85.3) 
D6 18.8% (8.5 – 37.8) 15.1% (3.4 – 48.4) 23.3% (12.2 – 28.2) 
S1 4.6% (0.7 – 23.9) 8.7% (0.6 – 14.7) 1.8% (0.2 – 9.0) 
S2 19.5% (2.1 – 39.1) 23.4% (2.1 – 34.0) 6.5% (1.8 – 16.5) 
S3 12.2% (4.2 – 45.0) 5.6% (0.2 – 16.6) 4.5% (0.5 – 12.7) 
S4 30.7% (7.3 – 42.7) 23.3% (2.9 – 29.3) 4.7% (0.4 – 13.6) 
S5 12.4% (1.1 – 65.4) 11.7% (0.9 – 32.7) 4.2% (0.4 – 23.4) 




Note the values quoted from the final row of Table 5.4 are an average of the 25th 
percentile, median and 75th percentile error for the pigs rather than an overall 25th 
percentile, median and 75th percentile error. The decision was made to represent 
population values in this way as the overall median is less representative than the 
average median due a differing number of heartbeats recorded for different pigs. 
The comparative behaviour of these 3 methods is well illustrated in Fig. 5.3, which 
shows the tracking of Ves for Pig S1. Method 1 agrees reasonably well with measured 
Ves during normal behaviour, but diverges significantly from measured Ves during 
recruitment manoeuvres and the onset of severe sepsis, where there are large vertical 
changes in Ves. Method 2 accurately captures these large vertical changes in Ves, 
reducing the large 75th percentile error in Method 1. Method 3 retains the tracking of 
large vertical changes in Method 2, and tracks normal behaviour more effectively by 
accounting for changes in Ees, significantly reducing median error.  
 
Fig. 5.3: Tracking of Ves. Comparison between the three methods in Section 5.2.5 for 




5.4.1 Method Development 
As seen in Table 5.3, the correlation coefficients across the 2 protocols and 10 pigs 
excluding D1 are reliably good, with a mean value of 0.84 and a minimum value of 
0.66. This result suggests the method effectively captures trends in Ves. The ability to 
track trends in Ves allows, in concert with SV, for tracking of preload which is important 
for patient diagnostics and monitoring purposes. That these high correlation 
coefficients are sustained across 10 subjects and 2 protocols encompassing elements 
such as sepsis and dobutamine, which dramatically alter cardiac function, provides a 
good initial validation of the method.  
While the ability to track trends is important for monitoring changes in patient 
condition, the ability to approximate the actual value of Ves is important for the method 
to be used as a component of larger models, and in providing a more complete picture 
of cardiac volume behaviour in the ICU. Table 5.3 shows the method is able to 
continuously estimate the value of Ves relatively effectively, with a mean median error 
of 10.6%, and mean 75th percentile error of 22.2%. Again, this accuracy is sustained 
over a number of subjects and a pair of different and demanding clinical protocols, 
suggesting the method is able to adapt to both short and long term changes in patient 
condition due to disease or drug therapy. 
From Fig. 5.1, and as previously discussed in Chapter 2 and further discussed in 
Chapter 7, Pig D1 appears to suffer from sensor drift over the duration of the 
experiment. While the overall shape of the Vlv waveform, changes in SV as discussed 
in Chapter 7, and inter-variable relationships remain present, both Ves and Ved show a 
steady, inexplicable drift downwards over the course of the experimental period, 
accounting for the radically different fitted exponent (n = -5.46) and high error values 
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generated when using n = 3, despite low errors in estimating the P-V loop of this pig 
in Chapter 7. 
With the exception of Pig D1, the considerable variation in the subject specific values 
of n across the two cohorts, which ranged from 0.98 (Pig D6) to 4.27 (Pig S5), only 
resulted in a minor increase in error and decrease in correlation coefficients with the 
use of the a-priori value of n = 3, derived from the Protocol S data. A comparison 
between Tables 5.1/5.2 and Table 5.3 shows the largest decrease in correlation 
coefficient is a relatively minor reduction from R = 0.89 to R = 0.83. A similar 
comparison of error values shows minor increases in error between Tables 5.1/5.2 and 
Table 5.3 in most cases, with the only major increase occurring for Pig D6.  
Pig D6 had the lowest subject specific exponent (n = 0.98) and poorest correlation 
coefficient when that subject specific exponent was used (R = 0.60). Fig. 5.2 shows 
using a value of n = 3 causes an overestimation of the decrease in Ves that results from 
a dobutamine infusion at about heartbeat 7000. However, the method still predicts the 
direction of change correctly, as well as appearing to accurately model the behaviour 
prior to and after the dobutamine infusion. This suggests that the low subject specific 
exponent may be driven primarily by the large shift induced by the dobutamine infusion 
as opposed to behaviour either beforehand or afterwards. Given the ability of the 
method to capture dobumatine shifts accurately for the other 5 pigs in Fig. 5.2, this case 
seems to be an exception, rather than the rule. 
There is a distinct overall increase in error values, although not a concordant decrease 
in R values, from the Protocol S development cohort to the Protocol D validation 
cohort. This result is to be expected, both due to value of n being selected based on 
Protocol S, and the fact that dobumatine induces sharp changes in Ees, disrupting the 
sympathetic relationship between Ees and HR. This disruption in the relationship 
between Ees and HR makes the Protocol D pigs an excellent and challenging validation 
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cohort, as well as an unsuitable development cohort, due to such external disruption in 
the relationship between Ees and HR not being typical behaviour.  
It is important to note that, despite the disruption the sympathetic relationship 
fundamental to the model developed in this chapter, overall error error values for both 
Protocol D and Protocol S are within acceptable levels. The method is still able to 
capture trends accurately, though the exact magnitude of the patient response to 
dobutamine is difficult to predict, as in Pig D6, resulting in the observed increased error 
associated with Protocol D. Thus, the ability of the method to estimate the value of Ves 
would benefit from recalibration after the administration of drugs such as dobutamine, 
although the method performs well enough, regardless.  
5.4.2 The Method in Context 
A direct evaluation of the effectiveness of three different ESPVR equations set out in 
Section 5.2.5 in tracking Ves allowed validation of assumptions that: 
 That Vd can be derived from Ves as in Eq. 5.3 (implemented in Method 2) 
 That Ees can be expressed as a function of HR as in Eq. 5.4 (implemented in 
Method 3) 
Method 1 serves as a control and uses a simplified ESPVR, assuming V0 = 0 and Ees is 
constant. This method tracks Ves reasonably well, yielding an overall median error of 
18.2% across all 10 pigs compared to Ves as directly measured. The assumption that V0 
can be neglected is often used due to a combination of V0 being difficult to measure 
directly, as it requires a significant artificial reduction in ventricular pressure [106], and 
V0 typically being relatively small [58]. This assumption is largely supported by these 
results, as an 18.2% median error seems acceptable when weighed against the type of 
highly invasive and involved protocol traditionally required to determine V0.  
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However, as shown in Fig. 5.3, this 18.2% median error fails to capture the extremely 
large inaccuracies associated with using Method 1 to track sudden changes in Ves due, 
for example, to recruitment manoeuvres or the onset of severe sepsis. This failure to 
track sudden changes leads to a significantly larger 75th percentile error of 46.4% for 
Method 1. This high error when sudden changes occur is of clinical concern in an ICU 
or cardiac surgery clinical scenario, where sudden changes and accurate, rapid 
determination of patient responses to these sudden changes is extremely important [46]. 
Method 2 introduces the assumption that Vd can be derived from baseline Ves, as in Eq. 
6.4, and that Vd can be used as a surrogate for V0.  There is a minor, but important 
physiological distinction between the two values: V0 is the ventricular volume at zero 
pressure, while Vd is the volume at which the ventricle cannot develop any systolic 
pressure [57]. However, the purpose of both terms is to account for the subject-specific 
inactive volume within the ventricle, and the two values have been shown to be similar 
for a given subject [57].  
Method 2 results in a notable decrease in 75th percentile error compared to Method 1 
from 46.4% to 34.5%, and is able to track sudden changes in Ves significantly more 
effectively, as shown in Fig 5.3. Overall, Method 2 is associated with a modest decrease 
in overall error (p < 0.05, paired two-tailed Student’s t-test), but does result in a modest 
increase in median error compared to Method 1 from 18.2% to 18.5%. Both Method 1 
and Method 2 fail to capture the dynamic nature of Ees, thus, large errors are reduced, 
but overall accuracy is not greatly improved. Regardless, these results provide support 
for the validity of Eq. 5.3, and the use of Vd as a surrogate for V0 in this method. The 
fact these error reductions are sustained over significant changes in cardiac output and 
ejection fraction as sepsis develops suggests the absolute value of Vd does not change 
significantly enough under such conditions to detract from method accuracy. 
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Method 3 further assumes that Ees can be expressed as a function of HR. This 
assumption is unusual, but is supported by the results. The full method sees a further, 
significant reduction in overall error compared to Methods 1 and 2 (p < 0.01 in both 
cases, paired two-tailed Student’s t-test), as well as a large reduction in average median 
error compared to both Methods 1 and 2, from 18.2% and 18.5% to 10.6% in Table 
5.4. This result suggests general tracking of trends in Ves is being significantly 
improved, also supporting the validity of expressing Ees as a function of HR. This 
behaviour can also be observed in Fig. 5.3. This result, combined with the minimal 
addition in method complexity required to include HR, which is very easy to measure, 
provides a strong case for the use of Method 3. 
However, it is still important to note the power law relationship between Ees and HR 
expressed in Eq. 5.4 is a significant simplification of actual cardiac behaviour. The 
cardiac system uses a large variety of responses to maintain cardiac output. The cubic 
(n = 3) used to approximate Ees changes as a function of HR attempts to mathematically 
approximate the sympathetic nature of some of these responses. However, the 
relationship between HR and Ees varies between subjects, as accounted for by 
calibration, and as time and condition change.  
5.4.3 Limitations 
There are a couple of limitations to this study that should be noted. First, the proposed 
method does require an echocardiography calibration to provide subject specific initial 
parameters. While echocardiography is non-invasive, and becoming increasingly 
commonplace in the ICU [127], the method still cannot be implemented entirely 
without an increase in the workload of clinicians. Second, the method was validated 
across a limited data set. While effort was made to ensure the experimental protocols 
encompassed a variety of procedures, conditions and drugs with a variety of effects, 
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this still represents only a fraction of the range of cardiac behaviour possible in an ICU. 
As such, further validation over more diverse data sets and subjects is needed.  
Specifically, there are several interventions that specifically alter either HR or 
contractility. Examples include inotropes, which increase contractility and were part of 
the validation, and vagus nerve stimulation [133], which decreases HR. The method’s 
ability to adapt to inotropes, albeit with some increase in error, suggests the method is 
capable of tracking changes through such interventions. Further, given that such 
interventions are instigated by a clinician, it would be relatively easy to recalibrate the 
method directly after an intervention should the method be shown to require it. 
5.5 Summary 
Management of cardiovascular disease in the ICU would benefit from better extraction 
of relevant cardiac metrics from the wealth of data regularly available in such an 
environment. A method was developed to allow clinical approximation of Ves beat-to-
beat, using a modified ESPVR, brief echocardiography calibration and continuous Pao 
and HR data. This method was validated across 11 pigs and 2 protocols, covering 
sepsis, dobutamine infusion, recruitment manoeuvres and fluid infusions. The method 
was able to track trends in Ves effectively across both protocols, with a mean correlation 
coefficient of R = 0.84. The method was also able to approximate the exact value of Ves 
effectively, with a mean-median magnitude of error of 10.6%, although these errors 
were consistently higher for the protocol involving dobutamine than sepsis. Overall, 
this method, combined with an existing method that provides SV, allows for a more 
complete picture of cardiac volume behaviour to be established in the ICU, including 
metrics such as preload. This method thus also provides the ability to non-additionally 










Time Varying Elastance Revisited 
With the additional benefits of non-additionally invasive estimation of unstressed or 
‘dead space’ ventricular volume (Vd) as described in Chapter 4, and end-systolic (Ves) 
and end-diastolic (Ved) volumes as described in Chapter 5, it is time to revisit the Time 
Varying Elastance (TVE) curve, first presented in Chapter 3. This chapter develops a 
more complex means of estimating the TVE curve without directly assuming a shape 
for the waveform. This method is thus more appropriate for the potential diagnostic use 
of the TVE curve, and provides a significant increase in method accuracy and 
complexity. 
6.1 Background 
As established in Chapter 3, the TVE curve is an important means of expressing cardiac 
dynamics [55], with potential applications as an input into larger models [93-97] or for 
direct diagnostic use [44, 89, 90, 99]. While the original definition of the TVE curve 
suggests a uniform curve scaled solely by end-systolic elastance (Ees) and tmax [55], the 
presence of large amounts of modern data and a more intact circulatory system in 
subjects appears to result in changes in the shape of the curve itself, potentially due to 
cardiovascular control and reflexes. These shape differences may provide information 
with diagnostic benefits [44, 89, 90, 99]. 
Chapter 3 provided a TVE curve matching the definition in [55], with a consistent 




complex means of estimating the TVE curve. It leverages the physiological estimation 
methods developed in Chapters 4 and 5, without assumptions of a constant shape and 
with more connection to underlying physiology to provide a non-additionally invasive 
estimate of the TVE curve for potential diagnostic use.  
This chapter thus presents a novel, minimally invasive method for deriving the TVE 
curve beat-by-beat. The method focuses on combining simple physiological 
assumptions with clinically available catheter waveforms to individually simulate the 
pressure and volume components that define the TVE curve, rather than generating the 
TVE curve itself. Importantly, this approach avoids the need to directly assume a shape 
for the TVE curve, as it is instead generated from these underlying waveforms. It is 
thus better equipped to capture variations in TVE shape over time and condition, as 
well as the corresponding alterations in intra-beat cardiac behaviour.  
Using only clinically feasible measurements mean the method has the potential for real-
time implementation at the patient bedside, without requiring additional, invasive 
instrumentation. Such a TVE curve could be used to provide additional, patient specific 
information on intra-beat behaviour and inter-beat variation in the functioning of the 
heart. Finally, monitoring the TVE curve, associated metrics, and their evolution over 
time could add significant new data and insight to improve diagnosis and treatment. 
6.2 Methods 
6.2.1 Proposed Method 







where Plv is the pressure in the left ventricle and Vlv is the volume in the left ventricle 
[55, 57]. Thus, the TVE curve is defined by two time-varying waveforms (Plv and Vlv) 
and one constant (Vd). Once again, these values can be measured directly, but doing so 
is not clinically feasible [66], so a surrogate estimation is required. 
The proposed method approximates these waveforms (Vlv, Plv) and constant (Vd) using 
four clinically available inputs, as shown in Fig. 6.1 Continuous aortic pressure (Pao) 
and heart rate (HR) are widely available. Continuous femoral pressure (Pfe) can easily 
be measured under clinical conditions, but is not a typical intensive care unit (ICU) 
measurement [73]. Finally, baseline Ves requires a short, baseline echocardiography, 
which is increasingly available, clinically [127].  
 
Fig. 6.1: Flowchart of the proposed method. Roman numerals indicate different 
method regions. 
The overall goal of this method is to use the clinically available inputs Pao, Pfe, HR and 
baseline Ves to determine the outputs Plv, Vd and Vlv, and thus the TVE curve e(t) as set 
out in Fig. 6.1 and Eq. 6.1. This resulting TVE curve can be experimentally validated 
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against the TVE curves derived from experimentally measured Plv and Vlv in animal 
models. The availability of a nearby continuous pressure measurement (Pao) forms an 
effective basis for the continuous approximation of Plv, and the availability of a baseline 
volume measurement (Ves) forms an effective basis for the approximation of baseline 
Vd, comprising Regions I and II in Fig. 6.1. 
There is no continuous volume measurement available for continuous approximation 
of Vlv. However, the methods presented in Chapters 4 and 5 can be used to provide 
volume information from clinically available data. Thus, these methods form the basis 
for the shaded central Region III in Fig. 6.1, which is considerably more complicated 
than Regions I and II. 
While the overall method involves approximating two output waveforms (Vlv, Plv) from 
two similar input waveforms (Pao and Pfe), it’s important to note all four waveforms 
(Plv, Vlv, Pao, Pfe) have distinct features. Different regions of behaviour are governed by 
different physiological phenomenon, and these waveforms have been extensively 
characterised [46]. As such, all four waveforms are heavily interconnected and 
information rich, making this task more reasonable than it might first appear. 
6.2.1.1 Determining Plv from Pao (Region I, Fig. 6.1) 
During systole (Region P1, Fig. 6.2), the aortic valve opens as blood is ejected from 
the heart. Thus, Pao is approximately equivalent to Plv with a slight phase lag (δ) and a 
pressure drop. While this pressure drop is non-negligible in conditions such as aortic 
stenosis [46],  valve dysfunction of any kind is present in just 3.61% of cardiovascular 
disease mortalities in the US [1]. Further, such conditions are typically chronic in 
nature, relatively easily diagnosed [134] and evolve slowly, while the method is 
designed to monitor short term changes in an ICU environment. As such, this 
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assumption should not significantly affect the methods’ applicability to the vast 
majority of the target cohort. 
During diastole (Region P2-3, Fig. 6.2), the aortic valve closes as the ventricle relaxes 
and fills with blood, and Plv and Pao diverge providing little direct information to 
estimate Plv. However, relaxation and filling are largely passive [46], so a generic 
exponential function can be used to approximate diastolic Plv.  These generic 
exponential functions consist of an exponential decay in early diastole (Region P2, Fig. 
6.2) as the ventricle relaxes, followed by an exponential increase (Region P3, Fig. 6.2) 
as the ventricle begins to contract. 
 
Fig. 6.2: Plv estimated via Pao compared to invasively measured Plv. Psys denotes the 
mean-systolic pressure and Pdia denotes the mean-diastolic pressure. Note Pao has 
been shifted left by δ. 
While atrial contraction contributes significantly to late diastolic filling, ventricular 
elastance remains largely passive in late diastole [46]. Thus, the TVE curve is typically 
at its baseline value until the beginning of ventricular contraction in early systole. 
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While atrial function affects the magnitude of the driver function, which is normalised 
in this work, and may affect its shape, this effect is indirect as the driver function 
represents the impact of contraction in driving pulsatile blood from the heart to the 
arterial system. Further, with the decreasing popularity of pulmonary artery catheters 
[49], none of the typically available instrumentation in an ICU provides a clear picture 
of atrial behaviour. As such, while the exponential in Region P3 is broadly intended to 
capture ventricular filling, no specific atrial behaviour component is integrated into this 
model, and there is no readily available data to do so directly 
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where τ is the relative length of early-diastole decrease in Plv (Region P2, Fig. 6.2) to 
late-diastole/early-systole increase in Plv (Region P3, Fig. 6.2), ρ is the asymptotic 
minimum pressure during diastole in the left ventricle, α1 governs the rate of decrease 
from Plv = Pao at end-systole towards Plv = ρ (Region P2, Fig. 6.2), α2 governs the rate 
of increase from Plv ≈ ρ in diastole to Plv = Pao at early-systole (Region P3, Fig. 6.2), 
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and δ is the lag between Plv and Pao. Due to the lack of available measured information 
apart from Pao at the beginning and end of diastole, the exponentials are generated using 
the generic values in Table 6.1, derived from a combination of observed experimental 
behaviour and expected behaviour discussed in medical literature, which give an 
approximation of the typical, passive physiological behaviour. 
Table 6.1: Parameter values for estimation of Plv [135]. 
Parameter Parameter Value 
τ 0.38 
ρ 6 mmHg 
α1 17.5 s-1 
α2 37.5 s-1 
δ 0.008 s 
 
6.2.1.2 Determining Vd from baseline Ves (Region II, Fig 6.1) 
This approach leverages the method established in Chapter 4 for estimating Vd from 
baseline ventricular volume measurements [59]. Defining Vd as a percentage of 
baseline Ves allows approximation of baseline Vd during the initial echocardiographic 
reading where measured Ves is available. While Vd has been shown to change with 
condition, there is no practical means of capturing this change short of additional 
echocardiography measurements. Thus, while intermittent measures are feasible, in this 
chapter Vd is fixed at a baseline value.  
𝑉𝑑 = 0.48 × 𝑉𝑒𝑠 (6.4) 
6.2.1.3 Determining Vlv from Pao, HR and Vd (Region III, Fig 6.1) 
Unlike pressure, little volume or flow information is readily available from the typical, 
clinically available instrumentation. Estimating Vlv thus relies on the methods presented 
in Chapters 4 and 5 for estimating ventricular volume information from clinically 
available pressure inputs. Vlv was estimated by combining beat-by-beat estimations of 
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the timing and height of the peaks and troughs of the waveform and a piecewise sine 
wave. The piecewise sine wave comprises a systolic region (Region V1, Fig. 6.3), 
where volume falls as blood is ejected, and a diastolic region (Region V2, Fig. 6.3), 
where volume rises during filling, with a 90° phase shift at the beginning of systole. 
Physiologically, a set of exponentials would potentially be more representative [46], 
but the piecewise sine wave achieves similar results with considerably fewer variables 
to define its shape, reducing the number of parameters to be determined. 
 
Fig. 6.3: Vlv estimated via Pao compared to invasively measured Vlv.  
Vlv changes are pressure driven, so Pao is used to determine timing of peaks and troughs 
in Vlv:  
t1
𝑣 = 𝑡(𝑃𝑎𝑜𝑚𝑖𝑛)𝑛
− 𝛿 (6.5a) 
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Determining the magnitude of the beat-by-beat troughs (Ves) is accomplished using the 
method set out in Chapter 5 to estimate Ves beat-by-beat under clinical conditions (Eq. 
6.7). Determining the magnitude of the beat-by-beat peaks (Ved) is accomplished by 
combining Ves with existing research approximating beat-by-beat Stroke Volume (SV) 
from clinical data [124]. This approach uses pulse wave velocity from Pao and Pfe to 
uniquely identify a three-element Windkessel model based on the reservoir-wave 
concept. This subject specific Windkessel model can then be used to convert measured 
Pao into an estimated SV beat-by-beat, with a 95% limit of agreement error of 26% 
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+ 𝑉𝑑 (6.7) 
𝑉𝑒𝑑 = 𝑉𝑒𝑠 + 𝑆𝑉 (6.8) 
where Eq. 6.7 expresses the relationship between Ees and HR developed in Chapter 5. 
6.2.1.4 Summary of Proposed Method  
The overall derivation of the TVE curve can be summarised: 
Initially or Intermittently: 
1. Calculate Vd using Eq. 6.4 and baseline Ves (Region II, Fig. 6.1) 
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2. Calculate EC using Eq. 6.7, PDN, HR, Vd and baseline Ves (Region III, Fig. 6.1) 
Every heartbeat: 
1. Estimate Plv using Eq. 6.2, Eq. 6.3 and Pao (Region I, Fig. 6.1) 
2. Determine Ves using Eq. 6.7, PDN, HR, Vd and EC (Region III, Fig. 6.1) 
3. Determine SV using Kamoi et al. [124], Pao and Pfe 
4. Determine Ved using Eq. 6.8, Ves and SV (Region III, Fig. 6.1) 
5. Estimate Vlv using Eq. 6.5, Eq. 6.6, Pao, Ves and Ved (Region III, Fig. 6.1) 
6. Calculate and normalise the TVE curve e(t) using Eq. 6.1 
The required clinical measurements include: 
 Continuously sampled Pao 
 Continuously sampled Pfe 
 Continuously sampled HR 
 A baseline, 10-heartbeat Ves 
All these measurements are either in widespread clinical use or possible to implement 
clinically without excessive burden on either clinicians or patients. 
6.2.2 Analysis and Validation 
The proposed method was validated on experimentally gathered data. A range of input 
(Pao) and output (Vlv, Plv) waveforms were continuously measured via catheter. This 
data allowed validation of individual model assumptions through comparison with 
directly measured output waveforms, as well as validation of the overall method 
through comparisons between the TVE curve as calculated using simulated and directly 
measured Vlv and Plv wave forms.   
6.2.2.1 Experimental Data 
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This chapter makes use of the 5 Protocol S pigs that were not subject to exclusion. The 
waveforms employed include continuously sampled Pao and Pfe as method inputs, and 
continuously sampled Plv and Vlv to provide the invasively measured TVE curve. The 
data set encompasses 46,318 heartbeats across 5 Piétrain pigs. A diverse clinical 
protocol provides the ability to assess intra- and inter- subject variability across a large 
amount of invasive and non-invasive measurements. Together they enable rigorous 
assessment and validation of the method. 
6.2.2.2 Model Validation 
The overall method presented here is designed to simulate the TVE curve beat-by-beat, 
without requiring invasive instrumentation of the heart or real-time image-based 
monitoring, neither of which is clinically or ethically feasible in care. As such, 
validation of the method relies on comparison of the simulated TVE curve to the 
invasively measured, ‘true’ TVE curve, which is calculated using the catheter measured 
Vlv and Plv waveforms for a single beat. This comparison is achieved by calculating the 
magnitude and signed ‘error area’ between the measured and simulated TVE curve, 
according to Eqs. 6.9 and 6.10: 
𝑚𝑎𝑔 =















where εsim and εmeas are the simulated and measured TVE curves, respectively, t is 
normalised time set to 1 for every heart beat to enable comparison over different beats, 
and εmag and εsgn and denote the magnitude and signed errors respectively. This 
approach is identical to the approach used in Chapter 3, enabling direct comparison. 
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6.3 Results  
The overall purpose of this model is to track the shape of the TVE curve, and how this 
shape changes when circulatory behaviour changes. Table 6.2 shows the area under the 
curve errors, εmag and εsgn, for all 5 Protocol S pigs. The median error is relatively small 
at 11.4%, suggesting the method is effective, and the interquartile range relatively 
narrow at 9.2% – 14.7%, suggesting the method is consistent. The method does not 
demonstrate a significant bias (p > 0.05, one sample Student’s t-test relative to a 
population bias of 0), with an average median of -2.5%, and an interquartile range of -
6.1% – 0.8. This method shows a statistically significant reduction in median errors 
relative to the method presented in Chapter 3 (p < 0.01, two-tailed unpaired Student’s 
t-test). 
Table 6.2: TVE curve percentage area under the curve errors (εmag and εsgn) associated 
with proposed method (identifying Ves and Ved), presented as median (25th – 75th 
percentile) 
Pig Mag. Percentage Error (εmag) Signed Percentage Error (εsgn) 
S1 11.6% (9.0 – 14.4) -4.9% (-7.0 – -2.6) 
S2 9.4% (7.8 – 11.6) 2.3% (-1.4 – 6.6) 
S3 11.4% (9.4 – 15.6) -7.8% (-12.6 – -4.5) 
S4 11.1% (9.5 – 13.0) -7.5% (-9.3 – -5.7) 
S5 13.4% (10.5 – 19.0) 5.2% (-0.3 – 10.1) 
Mean 11.4% (9.2 – 14.7) -2.5% (-6.1 – 0.8) 
 
Table 6.3 shows, as a point of comparison, the area under the curve errors associated 
with the method if the directly measured values for Ves and Ved are used. Using these 
measured values removes the majority of Region III, Fig. 6.1 (Eqs. 6.4 and 6.7-6.8) 
from the overall method, where a lot of relatively significant assumptions are made. 
The errors in Table 6.3 are very comparable to those in Table 6.2, with an overall 
modest reduction in average median error (11.4% to 10.2%) and bias (-2.5% to -2.2%), 
as expected when measuring Ves and Ved directly and invasively, rather than estimating 
them. Hence, the assumptions made had very little impact on error when removed.  
93 
 
Table 6.3: TVE curve percentage area under the curve error (εmag and εsgn) associated 
with using measured Ves and Ved values, presented as median (25th – 75th percentile) 
Pig Mag. Percentage Error (εmag) Signed Percentage Error (εsgn) 
S1 11.5% (9.0 – 13.3) -5.6% (-8.1 – -2.7) 
S2 8.5% (7.3 – 10.1) -0.7% (-3.7 – 2.2) 
S3 8.1% (7.1 – 9.1) -2.7% (-4.7 – -0.6) 
S4 11.4% (9.5 – 13.5) -7.8% (-9.9 – -5.6) 
S5 11.3% (9.8 – 13.5) 6.0% (2.8 – 9.0) 
Mean 10.2% (8.5 – 11.9) -2.2% (-4.7 – 0.5) 
 
Fig. 6.4 shows a variety of measured and modelled TVE curve shapes for each of the 
5 pigs, capturing both intra- and inter- subject variability. For each figure, Panel I shows 
a baseline waveform, Panel II a waveform during a RM and Panel III a waveform after 
endotoxin infusion has occurred and sepsis develops. The range of shapes and inter-pig 
variability indicated that assuming a generic population or cohort TVE curve as in 
Chapter 3 is not particularly valid, and is further supported by the range of intra-pig 
variability evidenced and captured by the method presented here. There are a variety 
of shoulder heights, relative gradient and maximum/minimum gradient timings that 
result in TVE curves with distinct shapes, variations which are well captured by the 
method. These TVE curves were also selected to demonstrate a range of error values 
similar to the interquartile error range for that pig (Table 6.2). Thus, these drivers are 
reasonably representative of the overall ability of the method to capture TVE curve 




















6.4.1 Model Validation 
Estimating the TVE curve using the proposed method resulted in a relatively low 
median magnitude error area, ranging from 9.4% to 13.4% (Table 6.2) across all pigs, 
and yielded a statistically significant reduction in median errors relative to the method 
presented in Chapter 3 (p < 0.01, two-tailed unpaired Student’s t-test). This narrow 
range of median magnitude errors implies the method is able to consistently and 
effectively capture inter-subject variations in TVE curve behaviour, suggesting it is 
generalizable to other subjects. This inter-subject variability is demonstrated well by 
various baseline drivers shown in Fig. 6.4. All 5 pigs demonstrate relatively distinct 
baseline TVE curve shapes, showing a considerable level of inter-subject variability 
impossible to capture with a generic cohort or population based TVE curve that relies 
on a basic assumed shape as in Chapter 3 [89, 90].  
The simulated TVE curve also had a relatively narrow average interquartile error range 
of 9.2% to 14.7% (Table 6.2), suggesting the method is able to relatively consistently 
and effectively capture inter-subject variations in TVE curve behaviour. Examples of 
the variation in TVE curve shape intra- and inter- subject are provided in Fig. 6.4. 
Accurate capture of relative changes and trends in patient behaviour are extremely 
important, as these changes are critical in assessing whether a patient is recovering, 
responding to treatment, or is not responding and in need of a change in treatment.  
Most pigs demonstrated notable changes and intra-pig variability in driver shape during 
recruitment manoeuvres and as sepsis developed. A couple of the more unusual driver 
shapes were not fully captured. For example, Panel 2 of Pig S4 in Fig. 6.4, where the 
driver measured driver displayed two peaks and the simulated driver only one.  
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The simulated TVE curve demonstrated consistently low signed area error, at -2.5% 
(IQR –6.1% to 0.8%), shown in Table 6.2. This result shows the method only slightly 
underestimates the TVE curve, supported further by 2 pigs having a slight positive bias 
and the other 3 a slight negative bias. This outcome further supports the ability of the 
TVE curve to accurately capture both intra- and inter- subject variability over time and 
condition. 
In assessing the impact of assumptions on the TVE curve, a comparison of Table 6.2, 
using approximated Ves and Ved, and Table 6.3, using measured Ves and Ved, show very 
similar error values. For example, overall median error fell from 11.4% to 10.2% and 
overall bias from -2.5% to -2.2%, only a modest reduction in error. This result implies 
that the body of assumptions and equations in Region III, Fig. 6.1 concerned with the 
approximating the Ves and Ved for simulation of Vlv do not result in a large increase in 
error compared to using measured Ves and Ved. The assumptions made in areas of the 
method not involving simulating Ves and Ved are relatively minimal, mostly involving 
using Pao to determine waveform timing. As such, it would seem that much of the error 
associated with this method is the result of assuming equations for parts of the two 
waveforms being reconstructed (Plv and Vlv), as shown in Figs. 6.2 and 6.3. Thus, the 
assumptions employed in Region III, Fig 6.1 appear to function as intended, and further 
reduction in error would probably require increased method complexity or an increase 
in the clinically available data. 
An important point to consider is the fact the TVE curve is consistently normalised to 
a duration and amplitude of 1.0, as it is designed specifically as an indicator of how the 
heart is behaving relatively over the course of a beat, to be coupled with a lumped 
metric (Ees) indicating the overall strength of that heartbeat [55, 89, 90]. This 
normalisation does mean that some of the errors associated with the various 
assumptions and approximations made throughout the method are reduced, and that 
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indicators of absolute cardiac work and its changes, for example, are not able to be 
directly extracted from the TVE curve created. Fortunately, the driver does not exist 
alone, the intent is that the shape of the TVE curve, indicative of transient, relative 
cardiac behaviour, be used alongside other existing metrics, such as Cardiac Output or 
Stroke Volume [108, 136], indicative of lumped, absolute cardiac behaviour, to provide 
further diagnostic information. 
6.4.2 Limitations 
There are study limitations that should be considered. First, all data presented is derived 
from a single protocol involving a single, but complex and varied [88], condition 
(sepsis). This data set encompasses several pigs, a full progression from healthy, 
baseline behaviour to cardiac failure and clinically standard ventilation and fluid 
interventions. Nevertheless, there is a much larger range of possible cardiac conditions, 
and further validation over several of these would be beneficial. However, the method 
already detects changes in haemodynamics, including those due to circulatory or 
cardiac muscle changes during sepsis in this study. Thus, the ability to detect changes 
due to inotropes should be similar to what is presented for the range of behaviours 
already observed in sepsis. Further, given inotrope infusions are determined and 
performed by a clinician, it would be possible to recalibrate the method directly after 
such an infusion to adjust to the new inotropic state if it proved necessary. Overall, the 
underlying physiology and data supporting the development of this method has been 
discussed in detail, and would be expected to generalise well to a wider range of 
conditions, as there are no intervention or condition specific assumptions made.  
The method also requires validation on human subjects to ensure the methodology as 
presented here remains physiologically accurate, though the strong similarities between 
porcine and human physiology and the effectiveness of porcine models are well 
established [137, 138]. Equally, only an animal model, as used here, allows the direct 
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validation against cardiac measured TVE curves, which would not be possible in 
humans.  Thus, only an animal trial allows this important first validation. 
The method does require an initial calibration via echocardiography or similar means. 
Echocardiography equipment is increasingly available in modern ICUs [127]. Further, 
echocardiography is non-invasive and the calibration period required is relatively short, 
requiring approximately 10 heartbeats. However, the requirement of such a calibration 
still prevents the method from being fully implementable without modest additional 
clinical workload using normal ICU instrumentation. 
6.5 Summary 
The TVE curve is an important, but difficult to clinically measure, expression of 
internal cardiac dynamics that captures the heart’s ability as a pump and can evolve 
over time, condition and patients. A novel, minimally invasive method for deriving the 
TVE curve beat-by-beat, by combining simple physiological assumptions with readily 
available catheter waveforms to individually simulate the components of the TVE 
curve, is proposed. This method was assessed across a cohort of 5 Piétrain pigs 
undergoing a progression from healthy behaviour to cardiac failure due to sepsis. The 
TVE curve generated by the method was shown to effectively track a directly measured 
function throughout the experiments, with low overall median magnitude (11.4%) and 
signed (-2.5%) area under the curve errors. There is the potential for this method to 
provide real time, patient specific information on intra-beat behaviour and inter-beat 
variation in the heart, at the patient bedside, without requiring additional, invasive 
instrumentation. However, due to the nature of the TVE curve, this method is limited 






The Pressure-Volume Loop 
While clinical estimation of time varying elastance (TVE) has promise, the lack of an 
absolute value component or current clinical metrics directly derived from the TVE 
curve makes it worth exploring clinical estimation of another cardiac metric based off 
the same inputs. The pressure volume (P-V) loop uses absolute values and is situated 
at the core of the concepts of elastance, ventricular dead space, and cardiac 
contractility. Non-invasive estimation of the P-V loop is considerably more demanding 
than the TVE curve, but concordantly provides significantly more information and 
easily derivable cardiac metrics due to the lack of waveform normalisation during the 
calculation process. 
7.1 Background 
A fundamental expression of cardiac dynamics and function is the left ventricular P-V 
loop [46] (Fig. 7.1), comprising: Filling; Contraction; Ejection; and Relaxation, a 
closed ‘loop’ describing the heartbeat. The area inside the P-V loop is the stroke work 
(SW), an important metric sensitive to cardiac dysfunction, corresponding to work done 
by the ventricle ejecting blood into the aorta [53, 54]. As discussed in Chapter 2, the 
positions of the upper left and lower right corners are points on the end-systolic 
pressure-volume relation (ESPVR) and end-diastolic pressure-volume relation 
(EDPVR) [55, 56] respectively, as is the unstressed or ‘dead space’ ventricular volume 
(Vd) [59]. The P-V loop thus provides information about contractility, which is also 




Clinical estimation of these relationships and associated properties is a major research 
area, typically focused on an individual component or relationship, such as ESPVR 
[91, 139], EDPVR [140] or preload recruitable stroke work (PRSW) [141, 142]. Thus, 
current methods do not provide all the information from the full P-V loop. Further, 
lacking direct left-ventricular pressure (Plv) and volume (Vlv) measurements, these 
methods frequently rely on continuous echocardiography, which is currently 
impractical [143]. There has been no work associated with minimally invasive 
estimation of the P-V loop using currently available, but indirect, catheter data. 
 
Fig. 7.1: Annotated, experimental P-V loop. The slight pressure decrease in ejection 
is due to the open chest experiment [144, 145]. 
This chapter applies the method presented in Chapter 6 for minimally invasive beat-
by-beat estimation of the Vlv and Plv profiles to obtain the left ventricular P-V loop. 
Using clinically available measurements enables potential real-time clinical 
implementation without additionally invasive instrumentation.  
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7.2 Materials and Methods 
7.2.1 Proposed Method 
The left ventricular P-V loop combines Vlv and Plv. As has been previously mentioned, 
direct measurement is highly invasive and not ethically feasible, clinically [66]. As 
such, this chapter employs the method developed in Chapter 6 to estimate Plv and Vlv 
from four clinically available inputs, shown in Fig. 7.2. As before, continuous aortic 
pressure (Pao) and heart rate (HR) are widely available. Continuous femoral pressure 
(Pfe) can easily be measured under clinical conditions, but is not a typical ICU 
measurement [73]. Finally, baseline end-systolic volume (Ves) require a short, baseline 
echocardiography, which is increasingly available, clinically [127]. Importantly, this 
approach is distinct from existing methods used for estimation of clinical metrics 
derived from the P-V loop [91, 139-142] relying on continuous echocardiography 
throughout the duration of monitoring. The short, baseline echocardiography reading 
of Ves minimises demands on specialist time and allows sharing of equipment across 
several ICU patients. 
While this method is largely identical to the method presented in Chapter 6 [135],  there 
are significant differences in the nature of estimating TVE and P-V loops. Specifically, 
TVE is calculated using the relative magnitude of the Plv and Vlv waveforms over time 
and involves significant processing of those waveforms that effectively filters some 
potential sources of error. Normalisation of TVE to a peak value of 1.0 may also limit 





Fig. 7.2: Summary flowchart of proposed method. 
In contrast, obtaining P-V loops requires the absolute values of the two waveforms over 
time, and even relatively small errors that would not necessarily effect TVE could lead 
to significant deviation of analytical and clinical metrics calculated from these loops. 
Thus, the two rely on different components of waveform information, and have 
different established roles and benefits in clinical literature, where there is often a 
greater reliance on the analytical and subjective assessment of P-V loops. This chapter 
thus constitutes a major extension of the applicability of the aforementioned method, 
and requires an entirely separate validation to ensure its accuracy and potential clinical 




7.2.1.1 Summary of Proposed Method 
P-V loop estimation from Fig. 7.2 (see Section 6.2.1 for a detailed description of the 
method) is summarised: 
Initially or Intermittently: 
1. Calculate Vd using Eq. 6.4 and baseline Ves from echocardiography 
2. Calculate EC using Eq. 6.7, PDN, HR and baseline Ves from echocardiography 
Every heartbeat: 
1. Simulate Plv using Eq. 6.2, Eq. 6.3 and Pao  
2. Determine Ves using Eq. 6.7, PDN, HR and EC  
3. Determine SV using Kamoi et al. [124], Pao and Pfe 
4. Determine Ved using Eq. 6.8, Ves and SV 
5. Simulate Vlv using Eq. 6.5, Eq. 6.6, Pao, Ves and Ved  
6. Use Plv and Vlv to generate the P-V loop 
The required clinical measurements include: 
 Continuously sampled Pao 
 Continuously sampled Pfe 
 Continuously sampled HR 
 A baseline, 10-heartbeat Ves 
All of which are either in widespread clinical use or possible to implement clinically 




7.2.2 Analysis and Validation 
Performance was evaluated over two experimentally gathered data sets, encompassing 
142,169 heartbeats from 11 Piétrain pigs across 2 protocols designed to provide diverse 
cardiac conditions [59, 83]. Each data set included direct measurements of method 
inputs (Pao, Pfe and HR) and outputs (Vlv, Plv), allowing direct validation on a beat-by-
beat basis of model generated P-V loops versus invasively measured left-ventricular P-
V loops. 
7.2.2.1 Experimental Data 
This chapter makes use of the 6 Protocol D and 5 Protocol S pigs that were not subject 
to exclusion. The waveforms employed include continuously sampled Pao and Pfe as 
method inputs, and continuously sampled Plv and Vlv to provide surrogate baseline 
echocardiography Ves readings as well as an invasively measured P-V loop for 
validation.  
7.2.2.2 Model Validation 
This method approximates beat-by-beat left ventricular P-V loops using clinically 
available Pao, HR, Pfe, and baseline Ves measurements. Validation compares beat-by-
beat model derived and invasively measured ‘true’ P-V loops. Specifically, the P-V 
loop’s enclosed area or stroke work and the absolute P-V loop values/position, assessed 
by: 
 Diastolic and Systolic Pressures: Direct comparison of invasively measured 
and estimated mean-systolic (Psys) and mean-diastolic (Pdia) pressures. Mean 
pressures were used due to the presence of plateaus of high and low pressures 
in the Plv waveform (Fig. 6.2). Results are expressed as overall percentage error 
quartiles, with inter-pig averages calculated using the mean of quartiles due to 
inter-pig variations in experimental monitoring length. 
105 
 
 Diastolic and Systolic Volumes: Direct comparison of invasively measured 
and estimated Ves and Ved. Because Vlv has distinct peaks and troughs, these 
individual points are compared (Fig. 6.3). Results are expressed as overall 
percentage error quartiles, with inter-pig averages calculated using the mean 
of quartiles due to inter-pig variations in experimental monitoring length. 
 Stroke Work: Direct comparison of the area enclosed by invasively measured 
P-V loop, calculated using admittance catheter data, and estimated P-V loop, 
calculated using the methodology described in this chapter, (SWM and SWE), as 
well as a simplified, clinically used SW approximation [76, 121, 141]: 
𝑆𝑊𝑆 = 𝑆𝑉 ×𝑀𝑆𝑃 (7.1) 
where MSP is the mean-systolic pressure in the aorta. Results are expressed as 
overall percentage error quartiles, with inter-pig averages calculated using the 
mean of quartiles due to inter-pig variations in experimental monitoring length. 
 Changes in Stroke Work: The ability to track SW trends is assessed by trend 
compass [146], comparing time dependent signals (SWM and SWE) over 180 
heartbeat (~3min) clinically relevant intervals. The trend compass assesses 
trend accuracy independent of point accuracy and does so in terms of the 
accuracy of the slope or trend between points, which is clinically relevant as 
such trends are often used to titrate care when they are used to assess a patient-
specific response to care or disease. The trend angle is defined for a given 
heartbeat n: 
𝐴 = [𝑡(𝑛 + 180) − 𝑡(𝑛) 𝑆𝑊𝐸(𝑛 + 180) − 𝑆𝑊𝐸(𝑛)] (7.2a) 
𝐵 = [𝑡(𝑛 + 180) − 𝑡(𝑛) 𝑆𝑊𝑀(𝑛 + 180) − 𝑆𝑊𝑀(𝑛)] (7.2b) 
106 
 




where θ, derived from a rearranged normalised dot product, is an indication of 
the angle between the two vectors. These angles, paired with the magnitude of 
the measured variable (SWM) are plotted on a radial plot. Note that in this 
chapter the magnitude of t(n+180) – t(n) was normalised to be equal to the 
overall mean of SWM and SWE, thus providing scale invariance and a 
comparable ‘difference and mean’ ratio to that used in a Bland-Altman plot 
[147]. 
Pearson’s correlation coefficients (R) are also evaluated. As the data set 
presented here is large (142,169 heartbeats), these correlation coefficients were 
re-calculated with only every 1 in 1000 and then 1 in 2000 beats from the first 
recorded heartbeat included to assess the sensitivity of the correlation 
coefficients to the size of the data set. 
Overall, individual validation of Psys, Pdia, Vsys and Vdia against direct measures allows 
individual evaluation of the effectiveness of the assumptions employed in the method, 
allowing a further, clearer evaluation of efficacy and potential errors of the method 
described in Chapter 6.  
7.3 Results 
7.3.1 Pressures and Volumes 
Table 7.1 shows errors estimating Psys for both protocols (median: 3.7-11.7% for 
Protocol D; median: 1.5-12.1% for Protocol S), suggesting assuming Pao represents Plv 
is effective during systole. Table 7.1 shows higher errors estimating Pdia (median: 
10.7% - 32.9% Protocol D; median: 6.4% - 23.8% Protocol S), which is expected due 
to the fixed nature of the approximation in Eq. 6.3. However, Pdia is frequently an order 
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of magnitude smaller than Psys, thus higher percentage errors do not necessarily 
translate into significant absolute errors. There was a weak correlation between errors 
in Psys and Pdia (R = 0.04) due to the fundamental differences between how the two are 
estimated. 
Table 7.1: Percentage errors for pressure estimation of Pdia and Psys.  Presented as 





Diastolic Pres. (Pdia) 
Mag. Error*: 
Systolic Pres. (Psys) 
D1 5,480 22.1% (8.3–58.2) 3.7% (3.2–4.3) 
D2 5,343 15.2% (7.9–21.9) 8.1% (7.8–8.6) 
D3 32,626 32.9% (14.7–87.0) 7.9% (7.1–8.8) 
D4 17,584 19.0% (10.9–27.2) 11.7% (10.2–12.7) 
D5 15,874 10.7% (4.9–18.1) 11.1% (10.4–11.9) 
D6 18,944 29.3% (13.7–70.7) 4.8% (4.1–5.5) 
Mean (D) 15,975 21.5% (10.1–47.2) 7.9% (7.1–8.6) 
S1 53,46 23.3% (8.5–30.7) 7.1% (4.8–10.4) 
S2 5,382 6.4% (2.9–12.9) 1.5% (0.6–2.6) 
S3 16,233 13.4% (5.8–19.8) 1.7% (1.1–2.6) 
S4 13,507 17.4% (12.8–26.2) 12.1% (10.1–13.7) 
S5 5,870 23.8% (14.9–31.2) 2.2% (1.3–4.2) 
Mean (S) 9,268 16.9% (9.0–24.2) 4.9% (3.6–6.7) 
Mean (D&S) 12,926 19.4% (9.6–36.7) 6.5% (5.5–7.7) 
*Magnitude here refers to the fact that the absolute value of the percentage error is taken prior to summary 
statistics being calculated, thus these errors are not representative of a bias and negative and positive errors 
do not cancel out. 
 
Estimated Ves is a function the assumptions described in Chapter 5 for deriving ESPVR 
(Eq. 6.7). Table 7.2 shows associated median errors of 13.5-75.2% (Protocol D) and 
2.0-6.6% (Protocol S), where Pig D1 is an outlier with 72.5% with the next highest 
protocol D error being 18.7%. Given the generally small value of Ves, moderate 
percentage errors do not necessarily translate into significant absolute errors. Estimated 
Ved is a function of the assumptions associated with Ves combined with those associated 
with deriving the SV as in Kamoi et al. [124]. The expected increase in error due to 
additional assumptions is partially offset by the fact that Ved is, on average, significantly 
larger than Ves. Thus, Ved errors in Table 7.2 (Protocol D: 6.5-25.5%; Protocol S:  4.5-
13.2%) are lower for Protocol D but higher for Protocol S than those for Ves. Again, 
108 
 
Pig D1 is an outlier with next highest at 12.6%. There was a notable correlation between 
errors in Ved and Ves (R = 0.80, Protocol D and R = 0.83, Protocol S), which is expected 
as Ves is a linear input in the estimation of Ved. Overall, Tables 7.1 – 7.2 suggest the 
method effectively locates P-V loops, and thus the method described in Chapter 6 not 
only captures the relative but also absolute behaviour of Plv and Vlv effectively. 
Table 7.2: Percentage errors for volume estimation of Ves and Ved. Presented as 





Systolic Vol., Ves 
Mag. Error: Diastolic 
Vol., Ved 
D1 5,480 75.2% (17.9–110.5) 25.5% (9.9–39.0) 
D2 5,343 14.5% (3.1–27.2) 8.7% (2.3–17.1) 
D3 32,626 15.4% (9.6–23.6) 9.5% (5.3–13.3) 
D4 17,584 13.5% (8.6–22.5) 6.5% (2.3–12.2) 
D5 15,874 17.9% (7.1–84.7) 12.6% (7.1–17.6) 
D6 18,944 18.7% (13.3–30.7) 9.9% (6.0–18.7) 
Mean (D) 15,975 25.9% (9.9–49.9) 12.1% (5.5–19.7) 
S1 5,346 2.0% (1.0–3.3) 4.5% (1.5–8.8) 
S2 5,382 6.6% (4.4–9.9) 13.2% (4.9–17.5) 
S3 16,233 4.5% (2.6–7.6) 6.2% (2.9–12.0) 
S4 13,507 4.7% (2.2–8.1) 5.6% (3.1–11.0) 
S5 5,870 4.3% (2.5–8.1) 5.3% (3.0–9.9) 
Mean (S) 9,268 4.4% (2.5–7.4) 7.0% (3.1–11.8) 
Mean (D&S) 12,926 15.0% (7.7–30.6) 9.5% (4.7–16.1) 
 
7.3.2 Stroke Work 
Errors for estimated SWE and simplified SWS (Eq. 7.1), relative to invasively measured 
SWM, are in Table 7.3. In 29 of 33 quartiles (25th, 50th and 75th for 11 pigs), SWE had 
lower errors than SWS. Table 7.3 also shows correlation coefficients between SWE and 
directly measured SWM with overall R = 0.73 (Dobutamine) and R = 0.84 (Sepsis), 
suggesting the method effectively tracks changes in condition. Table 7.4 shows that 
these correlation coefficients remain relatively steady even when the number of data 
points is reduced drastically. In both protocols, one pig has a significantly lower R value 
than the rest (Pig D3, R = 0.14 and Pig S2, R = 0.58). Errors in SWE were most strongly 
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correlated with errors in Psys (R = 0.70), with other correlations being poor (Pdia, R = 
0.04, Ves, R = -0.03, Ved, R = 0.16).  
Table 7.3: Percentage errors for stroke work estimation. Presented as median (25th – 
75th percentile) for Protocol D, Pigs D1 – D6 and S, Pigs S1 – S5. 
Pig 
Mag. Error: Est. 
Stroke Work (SWE) 
Mag. Error: Simp. 
Stroke Work (SWS) 
Corr. Coeff. 
(R) 
D1 3.5% (1.6–5.7) 8.9% (4.7–15.5) 0.90 
D2 26.0% (21.6–30.2) 33.7% (28.8–41.0) 0.94 
D3 32.6% (18.7–46.8) 43.7% (19.1–74.6) 0.14 
D4 30.0% (17.9–63.7) 61.5% (37.9–90.2) 0.68 
D5 27.8% (13.9–42.6) 40.1% (26.4–57.0) 0.70 
D6 17.2% (5.9–34.5) 22.7% (11.9–37.1) 0.80 
Mean (D) 22.9% (13.3–37.3) 35.1% (21.5–52.6) 0.73 
S1 15.6% (5.3–21.3) 30.6% (7.5–39.1) 0.95 
S2 16.4% (10.4–20.7) 14.3% (7.6–24.0) 0.58 
S3 24.6% (12.4–42.9) 43.1% (22.5–67.6) 0.88 
S4 41.2% (14.2–61.1) 57.4% (25.0–74.8) 0.84 
S5 20.8% (17.5–55.6) 8.9% (4.7–96.4) 0.92 
Mean (S) 23.6% (12.0–40.3) 30.9% (13.5–60.4) 0.84 
Mean (D&S) 23.2% (12.7–38.6) 33.2% (17.8–56.1) 0.77 
 
Table 7.4: Correlation coefficients for reduced data sets 
Data Set R, all data R, 1 in 1000 R, 1 in 2000 
D 0.73 0.75 0.75 
S 0.84 0.79 0.74 
D & S 0.77 0.76 0.75 
 
Figs. 7.3 – 7.4 present trend compasses comparing estimated SWE and invasively 
measured SWM with percentage of trends having abs(𝜃) < 0.0997° = tan−1(0.1),  or 
1 part in 10 gradient error [146]. The upper semicircle represents increasing SWM 
trends, and the lower, decreasing SWM trends. The right semicircle represents 
overestimation (ΔSWE > ΔSWM), and the left underestimation (ΔSWE < ΔSWM) of the 
trend. Protocol D had 84.4 – 93.1% in this band and Protocol S, 80.4 – 92.1%. Thus, 
while errors may be greater, trend accuracy is strong over clinically relevant periods 




Fig. 7.3: Trend compass plots for estimated and measured stroke work, Dobutamine 





Fig. 7.4: Trend compass plots for estimated and measured stroke work, Sepsis 






Fig. 7.5: Example P-V loops for different error quartiles, Dobutamine (Protocol D) 






Fig. 7.6: Example P-V loops for different error quartiles, Sepsis (Protocol S) Pigs. 




Figs. 7.5 – 7.6 present demonstrative P-V loops for both protocols, as examples of 
quartiles of lumped SW estimation error in Table 7.3, thus illustrating the qualitative 
range of errors. Significant inter- and intra- subject variability is present, but overall 
errors are not qualitatively large and supported by strong trend accuracy in Figs. 7.3 – 
7.4. Overall, these results show the method’s ability to approximate subject specific 
shape and location of P-V loops.  
7.4 Discussion 
7.4.1 Pressure and Volume 
Comparing invasively measured and estimated pressures and volumes in Tables 7.1 – 
7.2 assesses both method efficacy and, in isolation, the impact of underlying 
assumptions in a manner impossible when analysing TVE as in Chapter 6. Low errors 
in Table 7.1 suggest Pao and Plv remain similar in systole, while the aortic valve is open, 
even during administration of drugs and the progression of sepsis significantly altering 
cardiac function. Psys, is the only measured (Pao) edge of the P-V loop, resulting in 
expected lower errors in Table 7.1, and thus assuming Pao and Plv remain similar holds 
well. 
Pdia, results from assuming a set of fixed exponential waveforms, due to lack of 
available pressure data during diastole. Errors were thus higher and varied more 
between pigs in Table 7.1. However, since Pdia is roughly an order of magnitude smaller 
than Psys, larger percentage errors translate to less significant absolute errors and do not 
significantly affect the method’s ability to position a P-V loop. 
Ves, was estimated using a modified ESPVR encompassing several assumptions. 
Median errors in Table 7.2 show significant differences (p < 0.05, two-tailed Student’s 
t-test) between protocols D and S, possibly due to the use of dobutamine (Protocol D), 
which artificially alters the elastance used/found in estimating Ves, as well as due to an 
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outlying Pig D1. However, excluding this outlier, errors for both protocols were within 
acceptable levels. 
Ved was estimated using estimated Ves and estimated SV from Kamoi et al. [124], 
combining error contributions from both. This issue is partially offset by the fact Ved > 
Ves, resulting in lower overall errors for Protocol D and slightly higher, but still very 
low, errors for Protocol S in Table 7.2, after removing outlier Pig D1. Excluding D1, 
median errors throughout estimation of Ves and Ved do not exceed 20%, suggesting 
effective volumetric location of the P-V loop. 
Interestingly, Pig D1 has low SW errors (Table 7.3) and effective trend tracking (92.6%, 
Fig. 7.3), implying actual shape and changes in shape of the P-V loop were well 
captured with some measure of bias. Large errors in Ves and Ved may be due to a zeroing 
or sensor drift error in the volume catheter during this experiment. This possibility is 
supported by the percentage error in Ved for Pig D1 being 3 times lower than for Ves, in 
contrast to most other pigs where this percentage error is 1.5 -  2 times lower. This 
discrepancy suggests a large part of error for Pig D1 is a steady offset or bias, which 
would be significantly reduced by a larger magnitude Ved, as opposed to random error 
whose size depends on the measured value. Since a great deal of clinical management 
is titrated based on changes in measured state, this issue is significantly ameliorated by 
very good trend correlation. 
Existing single-beat estimation methods for ESPVR [139] and EDPVR [140] rely on 
continuous echocardiography to provide continuous SV and ejection fraction data, 
which are currently cost prohibitive for standard ICU use [143]. Other measurements 
are also often required, such as arm cuff pressures [139]. The method presented here 
avoids such requirements by employing echocardiography only for a short calibration 
period, reducing associated costs, complexity and demands on specialist time. More 
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importantly, this method provides a unified set of cardiac dynamic information, in 
contrast to a single relationship. 
7.4.2 Stroke Work 
Table 7.3 compares errors between method estimated SWE and a common, simplified 
approximation, SWS with directly measured value. Error in SWE was lower than SWS in 
29 of 33 quartiles assessed, suggesting this method’s added complexity provides 
greater accuracy. Overall, average errors are 22.9% for Protocol D and 23.6% for 
Protocol S, with Figs. 7.3 – 7.4 and Table 7.2 showing strong correlation and trend 
accuracy. These results are significant, as they suggest the method effectively tracks 
changes in patient condition, despite errors, which is extremely important in in titrating 
care in the ICU. 
Errors in SWE were most strongly correlated to errors in Psys (R = 0.70), with other 
correlations being poor (R = -0.03 to 0.16). This was of interest as estimation of Psys 
involves directly copying a section of Pao and assuming it is representative of Plv. As a 
large amount of the method’s information is derived from Pao, it is possible that 
differences between Plv and Pao while the aortic valve is open and the two should be at 
their most similar, uncluttered by any mathematical process, provide a reasonable 
predictor, albeit one unavailable clinically, of overall method accuracy for a given 
subject. 
Pig D3 exhibited significantly lower correlation (R = 0.14), which is not upheld by the 
trend compass in Fig. 7.3 with 93.0% within the specified θ band. The likely cause of 
this discrepancy is the long experimental time of Pig D3 (32,626 heartbeats), involving 
long periods without interventions where natural variation and noise dominate. R 
values punish ‘horizontal’ trend regions, as two variables that don’t change aren’t 
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necessarily correlated [119], while a trend compass makes no distinction and tracks 
trends independent of point accuracy [146].  
Figs. 7.5 – 7.6 illustrate the range of results for P-V loops in different error quartiles in 
Table 7.3. The large variations in loop size in Fig. 7.5 for Pigs D2 and D4 show the 
significant effect of dobutamine on the circulatory system. Similar large variations in 
loop size in Pigs S4 and S5 (Fig. 7.6) demonstrate the significant effect of sepsis on 
cardiac function. Overall, these figures demonstrate the ability of the method to capture 
the diverse range of locations and shapes the P-V loop can take across different subjects 
and conditions. Finally, in several cases, the high percentage errors are due to 
overestimation of relatively small SWM values (Pigs D4, S4, S5). Even in cases where 
error in SWE is relatively high, the method is qualitatively reasonably able to locate and 
approximate the P-V loop shape and offers very good trend tracking.  
There exist single-beat methods to estimate PRSW with strong correlation to measured 
SW, using non-invasive measurements and echocardiography [141]. This approach 
performed well using invasive measurements in dogs [141] and in humans. However, 
using non-invasive measurements reduced strong correlations to R = 0.66 or R = 0.71 
when subject specific baseline ventricular properties were incorporated (associated 
percentage errors aren’t reported) [142], which is lower than the overall method 
presented here (R  = 0.77). Further, this other method requires more expensive, 
continuous echocardiography [143], as opposed to a short echocardiography 
calibration. Finally, it also does not provide the unified set of absolute pressure, volume 
and P-V contour information provided by the method presented here. 
7.4.3 Limitations 
Inevitably, there are limitations. First, the proposed method requires two inputs that are 
not widely available in the ICU, although readily obtained clinically. Specifically, a 
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short, non-invasive echocardiography calibration period of approximately 10 
heartbeats and continuous Pfe as an input for the SV model [124], where it is used to 
estimate pulse wave velocity. While availability of echocardiography is becoming 
increasingly widespread in the ICU [127], this requirement still represents a modest 
additional clinical workload relative to normal ICU instrumentation. Pfe can be 
invasively measured clinically [73], but typically is not measured because it does not 
provide relevant additional information over Pao barring specific cases. However, 
combining Pao and Pfe to approximate SV adds new data and capability that may change 
this perception. Alternatively, Pfe can be ignored at the cost of some accuracy, as 
without Pfe one of the Windkessel elements must be fixed based on population values 
[108]. Existing studies show a shift from a 90% limit of agreement of less than 
±10 ml[124] to a 90% limit of agreement of −12.4 to 14.3 ml [108] in SV estimation.   
The data in this study is the product of a limited set of protocols and range of conditions. 
However, deliberately challenging protocols were selected, encompassing the complex 
and varied progression of sepsis [88], infusions of dobutamine to provide the largest 
possible disruptions to model assumptions about contractility, and several clinically 
standard interventions including recruitment manoeuvres. These are part of a far greater 
possible range of cardiac conditions, and the ability of the method to detect the effects 
of intra-ventricle conditions such as an ischemic attack, in addition to systemic 
conditions, should be validated with future work. However, such intra-ventricle 
conditions would be expected to affect diastolic/systolic timing and/or cardiac output, 
all of which influence the method through the medium of measured Pao, and thus be 
potentially detected with this method although it was not possible to validate that 
possibility in this study. Hence, the overall physiology and assumptions employed 
developing this method are expected to generalise well, as no condition or intervention 
specific assumptions were made. 
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Finally, validation on human subjects is required before the method can be considered 
for clinical validation or use in observational and/or intervention studies.  
7.5 Summary 
The method developed in Chapter 6 was validated for the minimally invasive beat-by-
beat estimation of the left ventricular P-V loop. This validation was performed across 
142,169 heartbeats of data from 11 Piétrain pigs that were subject to two distinct 
protocols encompassing sepsis, dobutamine administration and clinical interventions. 
The method demonstrated the ability to effectively locate the P-V loop, with overall 
median errors for Ves of 15.0%, Ved of 9.5%, Psys of 19.4% and Pdia of 6.5%, and to 
estimate SW effectively, with an overall median error of 23.2%. Further, the method 
was shown to be able to effectively track changes in SW, with a trend compass in band 
performance of 80.4% to 93.1%, and an average R value of 0.77. While the method 
requires further validation, specifically on human subjects, it has demonstrated 
potential as a means of providing additional insight into cardiac behaviour, both in the 











The end-systolic pressure-volume relation (ESPVR) has been present throughout this 
thesis. As was discussed in Chapter 4, linear extrapolation of the ESPVR to the volume 
axis provides V0, ventricular volume at zero pressure. Providing a sufficient range of 
ESPVR values for this extrapolation is a popular experimental method for 
approximating this parameter, but requires inducing a significant drop in cardiac 
output. This chapter provides an overview of the results of estimating V0 using the 
experimentally standard vena cava occlusion method, and frames the results against 
those in Chapter 4 and literature surrounding the ESPVR in general. 
8.1 Background 
The ESPVR is an important cardiac relation with a strong presence throughout this 
thesis. The ESPVR can be used to evaluate the contractile state of the heart, as well as 
the response of the heart to changing circulatory conditions for a given contractile state 
[57]. ESPVR, generally represented as a linear pressure-volume relationship, can also 
be extrapolated to the volume axis to determine V0, the volume of the heart at zero 
pressure, which is similar to Vd, the unstressed or ‘dead space’ ventricular volume, as 
discussed in Chapter 4. V0 and Vd are important aspects in normalising models of 
cardiac behaviour across different subjects or contractile states, as this volume is ‘non-




However, the linearity of the ESPVR only holds when either the curve is developed 
over a timescale sufficiently long for cardiac reflexes to not exert significant influence, 
or if cardiac reflexes are suppressed, for example by β-blockade as in [112] or 
ganglionectomy as in [113]. This issue presents something of a conundrum, as slowly 
but significantly reducing cardiac output (CO) over sustained period of time effects the 
cardiovascular system and can fail to provide a clinically desired ‘snapshot’ of 
contractile state due to the longer timescale. Similarly, suppression of cardiac reflexes 
through drugs or surgery significantly alters cardiovascular system behaviour and thus 
influences experimental results. The vena cava occlusion, favoured for its ability to 
cause a short, sharp drop in CO without long term effects on the subject, falls within 
the timescale where the influences of cardiac reflexes are significant and curvilinear 
behaviour can be observed if cardiac reflexes are not suppressed [112, 148, 149]. 
A potential workaround is to apply a curvilinear model to this short term ESPVR, 
potentially allowing determination of V0 while avoiding the disadvantages presented 
above. This approach has been attempted in previous studies involving canine subjects 
and quadratic models, and shifts from negative, non-physiological V0 values from 
linear models to small, positive, physiologically realistic V0 values from quadratic 
models noted [112, 148]. However, as noted in one of these papers, ‘a clear drawback 
of the parabolic equation, however, is that it lacks any inherent theoretical basis’ [148]. 
Further, these studies do not present end-systolic volume (Ves) values that allow for 
comparison with the method presented in Chapter 4, nor do they compare V0 and Vd as 
a means of further validation. 
This work examines data from repeated vena cava occlusion manoeuvres and compares 
a linear model with a nonlinear exponential model of the ESPVR in a case where 
reflexes are unsuppressed. An exponential model has a greater physiological 
precedence than a quadratic model, due to the general prevalence of exponentials in 
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physiological modelling as exemplified by the fact that EDPVR, a sister relationship 
to ESPVR, is typically expressed as an exponential [46]. Further, an exponential model 
behaves in a more physiological manner than a quadratic when extrapolated.  
The vena cava occlusion manoeuvres take place over a large pressure range and number 
of heartbeats in a number of different pigs, providing a broad range of data.  The unique 
aspects of this study are the number of heartbeats per pig across multiple occlusion 
manoeuvres available, the exploration of exponential modelling of the ESPVR as 
compared to the linear or quadratic models typically employed [150] and the use of 
porcine data as opposed to canine or rat data, which is important due to the close 
physiological resemblance of pigs to humans [151]. Further, these results are framed 
against baseline Ves values and compared to those obtained for Vd in Chapter 4. 
8.2 Methods 
8.2.1 Experimental Data 
This chapter makes use of the 6 Protocol D pigs that were not subject to exclusion. The 
waveforms are continuously sampled left-ventricular pressure (Plv) and volume (Vlv) 
over the course of multiple vena cava occlusions of between 10 and 20s duration, which 
are used to develop the ESPVR. Overall 1177 heartbeats during these vena cava 
occlusion manoeuvres were analysed. Data from the Protocol S pigs were not used in 
this chapter, as vena cava occlusions were not performed as part of this protocol. 
8.2.2 Modelling the ESPVR 
During vena cava occlusion manoeuvres end-systolic pressures and volumes were 
determined by finding and recording the maximum ratio of pressure to volume for each 
heartbeat. Two models were used for determining ESPVR and V0. The first is the 
traditional linear model, which was used as a means of comparison and to confirm a 
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significant departure from linear behaviour was being observed due to the action of 
cardiac reflexes: 
𝑃𝑒𝑠 = 𝐸𝑒𝑠(𝑉𝑒𝑠 − 𝑉0) (8.1) 
where Pes represents end-systolic pressure and Ees end-systolic elastance. The second 
model used was the exponential model: 
𝑃𝑒𝑠 = 𝑃∞(1 − e
−𝑚(𝑉𝑒𝑠−𝑉0)) (8.2) 
where P∞ is the asymptotic pressure and m an indication of the steepness of the 
exponential curve.  
The exponential model was selected as it captured observed nonlinear ESPVR 
behaviour with more physiological accuracy than previously employed quadratic 
curves, which can behave in a non-physiological manner when extrapolated. Both 
curves were fitted by using the Levenberg-Marquardt Algorithm to minimise the 
geometric mean deviation (GMD) [152]. Use of the GMD accounts for the fact that 
both the volume and pressure measurements taken are equally subject to measurement 
error. Linear and exponential ESPVR curves were compared based on Pearson’s 
correlation coefficient (R) values. Both the linear and exponential fit were evaluated 
using the correlation between measured Pes and Pes as determined via Eq. 8.1 (linear) 
and Eq. 8.2 (exponential) from measured Ves. This process ensured the comparison was 
a fair comparison between two linear, 1-1 fits, as R is designed for linear correlations. 
The resulting V0 values were also compared with values presented in literature, and 





8.2.3 Statistical Comparison of Models 
The Akaike information criterion (AIC) is a method of estimating the loss of 
information involved with using a model to represent a data set [153]. It presents a 
trade-off between goodness of fit against model complexity, and can be expressed for 
a least squares problem: 
𝐴𝐼𝐶 = 𝑛 log (
𝑅𝑆𝑆
𝑛
) + 2𝐾 (8.3) 
where n is the number of data points in the sample set, RSS is the residual sum of square 
errors and K is the number of parameters in the model. Lower values of the AIC are 
considered indicators of a more effective model than higher values. 
8.3 Results 
Combined end-systolic pressures and volumes for each pig, with linear and exponential 
fits, are shown in Fig. 8.1. Of note is the nonlinear behaviour in all pigs except Pig D6, 
and the fact that the curves for different positive end-expiratory pressure (PEEP) levels 
largely conform to a single exponential model. Also of note is the unusual behaviour 
of Pig D4, which appears to undergo a change in contractile state between PEEP 10 
and 15 and thus is split into two model lines. Example pressure-volume (P-V) loops 







Fig. 8.1: ESPVR linear and exponential model lines for Pigs D1 – D6, example P-V 
loops are overlaid. 
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The linearised correlation coefficients for each pig along with V0 and AIC values are 
presented in Table 8.1. 
Table 8.1: Correlation coefficients and V0 values for linear (V0, Lin) and exponential 



















D1 0.943 0.929 11.67 1.43 614.4 703.3 276 
D2 0.951 0.939 8.56 -3.29 560.9 595.2 154 
D3 0.929 0.923 9.38 3.78 981.3 1020.1 266 
D41 0.926 0.900 7.47 -5.87 428.5 467.1 111 
D42 0.978 0.947 11.1 4.73 146.8 216 89 
D5 0.717 0.708 3.31 -6.33 571.9 624.7 153 
D6 0.873 0.882 -5.72 -15.22 435.5 437.5 124 
 
Finally, the V0 values provided by the exponential model presented relative to baseline 
Ves in Table 8.2, to allow comparison with those results from Chapter 4.  
Table 8.2: V0 from exponential ESPVR expressed as a percentage of baseline Ves (V0, 
%Ves(0)). 
Pig 





D1 11.67 45.8 25.5% 
D2 8.56 52.1 16.4% 
D3 9.38 39.0 24.0% 
D41 7.47 18.2 41.1% 
D42 11.10 18.2 61.1% 
D5 3.31 8.5 38.9% 
D6 -5.72 20.0 -28.6% 
 
8.4 Discussion 
The exponential model demonstrates a reasonably consistent, if modest, overall 
improvement in correlation coefficient (p < 0.05, two-tailed, paired Student’s t-test), 
with only Pig D6 demonstrating a higher linear than exponential correlation coefficient 
in Table 1. Further, the exponential fit provided more physiologically reasonable, 
positive values for V0 in 6 out of 7 cases, while the linear fit provided non-
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physiological, negative V0 values in 4 of 7 cases. Negative V0 values are an 
acknowledged issue with linear ESPVR when generated rapidly [57], especially where 
cardiac reflexes are active. The exponential fits appear to go some way towards 
alleviating this issue, similar to the results of a quadratic fit, as previously reported 
[112, 148]. 
The AIC values for the exponential model in Table 1 are consistently, if modestly, 
lower than those for the linear model (p < 0.01, two-tailed, paired Student’s t-test). This 
result suggests that, even accounting for the additional parameter available to the 
exponential model, the exponential model provides an improvement in performance 
over the linear model. The combined AIC values, R values, and V0 values support the 
validity of an exponential model to account for nonlinear behaviour of the ESPVR in 
cases where cardiac reflexes are not supressed. 
The exponential model also performs in a more physiological manner as the boundary 
conditions are approached. Exponential models tend towards a positive asymptotic 
pressure as volume increases, rather than increasing indefinitely (linear) or potentially 
decreasing (quadratic). Indeed, the end-diastolic pressure-volume relation (EDPVR) is 
represented by an exponential curve [46].  
With the exception of Pig D6, the V0 values presented range from 16.4-41.1% of 
baseline Ves for the Protocol D pigs. These result agree well with V0 values reported in 
literature, for example 13-52% of baseline Ves in cross circulated dogs [109], and 24-
84% of baseline Ves, ignoring non-physiological negative results, in humans [58]. Other 
literature [111, 122] reports similarly sized, positive values, as might be expected. 
Further, V0 values presented here agree reasonably well with 44-53% of baseline Ves 
reported for the Protocol S pigs in Chapter 4. It is possible that the exponential method 
presented in this chapter underestimates Ves in some cases, as the method in presented 
Chapter 4 is more rigorous and reliant on a more robust pair of redundant linear 
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extrapolations rather than a single, significant, nonlinear extrapolation. Regardless, the 
exponential method does notably improve V0 estimation over the linear ESPVR under 
the conditions presented. 
As noted above, Pig D6 exhibits performance different from the other subjects. This 
pig demonstrated negative V0 values for both linear and exponential fits, larger 
correlation coefficients for linear than exponential fits and visually apparent linear 
behaviour. However, it is possible this behaviour is the result of the occlusion 
manoeuvres failing to move the P-V loops far enough left for curvilinear behaviour to 
become apparent in this specific pig, or due to the pig’s cardiac reflexes failing to 
perform effectively. This linearity also accounts for the negative V0 produced by the 
exponential fit, as the lack of the steeper gradient closer to the x-axis results in an 
exponential with extremely low curvature, approaching linear behaviour. 
Pig D4 exhibits an apparent change in contractile state between PEEP 15 and PEEP 20, 
with two quite separate, but distinctly curvilinear, ESPVR lines. As these two regions 
are able to be distinctly separated both in terms of PEEP level and temporally, the data 
was split into its two separate sections for model fitting. While this split increases 
overall R values, the core purpose of this paper is to compare linear and exponential R 
values, rather than obtaining a high R value. Thus, this approach is justified. It is worth 
noting that both of the exponential V0 values are positive and agree reasonably well, 
while the linear V0 values vary greatly and go from negative to positive. During the 
second occlusion manoeuvre at PEEP 15, the balloon used to occlude the vena cava 
failed to fully deflate, raising the possibility that it remained partially inflated for the 
remainder of the experiment, thus potentially causing the observed behaviour.  
Fitting a single ESPVR curve through data corresponding to different PEEP levels in a 
given specimen is unusual and provides for some interesting observations. ESPVR is 
supposedly relatively independent of cardiac preload and afterload [154, 155], and 
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dependent mainly on the contractile state of the individual. However, this assumption 
has been the subject of ongoing debate [57, 109, 156], and, as PEEP effects both 
preload and afterload [157], it is possible PEEP changes cause shifts in ESPVR. The 
data shown in Fig. 8.1 shows slight variability in ESPVR with PEEP changes, with no 
discernible trend as pressure increases (Pig D6, for example, shifts to the left as PEEP 
rises, while Pig D2 shifts to the right). This result agrees well with other animal studies, 
which show ESPVR is not altered significantly by PEEP [125, 158]. 
Use of an exponential ESPVR curve to model cases where cardiac reflexes are 
unsuppressed has interesting potential implications. While the difference between a 
linear and exponential ESPVR is minimal over the physiological range typically 
observed in an ICU, the exponential curve slightly shifts the expected cardiac response 
to changing circulatory conditions for a contractile state. A more significant change is 
in terms of providing more accurate estimates of V0 or Vd, as the two curves behave 
quite differently when extrapolated to the volume axis. While not as robust as the 
method presented in Chapter 4, this result has the potential to improve the accuracy of 
V0 estimation from the ESPVR when generated from short term interventions while 
cardiac reflexes are active. 
8.5 Summary 
The ESPVR has been observed to behave in a curvilinear fashion when generated over 
a short time span with cardiac reflexes not supressed, as in an ICU patient. Experiments 
were conducted encompassing 41 vena cava occlusion manoeuvres at a variety of 
PEEPs across 6 porcine specimens, and ESPVR assessed for each pig. The ESPVR 
curves were found to conform better to an exponential fit in 6 out of 7 cases, and 
provide more physiologically reasonable positive V0 values in 6 out of 7 cases, while 
the linear fit produced positive V0 values in only 3 out of 7 cases. This overall outcome 
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conforms to the notion that ESPVR is nonlinear where cardiac reflexes are not 










Arterial Transfer Functions 
An alternative means of looking at the circulation of blood is through direct waveform 
energetics. In this chapter, rather than manually creating a deterministic, 
physiologically relevant model, the pressure waveforms in the circulatory system are 
treated as inputs and outputs for a non-physiological transfer function based 
mathematical model, with the results interpreted in the frequency domain. This 
approach requires no a-priori physiological assumptions beyond what is located 
‘upstream’ and ‘downstream’, but implicitly assumes an overall linear behaviour 
between the two signals. It is thus more focused on the direct observation, interpretation 
and analysis of the available data. 
9.1 Background 
Transfer functions relate the outputs of a system to their inputs, and are popular in a 
wide variety of fields [159]. Transfer functions are expressed in the frequency domain, 
rather than the time domain, and are defined for linear time-invariant systems. While 
real world systems often do not strictly conform to the definition of ‘linear time-
invariant’, within certain boundaries their behaviour generally can be expressed as 
such. Transfer functions are used to mathematically analyse system behaviour and 
predict response to a wide range of inputs, for example a building’s seismic response 










where H(s) is the transfer function and Y(s) and X(s) are the system output and input, 
respectively, transformed onto the complex s-plane, which is used to express system 
behaviour in the frequency domain. Provided the inputs and outputs are periodic, the 
transformation from time to frequency domain can be achieved using Fourier 
transforms [163].  
Transfer functions can be applied to biological systems, including the circulatory 
system. Prior work investigated transfer functions between inter-beat averages of 
airway pressure, aortic pressure split into diastolic, systolic and pulsatile components, 
and heart rate [164, 165]. These works primarily focus on longer term trends and the 
circulatory system’s auto-regulation mechanisms. Additional results exist using 
transfer functions to estimate the aortic pressure waveform from a peripheral pressure 
waveform [166]. However, there is currently no work exploring the diagnostic potential 
of intra-beat cardiovascular pressure wave transfer functions. 
This chapter explores the ability of intra-beat transfer functions to provide diagnostic 
information across an animal trial dataset encompassing the development and 
progression of sepsis. In general, intra-beat transfer functions are applicable to any 
combination of two pressure or volume waveforms within the same region (systemic 
or pulmonary) of circulation. As sepsis primarily effects the systemic circulation, 






An experimental animal trial data set including the progression of sepsis was employed 
in this chapter. Sepsis typically results in a decrease in systemic resistance due to 
capillary leakage [88]. Thus, clear changes in a systemic intra-beat pressure wave 
transfer function are anticipated. 
9.2.1 Experimental Data 
This chapter makes use of the 5 Protocol S pigs that were not subject to exclusion. The 
waveforms employed include continuously sampled Pao and Pfe, used as the input and 
output waveforms for the transfer functions.  
9.2.2 Data Processing 
As experimentally gathered data from a biological system is not strictly linear time-
invariant, some post-processing is required to obtain suitable waveforms. First, 
waveforms were grouped into sets of 8, to provide a sufficient window length to capture 
lower frequency influences, such as the breathing cycle, given the 250 Hz sampling 
rate and average 60 bpm cardiac cycle. Second, for each of these sets of 8 heartbeats, 
the late-diastolic region of the first heartbeat (Region D, Fig. 9.1) was adjusted via a 
shear transform to match the beginning of the corresponding region for the final 
heartbeat. This transform is illustrated in Fig. 9.1 by the dashed horizontal line, where 
only a single heartbeat instead of 8 is shown for ease. The shear transform provides a 
repeating sequence of heartbeats without any step changes, a ‘periodic’ waveform 
suitable for a Fourier transform. These operations were performed for both Pao and Pfe, 




Fig. 9.1: Modification of Pao. Only one heartbeat is shown for clarity, though this 
operation actually performed between the 1st and 8th heartbeat of a set. 
The set of 8 heartbeats was then adjusted such that the signal began and ended at zero, 
and zero padded to a length of 4096 samples. This process provides a frequency 
resolution of approximately 0.06 Hz, covering an effective range from 0 – 125 Hz, 
yielding sufficient frequency resolution and range to easily separate breathing cycles 
set at 0.25 Hz by the ventilator, and heartbeats at ~1 – 2 Hz. Zero padding was used 
instead of a broader windowing function as a broad window risks including significant 
changes in Pao or Pfe, resulting in a signal that changes too dramatically to be 
approximated by a periodic function. Fourier transforms were performed using the 
MATLAB ‘fft’ function (R2014a, 64-bit, The Mathworks, Natwick, MA, USA). 
9.2.3 Data Presentation 
As the cardiovascular system is not linear time-invariant in the long term, this method 
generates a large number of short term transfer functions, which can evolve over time. 
Presentation of such a large number of transfer functions was performed in two 
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different fashions. The first manually divides the data into sections between 
interventions, where the system should behave in an approximately linear time-
invariant form. The transfer functions within each region are averaged, providing a 
small set of representative transfer functions. This approach results in far fewer transfer 
functions to be displayed, at the cost of averaging large areas of data where changes 
may be occurring in the shorter term. However, it allows the results to be presented in 
a 2-D profile, which aids interpreting the data. The second approach plots a full 3-D 
surface plot, showing the evolution of the transfer functions and phase plots over the 
course of the experiment for each pig. This approach provides a full indication of the 
evolution over time of the transfer function, but is more difficult to interpret than the 
profile plot in the first approach. 
9.3 Results 
Fig. 9.2 presents the transfer functions between Pao and Pfe, divided into regions over 
the clinical trial by hand. The transfer functions progress from a light to a dark cyan 
throughout the pre-sepsis procedures, with recruitment manoeuvres (RMs) denoted by 
dashed lines, and then magenta to red throughout the post-sepsis procedures, with RMs 
again denoted by dashed lines. The vertical dashed lines denote average breathing and 
heartbeat frequencies from left to right, respectively. Of note are the peaks and 
harmonics occurring at roughly 2 Hz, 4 Hz and 8 Hz, which occur relatively 
consistently across pigs. Beyond a frequency of about 8 Hz, the data is overwhelmed 
by signal noise. 
Fig. 9.3 presents the phase angle between Pao and Pfe, divided into regions by hand. 
There is a slight phase lag present at approximately the heartrate, and this phase lag 
steadily increases with frequency. Due to the extremely large phase lag occurring at 



























Figs. 9.4 and 9.5 present the surface plots generated from the transfer function and 
phase plot, respectively, over the course of the experiment. The axes here are limited 
to frequencies below 10 Hz, based on the high noise levels present at higher frequencies 
in Figures 9.2 and 9.3. One can observe the same set of peaks and harmonics in Fig. 4 
at 2 Hz, 4 Hz and 8 Hz, and phase lag in Fig. 9.5, as well as observe more clearly the 
evolution in these features over time.  
9.4 Discussion 
Fig. 2 shows the transfer function between Pao and Pfe. Interestingly, the largest peak 
occurs at a frequency of approximately 2 Hz, consistently higher than the average heart 
rate. This peak is present at roughly the same frequency for all 5 pigs, and is followed 
by harmonics at 4 Hz and 8 Hz, although the size of these harmonics varies between 
pigs. There is also a small, intermittent peak at a frequency corresponding to the 
respiratory rate. Above ~8 Hz the transfer function begins to oscillate rapidly, 
suggesting that noise, due to discretisation errors in the catheter and mains noise 
amongst other issues, is dominant, and the signal is no longer interpretable. However, 
as this frequency is significantly higher than the heartrate at approximately 1 – 2 Hz, it 
is likely only higher harmonics, rather than important signal information is being lost. 
Pigs that died before completion of the protocol (Pigs S1, S2 and S5) showed 
significantly less variation in low frequency energy transfer than pigs that survived the 
duration of the protocol (Pigs S3 and S4). In general, attenuation appears to occur as 
sepsis progresses. However, the degree of this attenuation varies, and Pig S5 is an 
exception.  
This long term low frequency attenuation suggests a loss of pressure in the periphery, 
consistent with sepsis [11, 167]. The fact that it does not manifest as strongly in pigs 
that rapidly died is interesting. It is possible this difference is due to data being 
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truncated once Pao and Pfe deteriorated to the point that features were difficult to make 
out. Pigs S1, S2 and S5 hit this point rapidly after endotoxin infusion.  
The magnitude of the peak at breathing frequency varies significantly with time. Some 
of this variation is likely due to the RMs used. However, some variation is also due to 
Pao and Pfe falling as sepsis progresses, resulting in a greater contribution of pressure 
variation due to breathing, which remains constant aside from RMs. 
Fig. 9.4 shows a full surface plot of the transfer function between Pao and Pfe. This plot 
reveals several interesting trends not observed in Fig. 9.2. First, sharp drops in the 
transfer function across all frequencies occur consistently with RM delivery, most 
obviously in Pigs S1 and S2. Pig S4 shows a clear, smooth, long term attenuation as 
sepsis progresses. Unfortunately, the other longer survivor, Pig S3, shows sharp 
variations in its transfer function, although clear attenuation is evident towards the end 
of monitoring. Pigs S4 and S5 shows a sharp peak appearing at the respiratory 
frequency towards the end of the monitoring period, which is also visible in Fig. 9.2. 
Fig. 9.3 shows the phase plot for the transfer function between Pao and Pfe. There is a 
phase lag at heartbeat frequency of about 30° – 50° which corresponds with what one 
would physiologically expect between Pao and Pfe. The magnitude of this phase lag 
varies over the course of the protocol, and clear trends are difficult to establish across 
all pigs. Above the heartbeat frequency, phase lag rapidly increases, resulting in a need 
to restrict the scale.  
There is generally a slight phase lead present at breathing frequency, which is 
interesting. As the aorta is in the thoracic cavity and the femoral artery is not, breathing 
directly effects Pao, but not Pfe. Fig. S5 shows the surface phase plots for the transfer 
function between Pao and Pfe. This plot confirms observations made from Fig. 9.3, 
namely that phase generally remains consistent for a given frequency regardless of 
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interventions, with only slight variations and no clear trends. Thus, there appears to be 
minimal clinical information in the phase plot and values. 
Overall, a major question to be raised is whether these transfer functions provide 
additional information that is easier to interpret than what is directly available from 
observing Pao and Pfe. Clinicians are already presented with a large volume of 
information in the intensive care unit (ICU), and additional diagnostic aids should seek 
to reduce the clinical burden of interpreting these large volumes of information. As 
such, due to the lack of clear and consistent trends between pigs and the relatively 
involved process of interpreting the figures, this process would offer more in the way 
of interesting insight into cardiovascular behaviour than useful direct diagnostic 
information or aid. 
A notable limitation of this method is that both Pao and Pfe are located upstream from 
the capillary beds of the systemic circulation, which are the physiological structures 
most effected by sepsis, as it is disease of the micro-circulation. Intuitively, one would 
expect the transfer function between Pfe and central venous pressure (Pvc) would 
provide better or further information about the state of these capillary beds. However, 
there are several difficulties involved with using Pvc, all of which stem from the low 
pressures present in the vena cava and venous circulation in general.  
First, discretisation error becomes large due to the amplitude of Pvc, roughly 8 mmHg 
to 12 mmHg [30], which is not significantly larger than pressure catheter resolution, 
resulting in a series of step changes rather than smooth contours. Second, as discussed 
in Chapter 2, Pvc is significantly affected by the behaviour of the right heart, which is 
the source of the ‘A’ and ‘C’ peaks in the signal, which have a roughly equal magnitude 
to the ‘V’ peak from upstream flow [46]. As such, a large amount of post processing 
would be necessary to make Pvc usable in a transfer function, likely resulting in the loss 




A method was developed to process aortic and femoral pressure waveforms into a form 
appropriate for developing a transfer function between the two. This method involved 
grouping the waveforms into sets of 8, and adjusted the signal such that they began and 
ended at 0. Transfer functions were developed for 5 pigs undergoing the progression 
of a model of septic shock, accompanied by several clinical interventions such as 
recruitment manoeuvres and fluid infusions. While the transfer functions matched 
physiologically expected behaviour, clear, consistent trends associated with diagnostic 
or monitoring potential were difficult to identify. As such, the next chapter explores 
alternative approaches that could provide a similar input/output focused methodology 
as a transfer function, while incorporating more a-priori physiological information and 










Arterial Waveform Energetics 
With transfer functions failing to provide clearly interpretable information directly 
from circulatory waveforms, due to the assumption of linear behaviour and large 
amounts of output data, an alternative method was explored. This method involves 
using a-priori knowledge to identify regions of circulatory waveforms that are linearly 
related, and employing these regions as inputs and outputs to a simple model. This 
combination of a-priori knowledge to select regions of circulatory waveforms and 
simple outputs aims to address the weaknesses of the method attempted in Chapter 9. 
10.1 Background 
As discussed in Chapter 2, the circulatory system can be broken down into pulmonary 
and systemic circulations. Due to the smaller diameter of arteries and veins in the 
pulmonary circulation, catheters are typically placed in the systemic circulation instead 
[46], popularly in the aorta, femoral artery or vena cava [47-49]. The catheter measured 
pressure waveform passing through the systemic circulation is modulated by the 
systemic circuit. Thus, the evolution of the pressure waveform from the aorta to the 
femoral artery and to the vena cava contains information on the condition of the 
systemic circulation. As the systemic circulation passes through every organ in the 
body, the state of the systemic circulation should contain a great deal of information 
about patient condition. There is potential to extract this information directly from the 
catheter pressure waveforms, without first having to model the entire circulatory 




Several existing methods compare input and output waveforms without specific 
modelling of the associated systems. Transfer functions, as explored in Chapter 9, are 
among the most common, generated using either fast Fourier transforms [168] or 
empirical mode decomposition [169]. While these two methods are adept at extracting 
information directly from waveforms, neither method is able to directly leverage the 
extensive a-priori knowledge available on the circulatory system. Further, both 
methods provide full spectra for every set of heartbeats analysed, an output that is not 
necessarily any easier to interpret than the initial waveforms, as demonstrated in 
Chapter 9. More specifically, and in contrast, clinical practice favours very simple, 
lumped approximations of the entire waveform, such as mean arterial pressure (MAP) 
and mean venous pressure (MVP) [46]. Hence, the metrics obtained must also be 
readily interpreted by clinical staff, while ensuring physiological and clinical relevance. 
This chapter proposes a method for bridging this gap between the complexity of 
information available and the simple, lumped values favoured clinically. It focuses on 
comparing timing, amplitude and mean values between analogous sections of the 
aortic, femoral and vena cava pressure waveforms. Similar to a transfer function, it is 
a direct comparison of an input to an output, but operates in the time domain and 
provides simple, lumped outputs instead of a full spectrum. This method has the 
potential to provide outputs for easy, rapid interpretation in a clinical environment, 
while retaining more information from the underlying pressure waveforms than the 
lumped parameters currently popular in critical care.  
10.2 Methods 
The method involves two distinct input-output comparisons. The first is between the 
aortic pressure (Pao, input) to femoral pressure (Pfe, output) and encompasses only the 
arterial system. The second is between the femoral pressure (Pfe, input) and vena cava 
pressure (Pvc, output) and encompasses both the arterial and venous systems. 
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10.2.1 From Aortic Pressure (Pao) to Femoral Pressure (Pfe) 
Both Pao and Pfe are situated in the arterial half of systemic circulation, and have very 
similar waveforms [46]. The primary distinction is the dicrotic notch in Pao, which is a 
sharp dip in pressure due to the aortic valve shutting at the end of systole. Due to the 
elastic nature of the arterial system, this sharp dip has been smoothed out by the time 
the pressure wave reaches the femoral artery, and thus is not present in Pfe. This 
difference must be accounted for when comparing the two waveforms. The process 
used to compare Pao and Pfe is thus defined: 
1. Select Pao and Pfe for a set of four heartbeats from beat i to beat i+3. A set of 
four heartbeats corresponds to approximately one breathing cycle as set by the 
mechanical ventilator (15 bpm), and thus minimises extreme fluctuations in 
the results. 














𝑡max (𝑃𝑓𝑒,𝑖) − 𝑡max (𝑃𝑎𝑜,𝑖)
⋮  ⋮
𝑡max (𝑃𝑓𝑒,𝑖+3) − 𝑡max (𝑃𝑎𝑜,𝑖+3)
𝑡min (𝑃𝑓𝑒,𝑖) − 𝑡min (𝑃𝑎𝑜,𝑖)
⋮  ⋮













where, for example, tmax(Pfe,i) represents the peak timing of the i
th beat of Pfe. 
δao→fe is thus a positive value, in ms, representing the amount of time by which 
Pfe lags Pao. 
3. Shift Pao right by δao→fe such that the peaks and troughs of Pao are aligned with 
those of Pfe. Henceforth, ?̂?𝑎𝑜 refers to Pao that has undergone this phase shift 
alignment. 
4. Use linear least squares on the regions of the aligned ?̂?𝑎𝑜 and Pfe to find relative 



































































where relative amplitude is Aao→fe, offset is Oao→fe, and α is a fixed value, 
typically set α = 0.2 s, of additional data prior to 𝑡min(?̂?𝑎𝑜) that is relevant to 
identification. These regions are highlighted in Fig. 10.1, and minimise the 
influence of the dicrotic notch on the linear least squares process. 
The resulting metrics characterising the relationship between the two pressure 
waveforms are the phase lag, δao→fe, the relative amplitude, Aao→fe, and the pressure 
offset, Oao→fe. 
 
Fig. 10.1: Pao scaled, offset and phase shifted to match Pfe. Bolded regions are those 
used in the linear least squares process. 
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10.2.2 From Femoral Pressure (Pfe) to Central Venous Pressure 
(Pvc) 
Pfe and Pvc differ significantly, in both magnitude and shape. Between the femoral 
artery and the vena cava sit the capillary beds of the systemic circulation, where vessel 
diameter and flow rate drop significantly [46]. Due to the resulting low magnitude of 
Pvc, the downstream behaviour of the right atria and ventricle exert significant effects 
on the waveform. The results of these downstream influences on Pvc must be ignored 
when attempting to interpret Pvc as a result of upstream Pfe. Thus, the region between 
the ‘V’ peak and the ‘Y’ trough of Pvc is used for linear least squares, as shown in Fig. 
10.2, while the ‘A’ peak and ‘C’ peaks, which are the results of downstream atrial and 
ventricular behaviour [46], are ignored. The ‘V’ peak can typically be identified as the 
peak sitting in the latter half of the Pvc waveform for a given heartbeat, and the ‘Y’ 
trough as the trough directly following the ‘V’ peak. 
 
Fig. 10.2: Pfe scaled, offset and phase shifted to match Pvc. Bolded regions are those 
used in the linear least squares process. 
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Unlike Pao and Pfe, the i
th beat of Pfe (Pfe,i) likely does not correspond to the i
th beat of 
Pvc (Pvc,i) as a pressure wave takes longer than a single heartbeat to pass through the 
systemic circulation. This point is expressed by Pfe,i corresponding instead to  Pvc,i+j, 
where ‘j’ is found on a subject specific basis by the optimisation problem: 





Eq. 10.3 yields the value of j providing the best agreement in directional peak to peak 
variation between Pvc and Pfe. This process functions by aligning the inter-beat Pfe and 
Pvc waveforms based on their response to lower frequency influences, such as 
breathing. The fact that, while unbound, j is consistently found to be j = 3 supports the 
validity of this approach, which yields a consistent and physiologically reasonable 
result.  
Thus, the final process used to compare Pfe and Pvc is defined: 
1. Select 4 heartbeats for both Pfe and Pvc, from the beginning of beat i to the end 
of beat i+3 for Pfe and from the beginning of beat i+j to the end of beat i+j+3 
for Pvc.  














𝑡max (𝑃𝑣𝑐,𝑖+𝑗) − 𝑡max (𝑃𝑓𝑒,𝑖)
⋮  ⋮
𝑡max (𝑃𝑣𝑐,𝑖+𝑗+3) − 𝑡max (𝑃𝑓𝑒,𝑖+3)
𝑡min (𝑃𝑣𝑐,𝑖+𝑗) − 𝑡min (𝑃𝑓𝑒,𝑖)
⋮  ⋮













note that tmax(Pvc) refers specifically to the ‘V’ peak of the waveform. δfe→vc is 
once again a positive value, in ms, this time representing the amount of time 
by which Pvc lags Pfe. 
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3. Shift Pfe right by δfe→vc such that the peaks and troughs of Pfe are aligned with 
those of Pvc. Henceforth, ?̂?𝑓𝑒 refers to Pfe that has undergone this phase shift, 
and is thus aligned with Pvc. 

































































where relative amplitude is Afe→vc, and offset is Ofe→vc. These regions are 
highlighted in Fig. 10.2, and minimise the influence the upstream behaviour of 
the right atria and ventricle on the linear least squares process. 
Once again, the parameters of interest are the phase lag, δfe→vc, the relative amplitude, 
Afe→vc, and the pressure offset, Ofe→vc. 
10.2.3 Experimental Data 
This chapter makes use of the 5 Protocol S pigs not subject to exclusion. The 
waveforms employed are continuously sampled Pao, Pfe and Pvc as method inputs and 
outputs for the derivation of both novel and current clinical metrics. 
10.2.4 Analyses 
The analysis of trends in the selected metrics will be largely qualitative, and focuses on 
the response of these metrics to clinical interventions. It’s worth noting that all metrics 
employed are relative, rather than absolute. These metrics focus on the change in 
pressure waveforms as they pass through the systemic circulation, rather than absolute 
values of these waveforms, which comprise many existing clinical metrics. The best 
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point of comparison for these metrics in current clinical practice are MAP and MVP, 
as well as the difference between the two ΔMP = MAP – MVP, a surrogate for systemic 
resistance [46] and broadly analogous to Ofe→vc. Thus, in comparing relative values to 
absolute values, it is the response to intervention or disease state that is critical in 
assessing diagnostic value. 
Here, comparisons in this analysis focus on the relative sensitivity of the novel and 
established clinical metrics to clinical interventions and changes in condition, and thus 
their relative clinical relevance as potential diagnostic aides. Comparisons encompass 
direct observation of the trends present, as well as presentation of p-values for a 
Wilcoxon signed-rank test comparing pre- and post- endotoxin behaviour [170].  
10.3 Results 
Fig. 10.3 presents the phase lag δao→fe, the relative amplitude Aao→fe, and the pressure 
drop Oao→fe, and Tables 10.1 – 10.2 the associated Wilcoxon signed-rank test p-values 
for pre- and post- endotoxin infusion. 
Table 10.1: Pre- and post- endotoxin comparison of δao→fe and Aao→fe, including 
associated Wilcoxon signed-rank test p-values, for aorta to femoral artery. The 
notation ‘up’ and ‘dn’ denote a statistically significant increase or decrease in the 
respective metric post endotoxin infusion. 





0.07 (0.01 - 0.09) 0.00 
dn 
1.47 (1.36 - 1.51) 0.00 
dn 0.04 (-0.15 - 0.09) 0.78 (0.30 - 1.21) 
S2 
0.13 (0.12 - 0.14) 0.00 
up 
1.33 (1.24 - 1.37) 0.00 
dn 0.15 (-0.01 - 0.14) 1.09 (0.31 - 1.29) 
S3 
-0.07 (-0.08 - -0.01) 0.00 
up 
0.88 (0.68 - 1.27) 0.00 
dn 0.10 (-0.05 - -0.01) 0.37 (0.32 - 0.47) 
S4 
0.13 (0.12 - 0.14) 0.12 
– 
1.49 (1.46 - 1.53) 0.00 
dn 0.13 (0.01 - 0.14) 1.15 (0.86 - 1.24) 
S5 
0.11 (0.10 - 0.12) 0.00 
up 
1.69 (1.53 - 1.74) 0.00 






Fig. 10.3: Novel metrics for aorta to femoral artery for all 5 Protocol S pigs. 
Transition from cyan to red or black to grey (where present) denotes pre- and post- 
endotoxin infusion regions in novel and current clinical metrics respectively. 
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Table 10.2: Pre- and post- endotoxin comparison of Oao→fe and MAP, including 
associated Wilcoxon signed-rank test p-values, for aorta to femoral artery. The 
notation ‘up’ and ‘dn’ denote a statistically significant increase or decrease in the 









1.18 (0.98 - 1.51) 0.49 
– 
60.1 (57.8 - 63.0) 0.00 
dn 0.99 (0.70 - 2.35) 34.8 (23.5 - 58.2) 
S2 
-1.91 (-3.01 - -0.63) 0.00 
dn 
52.4 (50.2 - 54.5 0.00 
dn -5.57 (-6.51 - -4.15) 41.0 (17.7 - 45.5) 
S3 
-8.65 (-11.68 - -5.85) 0.00 
dn 
83.0 (78.6 - 85.0 0.00 
dn -9.56 (-15.51 - -6.74) 60.7 (46.3 - 71.7) 
S4 
-0.64 (-1.80 - -0.12) 0.00 
up 
45.4 (44.2 - 47.6 0.00 
dn -0.17 (-0.55 - 3.68) 40.6 (37.1 - 42.3) 
S5 
1.42 (0.70 - 2.11) 0.00 
dn 
49.6 (47.2 - 50.3 0.00 
dn -1.37 (-7.85 - 0.23) 36.2 (16.8 - 43.1) 
 
From Tables 10.1 – 10.2 it is apparent that 2 metrics, relative amplitude and MAP, 
showed consistent, significant changes in a unified direction across the endotoxin 
infusion.  From Fig. 10.3 there are a number of interesting observations to make. Phase 
lag shows consistent spikes during recruitment manoeuvres, but inconsistent changes 
post endotoxin infusion. MAP and relative amplitude show very similar profiles, 
though long term trends can be quite different. Pressure drop can quite frequently be 
negative, which is not entirely unexpected as Pfe regularly has a larger peak pressure 
than Pao due to the narrower cross section of the femoral artery compared to the aorta. 
However, as expected, large negative spikes in pressure drop consistently occur post 
endotoxin infusion. 
Fig. 10.4 presents the phase lag, δfe→vc, relative amplitude, Afe→vc, and pressure drop, 
Ofe→vc, and Tables 10.3 – 10.4 the associated Wilcoxon signed-rank test p-values for 
pre- and post- endotoxin infusion. Tables 10.3 – 10.4 show all metrics change 
consistently and significantly between pre- and post- endotoxin infusion. This result 
matches expectations as the area between the femoral artery and vena cava includes the 
capillary beds and micro-circulation most effected by septic shock [88]. Phase lag 
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consistently decreases overall, though Fig. 10.4 shows this median decrease is 
accompanied by large variations. Relative amplitude and MVP consistently increase as 
well, in a broadly steady manner. Pressure drop and ΔMP consistently fall, as would 
be expected, corresponding to the loss in systemic resistance associated with sepsis.  
Table 10.3: Pre- and post- endotoxin comparison of δfe→vc and Afe→vc, including 
associated Wilcoxon signed-rank test p-values, for femoral artery to vena cava. The 
notation ‘up’ and ‘dn’ denote a statistically significant increase or decrease in the 
respective metric post endotoxin infusion. 





3.20 (3.19 - 3.21) 0.00 
dn 
0.01 (0.01 - 0.02) 0.00 
up 3.19 (3.18 - 3.22) 0.18 (0.01 - 8.00) 
S2 
2.80 (2.76 - 2.81) 0.00 
dn 
0.06 (0.06 - 0.07) 0.00 
up 2.76 (2.72 - 2.97) 0.21 (0.06 - 1.69) 
S3 
2.33 (2.32 - 2.35) 0.00 
dn 
0.15 (0.15 - 0.30) 0.00 
up 2.32 (2.32 - 2.36) 0.75 (0.15 - 1.38) 
S4 
2.98 (2.96 - 2.99) 0.00 
dn 
0.07 (0.07 - 0.11) 0.00 
up 2.96 (2.97 – 3.03) 0.15 (0.07 - 0.23) 
S5 
3.45 (3.44 - 3.47) 0.00 
dn 
0.05 (0.05 - 0.08) 0.00 
up 3.44 (3.40 - 3.45) 0.14 (0.05 - 0.60) 
 
Table 10.4: Pre- and post- endotoxin comparison of Ofe→vc and ΔMP, including 
associated Wilcoxon signed-rank test p-values, for femoral artery to vena cava. The 
notation ‘up’ and ‘dn’ denote a statistically significant increase or decrease in the 









43.4 (41.5 - 45.8) 0.00 
dn 
48.1 (45.9 - 50.8) 0.00 
dn 19.6 (9.4 - 41.5) 20.6 (3.1 - 45.4) 
S2 
44.8 (42.9 - 46.4) 0.00 
dn 
46.1 (44.9 - 47.2) 0.00 
dn 38.2 (19.9 - 42.9) 33.4 (4.9 - 38.0) 
S3 
81.6 (79.8 - 83.9) 0.00 
dn 
77.8 (73.9 - 79.2) 0.00 
dn 59.6 (45.0 - 79.8) 54.4 (35.9 - 65.1) 
S4 
33.4 (32.9 - 34.8) 0.00 
dn 
34.1 (33.0 - 36.8) 0.00 
dn 26.9 (22.1 - 32.9) 27.6 (25.4 - 28.5) 
S5 
40.8 (37.9 - 41.7) 0.00 
dn 
45.5 (42.0 - 46.6) 0.00 







Fig. 10.4: Novel metrics for femoral artery to vena cava for all 5 Protocol S pigs. 
Transition from cyan to red or black to grey (where present) denotes pre- and post- 




10.4.1 Pao to Pfe 
The phase lag between the aorta and femoral artery failed to show a consistent, 
statistically significant shift between pre- and post- endotoxin infusion. Consistent 
increases in phase lag occurred during recruitment manoeuvres, as the inflated lungs 
increase resistance to flow from the aorta in the thoracic cavity [171]. The presence of 
negative phase lag, while not physiological, can be explained by the short time taken 
to travel from the aorta to the femoral artery (≈0.1s) compared to the length of each 
heartbeat (≈0.8s). As the phase lag calculated was peak-to-peak lag, and the relative 
position of the peak within both the Pao and Pfe waveforms shifts distinctly in certain 
regions, this negative lag could result if the peak of Pfe occurred roughly in line with 
that of Pao, or even well before it in late sepsis when the waveforms become highly 
distorted [117]. Thus, these regions still represent a physiological change, but are 
difficult to interpret for clinical use with regards to pulse wave velocity. 
The relative pulse amplitude between aorta and femoral artery, along with the 
comparable MAP, showed consistent, statistically significant, downward shifts post-
endotoxin infusion. The fall in relative pulse amplitude corresponds to the loss in 
arterial tone experienced in sepsis [172], resulting in significant pulse energy being lost 
in the arterial system. Both metrics also showed consistent decreases during 
recruitment manoeuvres, again consistent with the increase in thoracic pressure and 
depression of the circulatory system associated with these manoeuvres. It is possible 
variations in long term trends between MAP and relative amplitude are due to MAP 
responding to filling and relative amplitude, being a relative metric, not responding to 
filling. For example, in Pig S1 at roughly beat 4000, filling causes an increase in MAP 
while relative amplitude remains unchanged. Additionally, at roughly beat 9000 in Pig 
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S4, filling causes MAP to remain roughly level, while relative amplitude shows a 
steady decrease as sepsis develops and arterial tone is lost. 
The pressure drop between the aorta and femoral artery failed to show a consistent, 
clear shift between pre- and post- endotoxin infusion. However, there are several 
topographical features of note. First, the pressure drop tends to increase during 
recruitment manoeuvres, in line with the behaviour of the previous metrics. Second, 
post endotoxin infusion all pigs show at least one sharp, but temporary, decrease in the 
pressure drop, corresponding to a significant increase in Pfe relative to Pao. It would 
seem likely this drop is due to Pao falling significantly and Pfe following suit slightly 
later, where it is important to note that the pressure wave travels faster than the blood 
itself, which is the cause of this lag. 
10.4.2 Pfe to Pvc 
The phase lag between femoral artery and vena cava showed a statistically significant 
change in all cases. While the mean values fell consistently, observation of the quartiles 
or the visual trend lines show Pigs S2 and S4 appear to see an increase in phase lag, 
while Pigs S3 and S5 see a fall in phase lag. There is a consistent decrease in phase lag 
during recruitment manoeuvres. This decrease is interesting as the opposite might be 
expected due to the vena cava, which is in the thoracic cavity, being upstream of the 
femoral artery, which is not in the thoracic cavity.  
The relative amplitude between the femoral artery and vena cava, along with MVP, 
consistently and significantly rose as sepsis developed. This result matches 
expectations, as sepsis causes a fall in systemic resistance as capillary beds, resulting 
in reduced attenuation of the pulse wave as well as absolute pressure [11]. In general, 
trends in MVP and relative amplitude match, with the main exception being Pig S3, 
where some disruption to the femoral catheter occurred during the experiment.  
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Finally, the pressure drop between the femoral artery and vena cava, along with ΔMP, 
both showed consistent, significant decreases as sepsis progressed. These results also 
agree well with the reduced systemic resistance typically observed during the 
progression of sepsis, as capillaries dilate and fluid is lost. Both trend lines show very 
close resemblance, and clear, consistent long term trends. A decease in both metrics 
occurs during recruitment manoeuvres, likely due to Pvc increasing due to being in the 
thoracic cavity, and Pfe decreasing due to upstream resistance.  
10.4.3 Novel and Clinical Metrics 
The novel metrics provide a set of interacting parameters designed to express the 
changes in a single pressure pulse as it moves through the systemic circulation. Several 
of these metrics were demonstrated to be consistently sensitive to changes in systemic 
circulation caused by sepsis. However, the analysis failed to demonstrate these metrics 
provide significant additional, physiologically significant information to that already 
available from clinical metrics such as MAP, MVP and ΔMP.  
As such, further analysis should be undertaken to compare not just whether the metrics 
are sensitive to changes induced by sepsis, but how sensitive and on what timescale 
these changes can be registered. The novel metrics do not require any more 
instrumentation to calculate than these existing metrics, and only minimal 
computational effort. However, without further analysis it is difficult to provide a clear 
case for their clinical use from the data presented.  
10.5 Summary 
A method was developed to use simple, lumped parameters to express the changes to 
a pressure pulse as it passed through the systemic circulation, with the goal of providing 
easy to interpret diagnostic information in a clinical environment. This model was 
evaluated on an animal model of sepsis, encompassing 5 pure Piétrain pigs and 
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compared to common lumped clinical metrics. While several model parameters 
demonstrated consistent, physiologically expected changes in response to sepsis, these 
changes were not demonstrably clearer or more consistent than those present in existing 
clinical metrics. While the novel method presented requires no additional clinical 
instrumentation or effort over existing metrics, further analysis of the degree and 








The main accomplishment of this thesis was developing a coherent, interlinked 
framework for the non-additionally invasive model-based and computational 
estimation of a number of clinically relevant cardiovascular metrics around the 
pressure-volume (P-V) loop, the concept of elastance, and the P-V loop itself. P-V 
loops and elastance are central to titrating clinical care. These metrics thus have the 
potential to aid in real-time clinical decision making at the patient bedside, closing the 
gap between the clinician’s conceptual model of underlying behaviour, and the surface 
level measured, and summarised metrics clinically available, which typically result in 
care based on simplistic, population responses instead of patient-specific responses. 
This outcome is accomplished by using simple, physiological models and computation 
to extract much more information from the variety of waveforms and metrics currently 
measured in the intensive care unit (ICU), creating a much clearer physiological and 
patient-specific picture for the clinician, and decision making. 
While there exist a variety of methods using similar approach to model a small part of 
the circulatory system, or estimate one of the various parameters estimated here, there 
is no comprehensive and cohesive framework for estimating the full family of 
physiological metrics. Similarly, there is no current framework for the non-additionally 
invasive estimation of the cardiac P-V loop, which is not directly available and sits at 




non-additionally invasive methods to obtain these P-V loops within this overall 
methodological framework. 
Chapters 3 – 8 cover the development of this framework for estimating this set of 
interlinked, popular, but currently clinically unavailable, physiological metrics. 
Specifically, Chapter 3 develops a simple model for estimation of the time varying 
elastance curve (TVE), which, similar to what was originally postulated in prior works, 
had a fixed shape with only timing subject to alteration. This approach provided a 
significant improvement over a fixed TVE curve as an input to larger models, but, 
understandably, held little additional diagnostic information in and of itself. Chapter 4 
developed a method for the non-additionally invasive estimation of the unstressed or 
‘dead space’ volume (Vd) of the left ventricle, a metric that traditionally requires highly 
invasive experimental procedures to measure or even estimate, and which may have 
direct diagnostic use. Chapter 5 looked at non-invasive estimation of the ESPVR, and 
thus Ves and Ved, which, combined with existing methods, provides typically 
unmeasured beat-by-beat ventricular volume profile information, as well as important 
clinical surrogates, such as Ved, a clinical surrogate for cardiac preload.  
Chapter 6 drew together developments of Chapters 4 and 5 to provide a more in depth 
and physiological estimation of the TVE curve, using underlying estimation of left-
ventricular pressure (Plv), volume (Vlv) and Vd to avoid assuming a fixed shape for the 
TVE curve itself. This approach preserves the dynamic shapes and thus potential 
diagnostic information in the TVE curve. The approach demonstrated a statistically 
significant improvement in error over the more static approach presented in Chapter 3. 
Chapter 7 employed the method used to estimate the TVE curve for the direct 
estimation of the P-V loop instead. While the P-V loop uses the same inputs as the TVE 
curve, specifically Vlv and Plv, the lack of normalisation and direct use of these 
waveforms means more clinical information is preserved, but also requires the 
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underlying model to be more accurate, as sources of error are not potentially attenuated 
by normalisation. This chapter demonstrated the method was capable of tracking trends 
in important clinical metrics derived from the P-V loop, such as stroke work, and in 
accurately locating the P-V loop itself, which are major advances over what is currently 
available today. 
Chapter 8 compared experimentally standard, but highly invasive and clinically 
unavailable, estimation of ventricular volume at zero pressure (V0) and the end-systolic 
pressure-volume relation (ESPVR) from a vena cava occlusion with the method 
presented in Chapter 4. An exponential fit helped account for the action of cardiac 
reflexes during the short occlusion period, providing a more accurate estimate of V0 
subject to these conditions than a linear fit, and one that broadly agreed with the 
estimates of Vd from Chapter 4. 
Finally, Chapters 9 and 10 explored an energetics based approach to directly extracting 
information from arterial and venous waveforms, and the relationships between them. 
Chapter 9 explored using transfer functions to compare the aortic and femoral 
pressures. While physiologically expected results were found, the spectral outputs from 
the transfer function were found to be too complicated for efficient use in an ICU 
environment. Chapter 10 explored a simpler means of comparing the aortic, femoral 
and central venous pressures, characterising each waveform as subject to a phase and 
magnitude offset as well as a scaling factor. This approach demonstrated sensitivity to 
changes in condition due to sepsis, and provided simple, intuitive metrics as outputs. 
However, its sensitivity relative to current clinically standard metrics, such as mean 
arterial (MAP) and venous (MVP) pressures, and the difference between them (ΔMP), 
needs to be further assessed.  
The methods developed in this thesis avoid the risks of parameter trade-off and 
identifiability inherent in larger, close looped models by combining a number of 
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smaller, open loop models where simultaneous parameter identification and non-linear 
least squares are not employed. At the same time, the methods developed in this thesis 
better leverage clinically available information to provide a cohesive, interlinked 
framework for the estimation of clinically relevant parameters. The potential to provide 
these parameters, which are familiar to clinicians, in a non-additionally invasive 
manner in real-time at the patient bedside has the potential to aid in clinical decision 








There are, as always, a variety of future avenues to extend and complement the research 
presented in this thesis. The following section presents several examples of such 
potential future work. 
12.1 Further Model Validation 
There are several possible paths for further validation of the work presented in this 
thesis. Most obviously, validation of the model on retrospective human clinical data 
would provide benefits in confirming the models’ applicability to the target species. 
However, the various metrics estimated are, as aforementioned, too invasive to measure 
directly in a clinical environment. Thus, such a validation would rely on expected 
trends in these clinical metrics subject to certain interventions or changes in condition, 
rather than a direct comparison to a gold standard invasive measurement. 
A second path for further validation is the validation of the work presented in this thesis 
across several other disease states that effect different parts of the cardiovascular 
system (CVS). For example, pulmonary embolism effects primarily the pulmonary, 
rather than systemic circulation, unlike sepsis. Further, method applicability to intra-
ventricular conditions such as arrhythmia and valvular dysfunction should be validated, 
as these conditions must manifest in the aortic pressure waveform for the model to 
detect them. However, the model has already been validated across sepsis, which is a 




directly alter elastance, where a number of key assumptions and the arguable focus of 
this thesis lie. Thus, the model framework presented in this thesis has been validated 
across a solid, challenging base of experimental data and cardiovascular conditions. 
12.2 Clinical Sensitivity of Metrics 
Several of the metrics that are clinically estimated by the modelling framework 
presented here have had only limited studies into their sensitivity to a variety of 
potential influences and conditions. In particular, the time varying elastance (TVE) 
curve and ventricular ‘dead space’ volume (Vd) and their response to various stimuli is 
not well documented due, in part, to the traditional difficulty in measuring or estimating 
these parameters under clinical conditions. An exploration of how TVE and Vd change 
in response to various clinical interventions and disease states, as well as a validation 
of the model’s ability to track these changes, and potential diagnostic significance 
should be undertaken. 
12.3 Incorporation of EDPVR 
With the end-systolic pressure-volume relation (ESPVR) incorporated into the method 
already, and Vd available, incorporation of the end-diastolic pressure volume relation 
(EDPVR) into the model would allow full characterisation of the contractile state of 
the heart, and the boundaries of the pressure-volume (P-V) loop. Specifically, when 
combined with clinically estimated end-diastolic volume (Ved), this would allow beat-
by-beat estimation of the diastolic pressure in the ventricle (Pdia), which is currently set 
to a constant value in the model. While this would be beneficial, it is worth noting that 
the typical shape of the EDPVR demonstrates the relative insensitivity of Pdia, as 
compared to systolic pressure in the ventricle (Psys), to changes in volume, thus 




12.4 Arterial Energetics Sensitivity 
Finally, further exploration of relative sensitivity of the metrics developed in Chapter 
10 is needed. While these metrics demonstrated consistent sensitivity to changes in the 
systemic circulation induced by sepsis, whether or not these metrics provide more 
information than is currently available clinical estimates such as mean arterial (MAP) 
and venous (MVP) pressures, and the difference between them (ΔMP) needs to be 
further explored. Specifically, the relative temporal sensitivities of these two sets of 
metrics should be compared, as sepsis is a fast acting condition [11, 33, 117, 172, 173] 
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